Header Logo

JOSEPH JANKOVIC

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
Address7200 CAMBRIDGE
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    U10NS044441     (JANKOVIC, JOSEPH)Sep 30, 2002 - Nov 30, 2015
    NIH
    Clinical center for the study of neuroprotection from PD
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mehanna R, Jankovic J. Systemic Symptoms in Huntington's Disease: A Comprehensive Review. Mov Disord Clin Pract. 2024 Mar 26. PMID: 38529740.
      Citations:    
    2. Terravecchia C, Mostile G, Chisari CG, Rascun? C, Terranova R, Cicero CE, Giuliano L, Donzuso G, Sciacca G, Luca A, Preux PM, Jankovic J, Zappia M, Nicoletti A. Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights: Response. J Neuroophthalmol. 2024 Mar 11. PMID: 38466367.
      Citations:    Fields:    
    3. Baizabal-Carvallo JF, Cavanna AE, Jankovic J, Baizabal-Carvallo JF, Jankovic J. Tics emergencies and malignant tourette syndrome: Assessment and management. Neurosci Biobehav Rev. 2024 Apr; 159:105609. PMID: 38447821.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Jankovic J. Is Dystonia an Immunologic Disorder? Parkinsonism Relat Disord. 2024 Feb 29; 106084. PMID: 38462402.
      Citations:    Fields:    
    5. Rodriguez-Porcel F, Sarva H, Joutsa J, Falup-Pecurariu C, Shukla AW, Mehanna R, Smilowska K, Lanza G, Filipovic SR, Shalash A, Ferris M, Jankovic J, Espay AJ, Pandey S, Post-Stroke Movement Disorders Study Group from the Movement Disorders Society. Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members. J Neurol Sci. 2024 Mar 15; 458:122925. PMID: 38340409.
      Citations:    Fields:    Translation:Humans
    6. Comella CL, Jankovic J, Hauser RA, Patel AT, Banach MD, Ehler E, Vitarella D, Rubio RG, Gross TM, ASPEN-1 Study Group. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial. Neurology. 2024 02 27; 102(4):e208091. PMID: 38295339; PMCID: PMC10962918.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    7. Yuan L, Chen X, Jankovic J, Deng H. CADASIL: A NOTCH3-associated cerebral small vessel disease. J Adv Res. 2024 Jan 02. PMID: 38176524.
      Citations:    Fields:    
    8. Anandan C, Jankovic J. Botulinum toxin treatment in parkinsonism. J Neurol Sci. 2024 Jan 15; 456:122810. PMID: 38056063.
      Citations:    Fields:    Translation:Humans
    9. Junker J, Hall J, Berman BD, Vidailhet M, Roze E, B?umer T, Malaty IA, Shukla AW, Jankovic J, Reich SG, Espay AJ, Duque KR, Patel N, Perlmutter JS, Jinnah HA, Dystonia Coalition Study Group, Brandt V, Br?ggemann N. Longitudinal predictors of health-related quality of life in isolated dystonia. J Neurol. 2024 Feb; 271(2):852-863. PMID: 37839041; PMCID: PMC10827910.
      Citations:    Fields:    Translation:Humans
    10. Vollstedt EJ, Madoev H, Aasly A, Ahmad-Annuar A, Al-Mubarak B, Alcalay RN, Alvarez V, Amorin I, Annesi G, Arkadir D, Bardien S, Barker RA, Barkhuizen M, Basak AN, Bonifati V, Boon A, Brighina L, Brockmann K, Carmine Belin A, Carr J, Clarimon J, Cornejo-Olivas M, Correia Guedes L, Corvol JC, Crosiers D, Dam?sio J, Das P, de Carvalho Aguiar P, De Rosa A, Dorszewska J, Ertan S, Ferese R, Ferreira J, Gatto E, Gen? G, Giladi N, G?mez-Garre P, Hanagasi H, Hattori N, Hentati F, Hoffman-Zacharska D, Illarioshkin SN, Jankovic J, Jes?s S, Kaasinen V, Kievit A, Klivenyi P, Kostic V, Koziorowski D, K?hn AA, Lang AE, Lim SY, Lin CH, Lohmann K, Markovic V, Martikainen MH, Mellick G, Merello M, Milanowski L, Mir P, ?ztop-?akmak ?, Pimentel MMG, Pulkes T, Puschmann A, Rogaeva E, Sammler EM, Skaalum Petersen M, Skorvanek M, Spitz M, Suchowersky O, Tan AH, Termsarasab P, Thaler A, Tumas V, Valente EM, van de Warrenburg B, Williams-Gray CH, Wu RM, Zhang B, Zimprich A, Solle J, Padmanabhan S, Klein C. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project. PLoS One. 2023; 18(10):e0292180. PMID: 37788254; PMCID: PMC10547150.
      Citations:    Fields:    Translation:Humans
    11. Li T, Le W, Jankovic J. Linking the cerebellum to Parkinson disease: an update. Nat Rev Neurol. 2023 11; 19(11):645-654. PMID: 37752351.
      Citations: 2     Fields:    Translation:Humans
    12. Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Harary E, Alexander J, Barkay H, Gordon MF. Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study. Mov Disord Clin Pract. 2023 Sep; 10(9):1388-1398. PMID: 37772282; PMCID: PMC10525047.
      Citations: 1     
    13. Cotton AC, Scorr L, McDonald W, Comella C, Perlmutter JS, Goetz CG, Jankovic J, Marsh L, Factor S, Jinnah HA. Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient? Mov Disord Clin Pract. 2023 Sep; 10(9):1399-1403. PMID: 37772296; PMCID: PMC10525044.
      Citations:    
    14. Terravecchia C, Mostile G, Chisari CG, Rascun? C, Terranova R, Cicero CE, Giuliano L, Donzuso G, Sciacca G, Luca A, Preux PM, Jankovic J, Zappia M, Nicoletti A. Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights. J Neuroophthalmol. 2024 Mar 01; 44(1):35-40. PMID: 37523235; PMCID: PMC10855993.
      Citations:    Fields:    Translation:Humans
    15. Jankovic J, Tsui J, Brin MF. Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore). 2023 Jul 01; 102(S1):e32403. PMID: 37499081; PMCID: PMC10374188.
      Citations:    Fields:    Translation:Humans
    16. Vanegas-Arroyave N, Jankovic J. Spinal cord stimulation for gait disturbances in Parkinson's disease. Expert Rev Neurother. 2023 Jul-Dec; 23(7):651-659. PMID: 37345383.
      Citations:    Fields:    Translation:Humans
    17. Makhoul K, Jankovic J. Real-world experience with VMAT2 inhibitors in Tourette syndrome. J Neurol. 2023 Sep; 270(9):4518-4522. PMID: 37301806.
      Citations: 1     Fields:    Translation:Humans
    18. Deng X, Yuan L, Jankovic J, Deng H. The role of the PLA2G6 gene in neurodegenerative diseases. Ageing Res Rev. 2023 08; 89:101957. PMID: 37236368.
      Citations:    Fields:    Translation:Humans
    19. Jankovic J, Carruthers J, Naumann M, Ogilvie P, Boodhoo T, Attar M, Gupta S, Singh R, Soliman J, Yushmanova I, Brin MF, Shen J. Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX?) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins (Basel). 2023 05 17; 15(5). PMID: 37235376; PMCID: PMC10224273.
      Citations:    Fields:    Translation:Humans
    20. Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J. Contrasting features between Tourette syndrome and secondary tic disorders. J Neural Transm (Vienna). 2023 07; 130(7):931-936. PMID: 37117738; PMCID: PMC10144877.
      Citations:    Fields:    Translation:Humans
    21. Albanese A, Bhatia KP, Cardoso F, Comella C, Defazio G, Fung VSC, Hallett M, Jankovic J, Jinnah HA, Kaji R, Krauss JK, Lang A, Tan EK, Tijssen MAJ, Vidailhet M. Isolated Cervical Dystonia: Diagnosis and Classification. Mov Disord. 2023 08; 38(8):1367-1378. PMID: 36989390; PMCID: PMC10528915.
      Citations: 1     Fields:    Translation:Humans
    22. Lenka A, Jankovic J. Peripherally-induced Movement Disorders: An Update. Tremor Other Hyperkinet Mov (N Y). 2023; 13:8. PMID: 37008994; PMCID: PMC10064913.
      Citations:    Fields:    Translation:Humans
    23. Hull M, Parnes M, Jankovic J. Botulinum Neurotoxin Injections in Children with Self-Injurious Behaviors. Toxins (Basel). 2023 03 23; 15(4). PMID: 37104174; PMCID: PMC10141007.
      Citations:    Fields:    Translation:Humans
    24. Schneider SA, Desai S, Phokaewvarangkul O, Rosca EC, Sringean J, Anand P, Bravo G?, Cardoso F, Cervantes-Arslanian AM, Chovatiya H, Crosiers D, Dijkstra F, Fearon C, Grandas F, Guedj E, M?ndez-Guerrero A, Hassan M, Jankovic J, Lang AE, Makhoul K, Muccioli L, O'Shea SA, Ostovan VR, Perez-Sanchez JR, Ramdhani R, Ros-Castell? V, Schulte C, Shah P, Wojtecki L, Pal PK. COVID19-associated new-onset movement disorders: a follow-up study. J Neurol. 2023 May; 270(5):2409-2415. PMID: 36943516; PMCID: PMC10029788.
      Citations: 1     Fields:    Translation:Humans
    25. Baizabal-Carvallo JF, Jankovic J. The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome. J Mov Disord. 2023 May; 16(2):163-167. PMID: 36872859; PMCID: PMC10236012.
      Citations:    
    26. Lenka A, Jankovic J. How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease? Expert Rev Neurother. 2023 02; 23(2):107-122. PMID: 36803618.
      Citations: 1     Fields:    Translation:Humans
    27. Makhoul K, Jankovic J. Driving Impairment in Movement Disorders. Mov Disord Clin Pract. 2023 Mar; 10(3):369-381. PMID: 36949799; PMCID: PMC10026316.
      Citations:    
    28. Baizabal-Carvallo JF, Alonso-Juarez M, Jankovic J. Oromandibular tics associated with Tourette syndrome. J Neurol. 2023 May; 270(5):2591-2596. PMID: 36723683.
      Citations: 2     Fields:    Translation:Humans
    29. Baizabal-Carvallo JF, Jankovic J. Secondary dystonia following parenchymal brain tumors. J Neurol Sci. 2023 03 15; 446:120577. PMID: 36738494.
      Citations:    Fields:    Translation:Humans
    30. Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, Kasten M, Br?ggemann N, Borsche M, Foroud T, Tolosa E, Garrido A, Annesi G, Gagliardi M, Bozi M, Stefanis L, Ferreira JJ, Correia Guedes L, Avenali M, Petrucci S, Clark L, Fedotova EY, Abramycheva NY, Alvarez V, Men?ndez-Gonz?lez M, Jes?s Maestre S, G?mez-Garre P, Mir P, Belin AC, Ran C, Lin CH, Kuo MC, Crosiers D, Wszolek ZK, Ross OA, Jankovic J, Nishioka K, Funayama M, Clarimon J, Williams-Gray CH, Camacho M, Cornejo-Olivas M, Torres-Ramirez L, Wu YR, Lee-Chen GJ, Morgadinho A, Pulkes T, Termsarasab P, Berg D, Kuhlenb?umer G, K?hn AA, Borngr?ber F, de Michele G, De Rosa A, Zimprich A, Puschmann A, Mellick GD, Dorszewska J, Carr J, Ferese R, Satake W, Toda T, Rossi M, Merello M, Lynch T, Olszewska DA, Lim SY, Ahmad-Annuar A, Tan AH, Al-Mubarak B, Hanagasi H, Koziorowski D, Ertan S, Gen? G, de Carvalho Aguiar P, Barkhuizen M, Pimentel MMG, Saunders-Pullman R, van de Warrenburg B, Bressman S, Toft M, Appel-Cresswell S, Lang AE, Skorvanek M, Boon AJW, Kr?ger R, Sammler EM, Tumas V, Zhang BR, Garraux G, Chung SJ, Kim YJ, Winkelmann J, Sue CM, Tan EK, Dam?sio J, Kliv?nyi P, Kostic VS, Arkadir D, Martikainen M, Borges V, Hertz JM, Brighina L, Spitz M, Suchowersky O, Riess O, Das P, Mollenhauer B, Gatto EM, Petersen MS, Hattori N, Wu RM, Illarioshkin SN, Valente EM, Aasly JO, Aasly A, Alcalay RN, Thaler A, Farrer MJ, Brockmann K, Corvol JC, Klein C, MJFF Global Genetic Parkinson's Disease Study Group, Gambardella S, Chase B, Markopoulou K. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Mov Disord. 2023 02; 38(2):286-303. PMID: 36692014.
      Citations: 2     Fields:    Translation:Humans
    31. Defazio G, Gigante AF, Hallett M, Berardelli A, Perlmutter JS, Berman BD, Jankovic J, B?umer T, Comella C, Ercoli T, Ferrazzano G, Fox SH, Kim HJ, Moukheiber ES, Richardson SP, Weissbach A, Jinnah HA. Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysis. Parkinsonism Relat Disord. 2022 Nov; 104:94-98. PMID: 36306537.
      Citations:    Fields:    Translation:Humans
    32. Lu S, Ma M, Mao X, Bacino CA, Jankovic J, Sutton VR, Bartley JA, Wang X, Rosenfeld JA, Beleza-Meireles A, Chauhan J, Pan X, Li M, Liu P, Prescott K, Amin S, Davies G, Wangler MF, Dai Y, Bellen HJ. De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement. Am J Hum Genet. 2022 10 06; 109(10):1932-1943. PMID: 36206744; PMCID: PMC9606480.
      Citations: 4     Fields:    Translation:HumansAnimals
    33. Clark LN, Gao Y, Wang GT, Hernandez N, Ashley-Koch A, Jankovic J, Ottman R, Leal SM, Rodriguez SMB, Louis ED. Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology. EBioMedicine. 2022 Nov; 85:104290. PMID: 36183486; PMCID: PMC9525816.
      Citations:    Fields:    Translation:Humans
    34. Vu JP, Cisneros E, Zhao J, Lee HY, Jankovic J, Factor SA, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Richardson SP, Stebbins GT, Elble RJ, Comella CL, Peterson DA. From null to midline: changes in head posture do not predictably change head tremor in cervical dystonia. Dystonia. 2022; 1. PMID: 37101941; PMCID: PMC10128866.
      Citations: 1     
    35. Defazio G, Hallett M, Berardelli A, Perlmutter JS, Berman BD, Jankovic J, B?umer T, Comella C, Ercoli T, Ferrazzano G, Fox SH, Kim HJ, Moukheiber ES, Pirio Richardson S, Weissbach A, Gigante AF, Jinnah HA. Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational Study. Mov Disord Clin Pract. 2022 Oct; 9(7):949-955. PMID: 36247913; PMCID: PMC9547140.
      Citations: 1     
    36. Gadot R, Vanegas Arroyave N, Dang H, Anand A, Najera RA, Taneff LY, Bellows S, Tarakad A, Jankovic J, Horn A, Shofty B, Viswanathan A, Sheth SA. Association of clinical outcomes and connectivity in awake versus asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2023 04 01; 138(4):1016-1027. PMID: 35932263; PMCID: PMC10215008.
      Citations:    
    37. Lenka A, Di Maria G, Lamotte G, Bahroo L, Jankovic J. Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease. Expert Rev Neurother. 2022 06; 22(6):489-498. PMID: 35710101.
      Citations:    Fields:    Translation:Humans
    38. Hill EJ, Robak LA, Al-Ouran R, Deger J, Fong JC, Vandeventer PJ, Schulman E, Rao S, Saade H, Savitt JM, von Coelln R, Desai N, Doddapaneni H, Salvi S, Dugan-Perez S, Muzny DM, McGuire AL, Liu Z, Gibbs RA, Shaw C, Jankovic J, Shulman LM, Shulman JM. Genome Sequencing in the Parkinson Disease Clinic. Neurol Genet. 2022 Aug; 8(4):e200002. PMID: 35747619; PMCID: PMC9210549.
      Citations:    
    39. Scorr LM, Cho HJ, Kilic-Berkmen G, McKay JL, Hallett M, Klein C, Baumer T, Berman BD, Feuerstein JS, Perlmutter JS, Berardelli A, Ferrazzano G, Wagle-Shukla A, Malaty IA, Jankovic J, Bellows ST, Barbano RL, Vidailhet M, Roze E, Bonnet C, Mahajan A, LeDoux MS, Fung VSC, Chang FCF, Defazio G, Ercoli T, Factor S, Wojno T, Jinnah HA. Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 2022; 1. PMID: 36248010; PMCID: PMC9557246.
      Citations: 2     
    40. Jankovic J, Baizabal-Carvallo JF, Alonso-Juarez M. Dystonic motor and phonic tics in Tourette syndrome. J Neurol. 2022 Oct; 269(10):5312-5318. PMID: 35567613.
      Citations:    Fields:    
    41. Du W, Bain PG, Defazio G, Jankovic J, Kim CY, Tan EK, Louis ED, Vidailhet M. The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases? Tremor Other Hyperkinet Mov (N Y). 2022; 12:15. PMID: 35646424; PMCID: PMC9104429.
      Citations:    Fields:    Translation:Humans
    42. Jankovic J, Baizabal-Carvallo JF. The clinical phenomenology and correlations of oculogyric tics. Acta Neurol Belg. 2022 Aug; 122(4):925-930. PMID: 35397742.
      Citations: 1     Fields:    Translation:Humans
    43. Zhang Z, Cisneros E, Lee HY, Vu JP, Chen Q, Benadof CN, Whitehill J, Rouzbehani R, Sy DT, Huang JS, Sejnowski TJ, Jankovic J, Factor S, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Berman BD, Richardson SP, Stebbins GT, Comella CL, Peterson DA. Hold that pose: capturing cervical dystonia's head deviation severity from video. Ann Clin Transl Neurol. 2022 05; 9(5):684-694. PMID: 35333449; PMCID: PMC9082391.
      Citations:    Fields:    Translation:Humans
    44. Vijayakumar D, Jankovic J. Slowing Parkinson's Disease Progression with Vaccination and Other Immunotherapies. CNS Drugs. 2022 04; 36(4):327-343. PMID: 35212935.
      Citations:    Fields:    Translation:HumansPHPublic Health
    45. Jankovic J, Baizabal-Carvallo JF. Sex differences in patients with Tourette syndrome. CNS Spectr. 2022 Feb 16; 1-7. PMID: 35170423.
      Citations: 1     Fields:    
    46. Liao C, Castonguay CE, Heilbron K, Vuokila V, Medeiros M, Houle G, Ross JP, Catoire H, Kang J, Mueller SH, Hopfner F, Clark LN, Soto-Beasley AI, Hallett M, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Seppi K, Berg D, Postuma RB, Jankovic J, Testa CM, Ross OA, Arzberger T, Louis ED, Mandich P, Vitale C, Barone P, Alonso-Navarro H, Rajput A, Dion PA, Rouleau GA, 23andMe Research Team, Ak?imen F, Diez-Fairen M, Girard SL, Lorenz D, Klebe S, Vilari?o-G?ell C, Bernard G, Dupr? N, Chouinard S, Garc?a-Mart?n E, Ag?ndez JAG, Jim?nez-Jim?nez FJ, Pastor P, Deuschl G, Kuhlenba?mer G, Meijer IA. Association of Essential Tremor With Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis. JAMA Neurol. 2022 02 01; 79(2):185-193. PMID: 34982113; PMCID: PMC8728658.
      Citations: 1     Fields:    Translation:HumansCells
    47. Vu JP, Cisneros E, Lee HY, Le L, Chen Q, Guo XA, Rouzbehani R, Jankovic J, Factor S, Goetz CG, Barbano RL, Perlmutter JS, Jinnah HA, Pirio Richardson S, Stebbins GT, Elble R, Comella CL, Peterson DA. Head tremor in cervical dystonia: Quantifying severity with computer vision. J Neurol Sci. 2022 Mar 15; 434:120154. PMID: 35101766; PMCID: PMC9059761.
      Citations: 1     Fields:    Translation:Humans
    48. Zhou ZD, Jankovic J, Ashizawa T, Tan EK. Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions. Nat Rev Neurol. 2022 03; 18(3):145-157. PMID: 35022573.
      Citations: 1     Fields:    Translation:HumansCells
    49. Lenka A, Jankovic J. Sports-Related Dystonia. Tremor Other Hyperkinet Mov (N Y). 2021; 11:54. PMID: 35036047; PMCID: PMC8698216.
      Citations:    Fields:    Translation:Humans
    50. Kilic-Berkmen G, Pirio Richardson S, Perlmutter JS, Hallett M, Klein C, Wagle-Shukla A, Malaty IA, Reich SG, Berman BD, Feuerstein J, Jankovic J, Mahajan A, Espay AJ, Barbano RL, LeDoux MS, Pantelyat A, Frank S, Stover N, Berardelli A, Leegwater-Kim J, Defazio G, Norris SA, Jinnah HA, Dystonia Coalition Investigators, Vidailhet M, Roze E. Current Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and Recommendations. Mov Disord Clin Pract. 2022 Feb; 9(2):183-190. PMID: 35146058; PMCID: PMC8810420.
      Citations: 2     
    51. Welton T, Cardoso F, Carr JA, Chan LL, Jankovic J, Tan EK, Deuschl G. Essential tremor. Nat Rev Dis Primers. 2021 11 11; 7(1):83. PMID: 34764294.
      Citations: 2     Fields:    Translation:HumansAnimals
    52. Hull M, Parnes M, Jankovic J. Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amid the COVID-19 Pandemic: A Cross-sectional Study. Neurol Clin Pract. 2021 Oct; 11(5):e686-e690. PMID: 34840884; PMCID: PMC8610548.
      Citations: 14     
    53. Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander J, Barkay H, Harary E. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 10 01; 4(10):e2128204. PMID: 34609495; PMCID: PMC8493441.
      Citations: 1     Fields:    Translation:Humans
    54. Jankovic J, Truong DD, Bologna M. Editorial "Parkinsonism across the spectrum of movement disorders and beyond". J Neurol Sci. 2022 Feb 15; 433:120013. PMID: 34625287.
      Citations:    Fields:    Translation:Humans
    55. Jankovic J, Baizabal-Carvallo JF, Alonso-Juarez M. Self-injurious behavior in Tourette syndrome. J Neurol. 2022 May; 269(5):2453-2459. PMID: 34596744.
      Citations:    Fields:    Translation:Humans
    56. Bologna M, Truong D, Jankovic J. The etiopathogenetic and pathophysiological spectrum of parkinsonism. J Neurol Sci. 2022 Feb 15; 433:120012. PMID: 34642022.
      Citations: 1     Fields:    Translation:Humans
    57. Bellows S, Jankovic J. Parkinsonism and tremor syndromes. J Neurol Sci. 2022 Feb 15; 433:120018. PMID: 34686357.
      Citations: 3     Fields:    Translation:Humans
    58. Coffey B, Jankovic J, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA, Stamler DA, Wieman M, Savola JM, Gordon MF, Alexander JK, Barkay H, Harary E. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 10 01; 4(10):e2129397. PMID: 34661664; PMCID: PMC8524312.
      Citations:    Fields:    Translation:Humans
    59. Billnitzer A, Jankovic J. The Clinical Value of Patient Home Videos in Movement Disorders. Tremor Other Hyperkinet Mov (N Y). 2021; 11:37. PMID: 34692230; PMCID: PMC8485864.
      Citations:    Fields:    Translation:Humans
    60. Scorr LM, Factor SA, Parra SP, Kaye R, Paniello RC, Norris SA, Perlmutter JS, Berman BD, Mailly M, Jankovic J, LeDoux MS, Barbano R, Chang FCF, Fung VSC, Pirio Richardson S, Blitzer A, Jinnah HA, B?umer T, Usnich T, Roze E, Vidailhet M. Oromandibular Dystonia: A Clinical Examination of 2,020 Cases. Front Neurol. 2021; 12:700714. PMID: 34603182; PMCID: PMC8481678.
      Citations: 1     
    61. Defazio G, Jinnah HA, Berardelli A, Perlmutter JS, Berkmen GK, Berman BD, Jankovic J, Comella C, Cotton AC, Ercoli T, Ferrazzano G, Fox S, Kim HJ, Moukheiber ES, Richardson SP, Weissbach A, Wrigth LJ, Hallett M, B?umer T. Diagnostic criteria for blepharospasm: A multicenter international study. Parkinsonism Relat Disord. 2021 10; 91:109-114. PMID: 34583301; PMCID: PMC9048224.
      Citations:    Fields:    Translation:Humans
    62. Mitsikostas DD, Dekundy A, Hanschmann A, Althaus M, Scheschonka A, Pagan F, Jankovic J. Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-na?ve subjects. Curr Med Res Opin. 2021 10; 37(10):1761-1768. PMID: 34384301.
      Citations:    Fields:    Translation:Humans
    63. Hafeez MU, Moore M, Hafeez K, Jankovic J. Exploring the role of botulinum toxin in critical care. Expert Rev Neurother. 2021 08; 21(8):881-894. PMID: 34281468.
      Citations: 1     Fields:    Translation:HumansCells
    64. Wang M, Sajobi T, Morgante F, Adler C, Agarwal P, Berardelli A, Berman BD, Blumin J, Brashear A, Deik A, Duque K, Espay AJ, Ferrazzano G, Feuerstein J, Fox S, Frank S, Hallett M, Jankovic J, LeDoux MS, Leegwater-Kim J, Mahajan A, Malaty IA, Ondo W, Pantelyat A, Pirio-Richardson S, Saunders-Pullman R, Suchowersky O, Truong D, Shukla AW, Perlmutter JS, Jinnah HA, Martino D, B?umer T, Borsche M, Roze E, Vidailhet M. Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion. Eur J Neurol. 2021 12; 28(12):3999-4009. PMID: 34296504; PMCID: PMC9100858.
      Citations:    Fields:    Translation:Humans
    65. Hill EJ, Jankovic J. Antiglutamic Acid Decarboxylase 65 Antibody-Associated Hemiataxia. Neurol Clin Pract. 2021 Aug; 11(4):e564-e566. PMID: 34484960; PMCID: PMC8382435.
      Citations:    
    66. Sun YV, Li C, Hui Q, Huang Y, Barbano R, Rodriguez R, Malaty IA, Reich S, Bambarger K, Holmes K, Jankovic J, Patel NJ, Berman BD, LeDoux MS, Espay AJ, Agarwal P, Pirio-Richardson S, Frank SA, Ondo WG, Saunders-Pullman R, Natividad S, Berardelli A, Pantelyat AY, Brashear A, Fox SH, Zittel S, Maurer A, Gelderblom M, Cruchaga C, Cotton AC, Kilic-Berkmen G, Freeman A, Factor SA, Scorr L, Bremner JD, Vaccarino V, Quyyumi AA, Perlmutter JS, Jinnah HA, Roze E, Vidailhet M, Chouinard S, Kasten M, Kr?mer UM, Neis M, B?umer T, Loens S, Borsche M, Volkmann J, Odorfer T, K?hn AA, Borngr?ber F, K?nig IR, Klein C, Lohmann K. A Multi-center Genome-wide Association Study of Cervical Dystonia. Mov Disord. 2021 12; 36(12):2795-2801. PMID: 34320236; PMCID: PMC8688173.
      Citations: 1     Fields:    Translation:Humans
    67. Lenka A, Jankovic J. Tremor Syndromes: An Updated Review. Front Neurol. 2021; 12:684835. PMID: 34381412; PMCID: PMC8350038.
      Citations: 1     
    68. Jankovic J, Baizabal-Carvallo JF. Beyond tics: movement disorders in patients with Tourette syndrome. J Neural Transm (Vienna). 2021 08; 128(8):1177-1183. PMID: 34302221.
      Citations:    Fields:    Translation:Humans
    69. Marsili L, Bologna M, Jankovic J, Colosimo C. Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal. Expert Opin Drug Saf. 2021 Jun; 20(6):695-705. PMID: 33831328.
      Citations: 1     Fields:    Translation:Humans
    70. Cisneros E, Vu JP, Lee HY, Chen Q, Benadof CN, Zhang Z, Pettitt EA, Joshi SK, Barbano RL, Jankovic J, Jinnah HA, Perlmutter JS, Berman BD, Mahajan A, Goetz CG, Stebbins GT, Comella CL, Peterson DA. Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia? Tremor Other Hyperkinet Mov (N Y). 2021 06 23; 11:21. PMID: 34221696; PMCID: PMC8231450.
      Citations:    Fields:    Translation:Humans
    71. Mostile G, Terranova R, Terravecchia C, Cicero CE, Giuliano L, Chisari C, Luca A, Preux PM, Jankovic J, Zappia M, Nicoletti A, Rascun? C, Dav? M. Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach. Parkinsonism Relat Disord. 2021 06; 87:124-129. PMID: 34030068.
      Citations: 4     Fields:    Translation:Humans
    72. Makhoul K, Jankovic J. Tourette Syndrome and Driving. Mov Disord Clin Pract. 2021 Jul; 8(5):763-768. PMID: 34307750; PMCID: PMC8287170.
      Citations:    
    73. Litvan I, Proudfoot JA, Martin ER, Standaert D, Riley D, Hall D, Marras C, Bayram E, Dubinsky RM, Bordelon Y, Reich S, Shprecher D, Kluger B, Cunningham C, Schellenberg GD, Jankovic J. Gene-Environment Interactions in Progressive Supranuclear Palsy. Front Neurol. 2021; 12:664796. PMID: 33897612; PMCID: PMC8062875.
      Citations:    
    74. Gatto EM, Walker RH, Gonzalez C, Cesarini M, Cossu G, Stephen CD, Balint B, Jankovic J, Morgante F, Jinnah HA, Rare Movement Disorders Study Group of the International Parkinson Disease, Movement Disorders Socie, Rodr?guez-Violante M. Worldwide barriers to genetic testing for movement disorders. Eur J Neurol. 2021 06; 28(6):1901-1909. PMID: 33730413.
      Citations: 1     Fields:    Translation:Humans
    75. Billnitzer A, Jankovic J. Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome. Mov Disord Clin Pract. 2021 Jul; 8(5):694-700. PMID: 34307741; PMCID: PMC8287163.
      Citations:    
    76. Bellows ST, Jankovic J. Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson's Disease in a Movement Disorders Clinic. Tremor Other Hyperkinet Mov (N Y). 2021 03 29; 11:12. PMID: 33828900; PMCID: PMC8015706.
      Citations: 6     Fields:    Translation:Humans
    77. Hull M, Parnes M, Jankovic J. Botulinum Neurotoxin Injections in Childhood Opisthotonus. Toxins (Basel). 2021 02 12; 13(2). PMID: 33673369; PMCID: PMC7918608.
      Citations:    Fields:    Translation:Humans
    78. Hill EJ, Mangleburg CG, Alfradique-Dunham I, Ripperger B, Stillwell A, Saade H, Rao S, Fagbongbe O, von Coelln R, Tarakad A, Hunter C, Dawe RJ, Jankovic J, Shulman LM, Buchman AS, Shulman JM. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity. Parkinsonism Relat Disord. 2021 03; 84:105-111. PMID: 33607526; PMCID: PMC7987213.
      Citations: 2     Fields:    Translation:Humans
    79. Zhang JF, Wang XX, Feng Y, Fekete R, Jankovic J, Wu YC. Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Front Psychiatry. 2021; 12:635494. PMID: 33633615; PMCID: PMC7900512.
      Citations: 2     
    80. Junker J, Berman BD, Hall J, Wahba DW, Brandt V, Perlmutter JS, Jankovic J, Malaty IA, Wagle Shukla A, Reich SG, Espay AJ, Duque KR, Patel N, Roze E, Vidailhet M, Jinnah HA, Br?ggemann N. Quality of life in isolated dystonia: non-motor manifestations matter. J Neurol Neurosurg Psychiatry. 2021 Feb 09. PMID: 33563813; PMCID: PMC8356023.
      Citations: 4     Fields:    
    81. Makhoul K, Jankovic J. Parkinson's disease after COVID-19. J Neurol Sci. 2021 03 15; 422:117331. PMID: 33540185.
      Citations: 11     Fields:    Translation:Humans
    82. Alfradique-Dunham I, Al-Ouran R, von Coelln R, Blauwendraat C, Hill E, Luo L, Stillwell A, Young E, Kaw A, Tan M, Liao C, Hernandez D, Pihlstrom L, Grosset D, Shulman LM, Liu Z, Rouleau GA, Nalls M, Singleton AB, Morris H, Jankovic J, Shulman JM. Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes. Neurol Genet. 2021 Apr; 7(2):e557. PMID: 33987465; PMCID: PMC8112852.
      Citations: 3     
    83. Tsetsos F, Yu D, Sul JH, Huang AY, Illmann C, Osiecki L, Darrow SM, Hirschtritt ME, Greenberg E, Muller-Vahl KR, Stuhrmann M, Dion Y, Rouleau GA, Aschauer H, Stamenkovic M, Sandor P, Barr CL, Grados MA, Singer HS, Hebebrand J, Hinney A, King RA, Fernandez TV, Barta C, Tarnok Z, Nagy P, Depienne C, Budman CL, Rizzo R, Lyon GJ, McMahon WM, Batterson JR, Cath DC, Malaty IA, Okun MS, Berlin C, Woods DW, Lee PC, Jankovic J, Robertson MM, Gilbert DL, Brown LW, Coffey BJ, Dietrich A, Hoekstra PJ, Kuperman S, Zinner SH, Wagner M, Knowles JA, Jeremy Willsey A, Tischfield JA, Heiman GA, Cox NJ, Freimer NB, Neale BM, Davis LK, Coppola G, Mathews CA, Scharf JM, Paschou P, Tourette Association of America International Consortium for Genetics, Coppola G, Darrow S, Davis LK, Dion Y, Freimer NB, Greenberg E, Kurlan R, Leckman JF, Lyon GJ, Malaty IA, Neale BM, Okun MS, Rouleau GA, Smit JH, Gilles de la Tourette GWAS Replication Initiative, Aschauer HAH, Barta C, Depienne C, Konstantinidis A, Paschou P, Tsetsos F, Wolanczyk T, Tourette International Collaborative Genetics Study, Brown L, Cheon KA, Fernandez TV, Garcia-Delgar B, Gilbert D, Grice DE, Hedderly T, Heiman GA, Heyman I, Huyser C, Kim YK, Kim YS, Koh YJ, Kook S, Leventhal BL, Plessen KJ, Roessner V, Shin EY, Song DH, Song J, Willsey AJ, Zinner S, Psychiatric Genomics Consortium Tourette Syndrome Working Group, Aschauer H, Fernandez T, Heiman G, Hoekstra P, Tischfield J, Woods D, Schl?gelhofer M, N?then MM, Worbe Y, Hartmann A, M?ller-Vahl K, Hagstr?m J, Madruga-Garrido M, Mir P, Morer A, M?nchau A. Synaptic processes and immune-related pathways implicated in Tourette syndrome. Transl Psychiatry. 2021 01 18; 11(1):56. PMID: 33462189; PMCID: PMC7814139.
      Citations: 6     Fields:    Translation:HumansCells
    84. Vu JP, Lee HY, Chen Q, Cisneros E, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Berman BD, Appelbaum MI, Stebbins GT, Comella CL, Peterson DA. Head tremor and pain in cervical dystonia. J Neurol. 2021 May; 268(5):1945-1950. PMID: 33417005; PMCID: PMC8076053.
      Citations: 5     Fields:    Translation:Humans
    85. Anandan C, Jankovic J. Botulinum Toxin in Movement Disorders: An Update. Toxins (Basel). 2021 Jan 08; 13(1). PMID: 33430071; PMCID: PMC7827923.
      Citations: 12     Fields:    Translation:Humans
    86. Niemann N, Billnitzer A, Jankovic J. Parkinson's disease and skin. Parkinsonism Relat Disord. 2021 01; 82:61-76. PMID: 33248395.
      Citations: 8     Fields:    Translation:Humans
    87. Tarakad A, Jankovic J. Recent advances in understanding and treatment of Parkinson's disease. Fac Rev. 2020; 9:6. PMID: 33659938; PMCID: PMC7886054.
      Citations: 4     
    88. Kordower JH, Okun MS, Jankovic J. Reply to: "Toward a Personalized Approach to Parkinson's Cell Therapy". Mov Disord. 2020 11; 35(11):2120-2121. PMID: 33463751.
      Citations:    Fields:    Translation:HumansCells
    89. Cisneros E, Stebbins GT, Chen Q, Vu JP, Benadof CN, Zhang Z, Barbano RL, Fox SH, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Adler CH, Factor SA, Reich SG, Rodriguez R, Severt LL, Stover NP, Berman BD, Comella CL, Peterson DA. It's tricky: Rating alleviating maneuvers in cervical dystonia. J Neurol Sci. 2020 Dec 15; 419:117205. PMID: 33160248; PMCID: PMC7728456.
      Citations: 3     Fields:    Translation:Humans
    90. Shaikh AG, Beylergil SB, Scorr L, Kilic-Berkmen G, Freeman A, Klein C, Junker J, Loens S, Br?ggemann N, M?nchau A, B?umer T, Vidailhet M, Roze E, Bonnet C, Jankovic J, Jimenez-Shahed J, Patel N, Marsh L, Comella C, Barbano RL, Berman BD, Malaty I, Wagle Shukla A, Reich SG, Ledoux MS, Berardelli A, Ferrazzano G, Stover N, Ondo W, Pirio Richardson S, Saunders-Pullman R, Mari Z, Agarwal P, Adler C, Chouinard S, Fox SH, Brashear A, Truong D, Suchowersky O, Frank S, Factor S, Perlmutter J, Jinnah HA. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574. PMID: 33046615; PMCID: PMC7905789.
      Citations: 16     Fields:    Translation:Humans
    91. Billnitzer A, Jankovic J. Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. Neurotherapeutics. 2020 10; 17(4):1681-1693. PMID: 32856174; PMCID: PMC7851278.
      Citations: 15     Fields:    Translation:Humans
    92. York MK, Benge JF, Hunter C, Jankovic J. A validation of a self-administered screening test for Parkinson's disease. J Neurol Sci. 2020 Nov 15; 418:117116. PMID: 32919368.
      Citations:    Fields:    Translation:Humans
    93. Norris SA, Jinnah HA, Klein C, Jankovic J, Berman BD, Mahajan A, Espay AJ, Murthy AV, Fung VSC, LeDoux MS, Chang FCF, Vidailhet M, Testa C, Barbano R, Malaty IA, Loens S, Wright LJ, Perlmutter JS, Roze E, B?umer T. Clinical and Demographic Characteristics of Upper Limb Dystonia. Mov Disord. 2020 11; 35(11):2086-2090. PMID: 32845549; PMCID: PMC8350751.
      Citations: 1     Fields:    Translation:Humans
    94. Robak LA, Du R, Yuan B, Gu S, Alfradique-Dunham I, Kondapalli V, Hinojosa E, Stillwell A, Young E, Zhang C, Song X, Du H, Gambin T, Jhangiani SN, Coban Akdemir Z, Muzny DM, Tejomurtula A, Ross OA, Shaw C, Jankovic J, Bi W, Posey JE, Lupski JR, Shulman JM. Integrated sequencing and array comparative genomic hybridization in familial Parkinson disease. Neurol Genet. 2020 Oct; 6(5):e498. PMID: 32802956; PMCID: PMC7413630.
      Citations: 4     
    95. Rezvanian S, Litvan I, Standaert D, Jankovic J, Reich SG, Hall D, Shprecher DR, Bordelon Y, Dubinsky R, Kluger B. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism Relat Disord. 2020 09; 78:56-60. PMID: 32731191.
      Citations: 4     Fields:    Translation:Humans
    96. Jankovic J, Okun MS, Kordower JH. Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson's Disease. Mov Disord. 2020 08; 35(8):1312-1314. PMID: 32529662.
      Citations: 6     Fields:    Translation:HumansCells
    97. Bhidayasiri R, Kane JM, Frei KP, Caroff SN, Fahn S, Jankovic J, Hauser RA, Truong DD, Correll CU. Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool. Parkinsonism Relat Disord. 2020 08; 77:141-145. PMID: 32823151.
      Citations:    Fields:    Translation:Humans
    98. Jankovic J, Tan EK. Parkinson's disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020 08; 91(8):795-808. PMID: 32576618.
      Citations: 66     Fields:    Translation:Humans
    99. Jankovic J. Treatment of Movement Disorders. Neurol Clin. 2020 05; 38(2):xiii-xiv. PMID: 32279722.
      Citations:    Fields:    
    100. Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol. 2020 06; 16(6):303-318. PMID: 32332985.
      Citations: 65     Fields:    Translation:HumansAnimals
    101. Jankovic J, Baizabal-Carvallo JF. Reply to Gender Differences in Functional Movement Disorders: Sociocultural or Biological? Mov Disord Clin Pract. 2020 May; 7(4):480-481. PMID: 32373674; PMCID: PMC7197323.
      Citations:    
    102. Pick S, Anderson DG, Asadi-Pooya AA, Aybek S, Baslet G, Bloem BR, Bradley-Westguard A, Brown RJ, Carson AJ, Chalder T, Damianova M, David AS, Edwards MJ, Epstein SA, Espay AJ, Goldstein LH, Hallett M, Jankovic J, Joyce EM, Kanaan RA, Keynejad RC, Kozlowska K, LaFaver K, LaFrance WC, Lang AE, Lehn A, Lidstone S, Maurer CW, Mildon B, Morgante F, Myers L, Nicholson C, Nielsen G, Perez DL, Popkirov S, Reuber M, Rommelfanger KS, Schwingenshuh P, Serranova T, Shotbolt P, Stebbins GT, Stone J, Tijssen MA, Tinazzi M, Nicholson TR, Garcin B. Outcome measurement in functional neurological disorder: a systematic review and recommendations. J Neurol Neurosurg Psychiatry. 2020 06; 91(6):638-649. PMID: 32111637; PMCID: PMC7279198.
      Citations: 19     Fields:    Translation:Humans
    103. Bashir HH, Jankovic J. Treatment of Tardive Dyskinesia. Neurol Clin. 2020 05; 38(2):379-396. PMID: 32279716.
      Citations: 3     Fields:    Translation:Humans
    104. Bellows S, Jankovic J. Reply to Comment on Re-Visiting Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491. Toxins (Basel). 2020 01 23; 12(2). PMID: 31979241; PMCID: PMC7076880.
      Citations: 1     Fields:    
    105. Chen Q, Vu JP, Cisneros E, Benadof CN, Zhang Z, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Appelbaum MI, Stebbins GT, Comella CL, Peterson DA. Postural Directionality and Head Tremor in Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2020; 10. PMID: 32015932; PMCID: PMC6988138.
      Citations: 6     Fields:    Translation:Humans
    106. Jankovic J. Treatment of tics associated with Tourette syndrome. J Neural Transm (Vienna). 2020 05; 127(5):843-850. PMID: 31955299.
      Citations: 6     Fields:    Translation:Humans
    107. Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, Gibbs JR, Hernandez DG, Kumaran R, Langston R, Bonet-Ponce L, Alcalay RN, Hassin-Baer S, Greenbaum L, Iwaki H, Leonard HL, Grenn FP, Ruskey JA, Sabir M, Ahmed S, Makarious MB, Toft M, van Hilten JJ, Marinus J, Sharma M, Siitonen A, Majamaa K, Eerola-Rautio J, Tienari PJ, 23andMe Research Team, Pantelyat A, Hillis AE, Dawson TM, Rosenthal LS, Albert MS, Resnick SM, Ferrucci L, Morris CM, Pletnikova O, Troncoso J, Grosset D, Noyce AJ, Masliah E, Wood N, Hardy J, Shulman LM, Jankovic J, Shulman JM, Cannon P, Scholz SW, Morris H, Cookson MR, Nalls MA, Gan-Or Z, Singleton AB, Pihlstr?m L, Schulte C, Brockmann K, Lesage S, Corvol JC, Brice A, Heutink P, Gasser T. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. Brain. 2020 01 01; 143(1):234-248. PMID: 31755958; PMCID: PMC6935749.
      Citations: 55     Fields:    Translation:HumansCells
    108. Tanner CM, Pahwa R, Hauser RA, Oertel WH, Isaacson SH, Jankovic J, Johnson R, Chernick D, Hubble J. EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease. J Parkinsons Dis. 2020; 10(2):543-558. PMID: 31929122; PMCID: PMC7242830.
      Citations: 6     Fields:    Translation:Humans
    109. Jankovic J, Baizabal-Carvallo JF. Gender Differences in Functional Movement Disorders. Mov Disord Clin Pract. 2020 Feb; 7(2):182-187. PMID: 32071937; PMCID: PMC7011817.
      Citations: 12     
    110. Alonso-Juarez M, Jankovic J, Baizabal-Carvallo JF. Functional gait disorders, clinical phenomenology, and classification. Neurol Sci. 2020 Apr; 41(4):911-915. PMID: 31832998.
      Citations: 5     Fields:    Translation:Humans
    111. Deng H, Wu S, Jankovic J. [Essential tremor: genetic update]. Expert Rev Mol Med. 2019 12 10; 21:e8. PMID: 31818346.
      Citations: 8     Fields:    Translation:HumansAnimals
    112. Bellows S, Jankovic J. Treatment of dystonia and tics. Clin Park Relat Disord. 2020; 2:12-19. PMID: 34316614; PMCID: PMC8302199.
      Citations: 1     
    113. Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R, Krohn L, Siitonen A, Iwaki H, Leonard H, Faghri F, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Sutherland M, Tienari P, Majamaa K, Toft M, Andreassen OA, Bangale T, Yang J, Gan-Or Z, Shulman JM, Wood NW, Hinds DA, Hardy JA, Morris HR, Gratten J, Visscher PM, Graham RR, Singleton AB, 23andMe Research Team, System Genomics of Parkinson's Disease Consortium, International Parkinson's Disease Genomics Consortium, Sim?n-S?nchez J, Schulte C, Sharma M, Pihlstr?m L, Botia JA, Martinez M, Corvol JC, Lesage S, Brice A, Gasser T, Heutink P. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019 12; 18(12):1091-1102. PMID: 31701892; PMCID: PMC8422160.
      Citations: 390     Fields:    Translation:Humans
    114. Louis ED, Bares M, Fahn S, Frucht SJ, Jankovic J, Ondo WG, Pal PK, Tan EK, Benito-Leon J. Essential tremor-plus: a controversial new concept. Lancet Neurol. 2020 03; 19(3):266-270. PMID: 31767343; PMCID: PMC10686582.
      Citations: 28     Fields:    Translation:Humans
    115. Jankovic J. Reader response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy. Neurology. 2019 10 22; 93(17):766-767. PMID: 31636230.
      Citations: 1     Fields:    
    116. Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C, Kluger B, Olfati N, Jankovic J. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism Relat Disord. 2019 12; 69:34-39. PMID: 31665686; PMCID: PMC6914266.
      Citations: 7     Fields:    Translation:Humans
    117. Bellows S, Jankovic J. Immunogenicity Associated with Botulinum Toxin Treatment. Toxins (Basel). 2019 08 26; 11(9). PMID: 31454941; PMCID: PMC6784164.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    118. Rabadia SV, Litvan I, Juncos J, Bordelon Y, Riley DE, Standaert D, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J, ENGENE PSP study. Hypertension and progressive supranuclear palsy. Parkinsonism Relat Disord. 2019 09; 66:166-170. PMID: 31420308.
      Citations: 6     Fields:    Translation:Humans
    119. Thenganatt MA, Jankovic J. Psychogenic (Functional) Movement Disorders. Continuum (Minneap Minn). 2019 Aug; 25(4):1121-1140. PMID: 31356296.
      Citations: 12     Fields:    Translation:Humans
    120. Dashtipour K, Mari Z, Jankovic J, Adler CH, Schwartz M, Brin MF. Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study. J Neurol Sci. 2019 Oct 15; 405:116413. PMID: 31494402.
      Citations: 6     Fields:    Translation:Humans
    121. Niemann N, Jankovic J. Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. Parkinsonism Relat Disord. 2019 10; 67:74-89. PMID: 31272925.
      Citations: 13     Fields:    Translation:Humans
    122. Savitt D, Jankovic J. Targeting a-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics. Drugs. 2019 Jun; 79(8):797-810. PMID: 30982161.
      Citations: 27     Fields:    Translation:Humans
    123. Mehanna R, Jankovic J. Young-onset Parkinson's disease: Its unique features and their impact on quality of life. Parkinsonism Relat Disord. 2019 08; 65:39-48. PMID: 31176633.
      Citations: 12     Fields:    Translation:HumansAnimals
    124. Savitt D, Jankovic J. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene. J Neurol Sci. 2019 Jul 15; 402:57-61. PMID: 31103960.
      Citations: 6     Fields:    Translation:HumansCells
    125. Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med. 2019 07; 7(7):e00736. PMID: 31087512; PMCID: PMC6625130.
      Citations: 15     Fields:    Translation:HumansCells
    126. Pringsheim T, Okun MS, M?ller-Vahl K, Martino D, Jankovic J, Cavanna AE, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M, Holler-Managan Y, Piacentini J. Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 05 07; 92(19):896-906. PMID: 31061208; PMCID: PMC6537133.
      Citations: 61     Fields:    Translation:Humans
    127. Pringsheim T, Holler-Managan Y, Okun MS, Jankovic J, Piacentini J, Cavanna AE, Martino D, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M, M?ller-Vahl K. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 05 07; 92(19):907-915. PMID: 31061209; PMCID: PMC6537130.
      Citations: 44     Fields:    Translation:Humans
    128. Migliore S, Jankovic J, Squitieri F. Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon? Front Neurol. 2019; 10:453. PMID: 31114543; PMCID: PMC6503085.
      Citations: 8     
    129. Merola A, Dwivedi AK, Shaikh AG, Tareen TK, Da Prat GA, Hampf J, Mahajan A, Marsili L, Jankovic J, Comella CL, Berman BD, Perlmutter JS, Jinnah HA, Espay AJ, Kauffman MA. Head tremor at disease onset: an ataxic phenotype of cervical dystonia. J Neurol. 2019 Aug; 266(8):1844-1851. PMID: 31028543; PMCID: PMC6642013.
      Citations: 12     Fields:    Translation:Humans
    130. Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, van Hilten JJ, Marinus J, 23andMe Research Team, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB, International Parkinson's Disease Genomics Consortium (IPDGC), Pihlstr?m L, Sim?n-S?nchez J, Schulte C, Lesage S, Corvol JC, Brice A, Gasser T, Heutink P. Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and a-synuclein mechanisms. Mov Disord. 2019 06; 34(6):866-875. PMID: 30957308; PMCID: PMC6579628.
      Citations: 105     Fields:    Translation:Humans
    131. Niemann N, Jankovic J. Real-World Experience With VMAT2 Inhibitors. Clin Neuropharmacol. 2019 Mar/Apr; 42(2):37-41. PMID: 30870235.
      Citations: 8     Fields:    Translation:Humans
    132. Yu D, Sul JH, Tsetsos F, Nawaz MS, Huang AY, Zelaya I, Illmann C, Osiecki L, Darrow SM, Hirschtritt ME, Greenberg E, Muller-Vahl KR, Stuhrmann M, Dion Y, Rouleau G, Aschauer H, Stamenkovic M, Sandor P, Barr CL, Grados M, Singer HS, Hebebrand J, Hinney A, King RA, Fernandez TV, Barta C, Tarnok Z, Nagy P, Depienne C, Worbe Y, Hartmann A, Budman CL, Rizzo R, Lyon GJ, McMahon WM, Batterson JR, Cath DC, Malaty IA, Okun MS, Berlin C, Woods DW, Lee PC, Jankovic J, Robertson MM, Gilbert DL, Brown LW, Coffey BJ, Dietrich A, Hoekstra PJ, Kuperman S, Zinner SH, Atzmon G, Barzilai N, Wagner M, Moessner R, Ophoff R, Pato CN, Pato MT, Knowles JA, Roffman JL, Smoller JW, Buckner RL, Willsey AJ, Tischfield JA, Heiman GA, Stefansson H, Posthuma D, Cox NJ, Pauls DL, Freimer NB, Neale BM, Davis LK, Paschou P, Coppola G, Mathews CA, Scharf JM, Tourette Association of America International Consortium for Genetics, the Gilles de la Tourette GWA, Schl?gelhofer M, N?then MM, Lu?vigsson P, S?mundsen E, Thorarensen ?, Stefansson K. Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies. Am J Psychiatry. 2019 03 01; 176(3):217-227. PMID: 30818990; PMCID: PMC6677250.
      Citations: 64     Fields:    Translation:Humans
    133. Wijemanne S, Jankovic J. Hand, foot, and spine deformities in parkinsonian disorders. J Neural Transm (Vienna). 2019 03; 126(3):253-264. PMID: 30809710.
      Citations: 5     Fields:    Translation:Humans
    134. Hallett M, Jankovic J, Baizabal-Carvallo JF. Pathogenesis and pathophysiology of functional (psychogenic) movement disorders. Neurobiol Dis. 2019 07; 127:32-44. PMID: 30798005.
      Citations: 36     Fields:    Translation:Humans
    135. Jankovic J, Baizabal-Carvallo JF. The Wide Spectrum of Functional Movement Disorders. JAMA Neurol. 2019 02 01; 76(2):235-236. PMID: 30535193.
      Citations:    Fields:    Translation:Humans
    136. Savitt D, Jankovic J. Levodopa-induced dyskinesias in mitochondrial membrane protein-associated neurodegeneration. Neurol Clin Pract. 2019 Feb; 9(1):e7-e9. PMID: 30859014; PMCID: PMC6382374.
      Citations: 1     
    137. Mittal SO, Lenka A, Jankovic J. Botulinum toxin for the treatment of tremor. Parkinsonism Relat Disord. 2019 06; 63:31-41. PMID: 30709779.
      Citations: 12     Fields:    Translation:Humans
    138. Tarakad A, Jankovic J. Essential Tremor and Parkinson's Disease: Exploring the Relationship. Tremor Other Hyperkinet Mov (N Y). 2018; 8:589. PMID: 30643667; PMCID: PMC6329774.
      Citations: 25     Fields:    Translation:Humans
    139. Jankovic J. Pathogenesis-targeted therapeutic strategies in Parkinson's disease. Mov Disord. 2019 01; 34(1):41-44. PMID: 30484897.
      Citations: 12     Fields:    Translation:HumansCells
    140. Parnes M, Bashir H, Jankovic J. Is Benign Hereditary Chorea Really Benign? Brain-Lung-Thyroid Syndrome Caused by NKX2-1 Mutations. Mov Disord Clin Pract. 2019 Jan; 6(1):34-39. PMID: 30746413; PMCID: PMC6335533.
      Citations: 4     
    141. Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, Br?ggemann N. Predictors of alcohol responsiveness in dystonia. Neurology. 2018 11 20; 91(21):e2020-e2026. PMID: 30341158; PMCID: PMC6260199.
      Citations: 5     Fields:    Translation:Humans
    142. Balint B, Valente EM, Pisani A, Rothwell J, Jankovic J, Vidailhet M, Bhatia KP, Mencacci NE. Author Correction: Dystonia. Nat Rev Dis Primers. 2018 Oct 19; 4(1):37. PMID: 30341354.
      Citations: 3     Fields:    
    143. Jankovic J. Reader response: The nature of postural tremor in Parkinson disease. Neurology. 2018 10 09; 91(15):723. PMID: 30297509.
      Citations: 1     Fields:    Translation:Humans
    144. Jankovic J, Goodman I, Safirstein B, Marmon TK, Schenk DB, Koller M, Zago W, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaacson SH, Omidvar O, Ellenbogen A, Kinney GG. Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2018 10 01; 75(10):1206-1214. PMID: 29913017; PMCID: PMC6233845.
      Citations: 81     Fields:    Translation:HumansCTClinical Trials
    145. Testa CM, Jankovic J. Huntington disease: A quarter century of progress since the gene discovery. J Neurol Sci. 2019 01 15; 396:52-68. PMID: 30419368.
      Citations: 13     Fields:    Translation:HumansCells
    146. Valente EM, Pisani A, Jankovic J, Vidailhet M, Balint B, Mencacci NE, Rothwell J, Bhatia KP. Dystonia. Nat Rev Dis Primers. 2018 09 20; 4(1):25. PMID: 30237473.
      Citations: 69     Fields:    Translation:Humans
    147. Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM, Coffman KA, McCracken JT, Juncos J, Grant JE, Chipkin RE. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Mov Disord. 2018 08; 33(8):1272-1280. PMID: 30192018.
      Citations: 11     Fields:    Translation:Humans
    148. Larson P, Starr PA, Okun MS, Wharen RE, Uitti RJ, Guthrie BL, Peichel D, Pahwa R, Foote K, Marshall FJ, Jankovic J, Simpson R, Phibbs F, Neimat JS, Stewart RM, Dashtipour K, Mitchell KT, Walker HC, Ostrem JL. Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms. Parkinsonism Relat Disord. 2019 03; 60:126-132. PMID: 30220556.
      Citations: 14     Fields:    Translation:Humans
    149. Telkes I, Viswanathan A, Jimenez-Shahed J, Abosch A, Ozturk M, Gupte A, Jankovic J, Ince NF. Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease. Proc Natl Acad Sci U S A. 2018 09 04; 115(36):E8567-E8576. PMID: 30131429; PMCID: PMC6130371.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    150. Jankovic J. Essential Tremor. N Engl J Med. 2018 08 09; 379(6):595. PMID: 30091352.
      Citations:    Fields:    Translation:Humans
    151. Machol K, Jankovic J, Vijayakumar D, Burrage LC, Jain M, Lewis RA, Fuller GN, Xu M, Penas-Prado M, Gule-Monroe MK, Rosenfeld JA, Chen R, Eng CM, Yang Y, Lee BH, Moretti PM, Undiagnosed Diseases Network, Dhar SU. Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma. Neurol Genet. 2018 Aug; 4(4):e248. PMID: 30046660; PMCID: PMC6055357.
      Citations: 4     
    152. Niemann N, Jankovic J. Botulinum Toxin for the Treatment of Hand Tremor. Toxins (Basel). 2018 07 19; 10(7). PMID: 30029483; PMCID: PMC6070882.
      Citations: 15     Fields:    Translation:Humans
    153. Bashir H, Jankovic J. Deutetrabenazine for the treatment of Huntington's chorea. Expert Rev Neurother. 2018 08; 18(8):625-631. PMID: 29996061.
      Citations: 1     Fields:    Translation:Humans
    154. Margraf NG, Wolke R, Granert O, Berardelli A, Bloem BR, Djaldetti R, Espay AJ, Fasano A, Furusawa Y, Giladi N, Hallett M, Jankovic J, Murata M, Tinazzi M, Berg D, Volkmann J, Deuschl G. Consensus for the measurement of the camptocormia angle in the standing patient. Parkinsonism Relat Disord. 2018 07; 52:1-5. PMID: 29907329.
      Citations: 11     Fields:    Translation:Humans
    155. Jankovic J, Truong D, Patel AT, Brashear A, Evatt M, Rubio RG, Oh CK, Snyder D, Shears G, Comella C. Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study. Mov Disord Clin Pract. 2018 May-Jun; 5(3):273-282. PMID: 30009213; PMCID: PMC6032882.
      Citations: 15     
    156. Niemann N, Jankovic J. Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):609. PMID: 29524074.
      Citations:    Fields:    
    157. Niemann N, Jankovic J. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors. Drugs. 2018 04; 78(5):525-541. PMID: 29484607.
      Citations: 6     Fields:    Translation:Humans
    158. Jankovic J, Marsh L, Patel A, Jinnah HA, Comella C, Barbano R, Perlmutter J, members of the Dystonia Coalition, Mahajan A, Patel N. Cervical dystonia and substance abuse. J Neurol. 2018 Apr; 265(4):970-975. PMID: 29569175.
      Citations: 2     Fields:    Translation:Humans
    159. Albanese A, Cardoso F, Fujinaga Y, Jankovic J, Schiavo G, Rummel A. Toxins 2017 conference in Madrid. Toxicon. 2018 Jun 01; 147:1. PMID: 30837060.
      Citations:    Fields:    
    160. Jankovic J. Parkinson's disease tremors and serotonin. Brain. 2018 03 01; 141(3):624-626. PMID: 30063797.
      Citations: 3     Fields:    Translation:Humans
    161. Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I, ENGENE-PSP Study. Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. Mov Disord. 2018 03; 33(3):468-472. PMID: 29460982; PMCID: PMC5840026.
      Citations: 9     Fields:    Translation:Humans
    162. Frei K, Truong DD, Fahn S, Jankovic J, Hauser RA. The nosology of tardive syndromes. J Neurol Sci. 2018 06 15; 389:10-16. PMID: 29433810.
      Citations: 11     Fields:    Translation:Humans
    163. Savitt D, Jankovic J. Tardive syndromes. J Neurol Sci. 2018 06 15; 389:35-42. PMID: 29506749.
      Citations: 19     Fields:    Translation:Humans
    164. Jankovic J. Immunologic treatment of Parkinson's disease. Immunotherapy. 2018 02; 10(2):81-84. PMID: 29260621.
      Citations: 4     Fields:    Translation:HumansAnimals
    165. Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study. Neurology. 2018 02 13; 90(7):e559-e564. PMID: 29343468.
      Citations: 9     Fields:    Translation:Humans
    166. Lotia M, York MK, Strutt AM, Jankovic J. Leg stereotypy syndrome: phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):692-695. PMID: 29332008.
      Citations: 1     Fields:    Translation:Humans
    167. Deng H, Fan K, Jankovic J. The Role of TMEM230 Gene in Parkinson's Disease. J Parkinsons Dis. 2018; 8(4):469-477. PMID: 30175983; PMCID: PMC6218139.
      Citations: 3     Fields:    Translation:Humans
    168. Jankovic J, Baizabal-Carvallo JF. Autoimmune and paraneoplastic movement disorders: An update. J Neurol Sci. 2018 02 15; 385:175-184. PMID: 29406902.
      Citations: 22     Fields:    Translation:Humans
    169. Deng H, Wang P, Jankovic J. The genetics of Parkinson disease. Ageing Res Rev. 2018 Mar; 42:72-85. PMID: 29288112.
      Citations: 148     Fields:    Translation:HumansAnimalsCells
    170. Robak LA, van Rooij J, Kraaij R, Jankovic J, Shulman JM, Jansen IE, Uitterlinden AG, International Parkinson?s Disease Genomics Consortium (IPDGC), Heutink P. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. Brain. 2017 12 01; 140(12):3191-3203. PMID: 29140481; PMCID: PMC5841393.
      Citations: 131     Fields:    Translation:Humans
    171. Bashir H, Jankovic J. Treatment options for chorea. Expert Rev Neurother. 2018 Jan; 18(1):51-63. PMID: 29120264.
      Citations: 11     Fields:    Translation:Humans
    172. Pulliam CL, Jankovic J, Ramirez-Castaneda JL, Heldman DA, Vittal P, Goetz CG, Ouyang B. Does Added Objective Tremor Monitoring Improve Clinical Outcomes in Essential Tremor Treatment? Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):96-98. PMID: 30746399; PMCID: PMC6336186.
      Citations: 2     
    173. Jankovic J. Parkinson disease: Exenatide - a drug for diabetes and Parkinson disease? Nat Rev Neurol. 2017 Nov; 13(11):643-644. PMID: 28960185.
      Citations: 6     Fields:    Translation:Humans
    174. Oshima M, Deitiker P, Jankovic J, Atassi MZ. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule. Immunol Invest. 2018 Jan; 47(1):18-39. PMID: 28891721.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    175. Jankovic J. An update on new and unique uses of botulinum toxin in movement disorders. Toxicon. 2018 Jun 01; 147:84-88. PMID: 28888928.
      Citations: 28     Fields:    Translation:Humans
    176. Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Pal PK, Rodriguez Oroz MC, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM, International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders, Munchau A, Rodr?guez-Violante M, Sch?ls L. Treatable inherited rare movement disorders. Mov Disord. 2018 01; 33(1):21-35. PMID: 28861905; PMCID: PMC5921079.
      Citations: 23     Fields:    Translation:Humans
    177. Jankovic J. Statin-related musculoskeletal pain in Parkinson's disease. Pain. 2017 09; 158(9):1840. PMID: 28816887.
      Citations: 1     Fields:    
    178. Deitiker P, Oshima M, Jankovic J, Atassi MZ. Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule. Immunol Lett. 2017 10; 190:257-264. PMID: 28823519.
      Citations:    Fields:    Translation:HumansCells
    179. Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM, Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators. Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea. JAMA Neurol. 2017 08 01; 74(8):977-982. PMID: 28692723; PMCID: PMC5710322.
      Citations: 11     Fields:    Translation:Humans
    180. Rousseaux MWC, Shulman JM, Jankovic J. Progress toward an integrated understanding of Parkinson's disease. F1000Res. 2017; 6:1121. PMID: 28751973; PMCID: PMC5510019.
      Citations: 11     Fields:    
    181. Tarakad A, Jankovic J. Anosmia and Ageusia in Parkinson's Disease. Int Rev Neurobiol. 2017; 133:541-556. PMID: 28802932.
      Citations: 27     Fields:    Translation:Humans
    182. Jankovic J, Baizabal-Carvallo JF. Functional (psychogenic) stereotypies. J Neurol. 2017 Jul; 264(7):1482-1487. PMID: 28653211.
      Citations: 4     Fields:    Translation:Humans
    183. Jankovic J. Botulinum toxin: State of the art. Mov Disord. 2017 Aug; 32(8):1131-1138. PMID: 28639368.
      Citations: 54     Fields:    Translation:HumansAnimals
    184. Tarakad A, Jankovic J. Diagnosis and Management of Parkinson's Disease. Semin Neurol. 2017 04; 37(2):118-126. PMID: 28511252.
      Citations: 31     Fields:    Translation:Humans
    185. Carecchio M, Iodice A, Pons R, Panteghini C, Zorzi G, Zibordi F, Bonakis A, Dinopoulos A, Jankovic J, Stefanis L, Bhatia KP, Monti V, R'Bibo L, Veneziano L, Garavaglia B, Fusco C, Wood N, Stamelou M, Nardocci N, Mencacci NE. ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients. Parkinsonism Relat Disord. 2017 Aug; 41:37-43. PMID: 28511835; PMCID: PMC5549507.
      Citations: 20     Fields:    Translation:Humans
    186. Pirio Richardson S, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Hallett M, Altenm?ller E, Prudente CN. Research Priorities in Limb and Task-Specific Dystonias. Front Neurol. 2017; 8:170. PMID: 28515706; PMCID: PMC5413505.
      Citations: 13     
    187. Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Ondo W, Malaty IA, McDonald WM, Marsh L, Zurowski M, Vidailhet M, Bonnet C, Rodr?guez R, B?umer T, Br?ggemann N. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 07; 88(7):595-602. PMID: 28438790; PMCID: PMC5659143.
      Citations: 25     Fields:    Translation:Humans
    188. Robledo I, Jankovic J. Media hype: Patient and scientific perspectives on misleading medical news. Mov Disord. 2017 Sep; 32(9):1319-1323. PMID: 28370445.
      Citations: 13     Fields:    Translation:Humans
    189. Wharen RE, Okun MS, Guthrie BL, Uitti RJ, Larson P, Foote K, Walker H, Marshall FJ, Schwalb J, Ford B, Jankovic J, Simpson R, Dashtipour K, Phibbs F, Neimat JS, Stewart RM, Peichel D, Pahwa R, Ostrem JL, SJM DBS ET Study Group. Thalamic DBS with a constant-current device in essential tremor: A?controlled clinical trial. Parkinsonism Relat Disord. 2017 Jul; 40:18-26. PMID: 28400200.
      Citations: 16     Fields:    Translation:Humans
    190. Wijemanne S, Vijayakumar D, Jankovic J. Apraclonidine in the treatment of ptosis. J Neurol Sci. 2017 May 15; 376:129-132. PMID: 28431598.
      Citations: 5     Fields:    Translation:Humans
    191. Kanaan RAA, Duncan R, Goldstein LH, Jankovic J, Cavanna AE. Are psychogenic non-epileptic seizures just another symptom of conversion disorder? J Neurol Neurosurg Psychiatry. 2017 05; 88(5):425-429. PMID: 28235779.
      Citations: 9     Fields:    Translation:Humans
    192. Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Pahwa R, Poewe W, Anand R, Kulisevsky J. Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. JAMA Neurol. 2017 Feb 01; 74(2):216-224. PMID: 27942720.
      Citations: 40     Fields:    Translation:Humans
    193. Jankovic J, Squitieri F. Letter re: Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology. 2017 01 17; 88(3):334. PMID: 28093514.
      Citations:    Fields:    Translation:HumansCells
    194. Jankovic J. Movement disorders in 2016: Progress in Parkinson disease and other movement disorders. Nat Rev Neurol. 2017 Feb; 13(2):76-78. PMID: 28084323.
      Citations: 9     Fields:    Translation:Humans
    195. Jankovic J, Baizabal-Carvallo JF. Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders. J Neurol Neurosurg Psychiatry. 2017 05; 88(5):453-455. PMID: 27986829.
      Citations: 2     Fields:    Translation:Humans
    196. Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J, ENGENE PSP study. Understanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017 02; 35:75-81. PMID: 28007518.
      Citations: 6     Fields:    Translation:Humans
    197. Jankovic J, Baizabal-Carvallo JF. Distinguishing features of psychogenic (functional) versus organic hemifacial spasm. J Neurol. 2017 Feb; 264(2):359-363. PMID: 27942912.
      Citations: 5     Fields:    Translation:Humans
    198. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M, Huntington Study Group 2CARE Investigators and Coordinators. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88(2):152-159. PMID: 27913695; PMCID: PMC5224719.
      Citations: 42     Fields:    Translation:Humans
    199. Jankovic J. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother. 2016 Dec; 17(18):2461-2470. PMID: 27819145.
      Citations: 33     Fields:    Translation:HumansAnimals
    200. Jankovic J, Albanese A. Editorial: Toxins 2017. Toxicon. 2016 Dec 25; 123S:S1. PMID: 27889226.
      Citations:    Fields:    
    201. Vijayakumar D, Wijemanne S, Jankovic J. Treatment of blepharospasm with apraclonidine. J Neurol Sci. 2017 Jan 15; 372:57-59. PMID: 28017248.
      Citations: 2     Fields:    Translation:Humans
    202. Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D. Deutetrabenazine in Tics Associated with Tourette Syndrome. Tremor Other Hyperkinet Mov (N Y). 2016; 6:422. PMID: 27917309; PMCID: PMC5133390.
      Citations: 18     Fields:    
    203. Hopfner F, Clark LN, Tittmann L, Soto-Ortolaza AI, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Shulman JM, Haubenberger D, Pastor P, Jankovic J, Testa CM, Zeuner KE, Ross OA, Louis ED, M?ller SH, Girard SL, Merner ND, Bourassa CV, Lorenz D, Klebe S, Dion PA, Wurster I, Srulijes K, Vilari?o-G?ell C, Postuma RB, Bernard G, Ladwig KH, Dupr? N, Strauch K, Panisset M, Winkelmann J, Reischl E, Arzberger T, Chouinard S, Deuschl G, Kuhlenb?umer G, Rouleau GA. Genome-wide association study in essential tremor identifies three new loci. Brain. 2016 12; 139(Pt 12):3163-3169. PMID: 27797806; PMCID: PMC5382938.
      Citations: 32     Fields:    Translation:Humans
    204. Jankovic J, Tagliati M, Peichel D, Okun MS, Tr?ster AI. Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease. Mov Disord. 2017 03; 32(3):433-440. PMID: 27753157; PMCID: PMC5363377.
      Citations: 22     Fields:    Translation:Humans
    205. Oshima M, Deitiker P, Jankovic J, Atassi MZ. Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. J Neuroimmunol. 2016 11 15; 300:36-46. PMID: 27806874.
      Citations: 2     Fields:    Translation:HumansCells
    206. Albanese A, Bhatia K, DeLong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Mink JW, Teller JK. "Complex" dystonia is not a category in the new 2013 consensus classification. Mov Disord. 2016 11; 31(11):1758-1759. PMID: 27612445; PMCID: PMC5983033.
      Citations: 1     Fields:    Translation:Humans
    207. Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E, Chouinard S, Beland M. Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. JAMA. 2016 Jul 05; 316(1):40-50. PMID: 27380342.
      Citations: 48     Fields:    Translation:Humans
    208. Jankovic J, Baizabal-Carvallo JF. Functional (psychogenic) saccadic oscillations and oculogyric crises. Lancet Neurol. 2016 07; 15(8):791. PMID: 27302355.
      Citations:    Fields:    Translation:Humans
    209. Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, Cheng L, Zhai H, Deng S, Nuytemans K, Corbett NJ, Kim MJ, Deng H, Tang B, Yang Z, Xu Y, Chan P, Huang B, Gao XP, Song Z, Liu Z, Fecto F, Siddique N, Foroud T, Jankovic J, Ghetti B, Nicholson DA, Krainc D, Melen O, Vance JM, Pericak-Vance MA, Ma YC, Rajput AH, Siddique T. Identification of TMEM230 mutations in familial Parkinson's disease. Nat Genet. 2016 07; 48(7):733-9. PMID: 27270108; PMCID: PMC6047531.
      Citations: 64     Fields:    Translation:HumansCells
    210. Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs. 2016 May; 76(7):779-87. PMID: 27091214.
      Citations: 14     Fields:    Translation:Humans
    211. Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. Drugs. 2016 May; 76(7):759-77. PMID: 27091215.
      Citations: 33     Fields:    Translation:Humans
    212. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016 May 10; 86(19):1818-26. PMID: 27164716; PMCID: PMC4862245.
      Citations: 165     Fields:    Translation:Humans
    213. LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah HA, Rosen AR, Hedera P, Comella CL, Weissbach A, Junker J, Jankovic J, Barbano RL, Reich SG, Rodriguez RL, Berman BD, Chouinard S, Severt L, Agarwal P, Stover NP. Clinical and genetic features of cervical dystonia in a large multicenter cohort. Neurol Genet. 2016 Jun; 2(3):e69. PMID: 27123488; PMCID: PMC4830199.
      Citations: 20     
    214. Comella CL, Perlmutter JS, Jinnah HA, Waliczek TA, Rosen AR, Galpern WR, Adler CA, Barbano RL, Factor SA, Goetz CG, Jankovic J, Reich SG, Rodriguez RL, Severt WL, Zurowski M, Fox SH, Stebbins GT. Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord. 2016 Apr; 31(4):563-9. PMID: 26971359; PMCID: PMC4833533.
      Citations: 15     Fields:    Translation:Humans
    215. Lotia M, Jankovic J. New and emerging medical therapies in Parkinson's disease. Expert Opin Pharmacother. 2016; 17(7):895-909. PMID: 26830844.
      Citations: 10     Fields:    Translation:Humans
    216. Jankovic J, Baizabal-Carvallo JF. Parkinsonism, movement disorders and genetics in frontotemporal dementia. Nat Rev Neurol. 2016 Mar; 12(3):175-85. PMID: 26891767.
      Citations: 35     Fields:    Translation:HumansAnimals
    217. Lotia M, Jankovic J. Botulinum Toxin for the Treatment of Tremor and Tics. Semin Neurol. 2016 Feb; 36(1):54-63. PMID: 26866497.
      Citations: 6     Fields:    Translation:HumansAnimals
    218. Thenganatt MA, Jankovic J. Recent Advances in Understanding and Managing Tourette Syndrome. F1000Res. 2016; 5. PMID: 26918185; PMCID: PMC4755417.
      Citations: 17     Fields:    
    219. Jankovic J. How Do I Examine for Re-Emergent Tremor? Mov Disord Clin Pract. 2016 Mar-Apr; 3(2):216-217. PMID: 30363601; PMCID: PMC6178735.
      Citations: 3     
    220. Jankovic J, Baizabal-Carvallo JF. Psychogenic Ophthalmologic Movement Disorders. J Neuropsychiatry Clin Neurosci. 2016; 28(3):195-8. PMID: 26792096.
      Citations: 2     Fields:    Translation:Humans
    221. Jankovic J, Baizabal-Carvallo JF. Movement disorders induced by deep brain stimulation. Parkinsonism Relat Disord. 2016 Apr; 25:1-9. PMID: 26806438.
      Citations: 25     Fields:    Translation:Humans
    222. Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan; 73(1):102-10. PMID: 26569098.
      Citations: 22     Fields:    Translation:HumansCells
    223. Farlow JL, Robak LA, Hetrick K, Bowling K, Boerwinkle E, Coban-Akdemir ZH, Gambin T, Gibbs RA, Gu S, Jain P, Jankovic J, Jhangiani S, Kaw K, Lai D, Lin H, Ling H, Liu Y, Lupski JR, Muzny D, Porter P, Pugh E, White J, Doheny K, Myers RM, Shulman JM, Foroud T. Whole-Exome Sequencing in Familial Parkinson Disease. JAMA Neurol. 2016 Jan; 73(1):68-75. PMID: 26595808; PMCID: PMC4946647.
      Citations: 33     Fields:    Translation:Humans
    224. Thenganatt MA, Jankovic J. Psychogenic (functional) parkinsonism. Handb Clin Neurol. 2016; 139:259-262. PMID: 27719845.
      Citations: 2     Fields:    Translation:Humans
    225. Molho ES, Stacy M, Gillard P, Charles D, Adler CH, Jankovic J, Schwartz M, Brin MF. Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry. Mov Disord Clin Pract. 2016 Mar-Apr; 3(2):130-138. PMID: 27774495; PMCID: PMC5064605.
      Citations: 16     
    226. Oshima M, Deitiker P, Jankovic J, Aoki KR, Atassi MZ. Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 2016 Apr; 221(4):568-76. PMID: 26701846.
      Citations: 1     Fields:    Translation:HumansCells
    227. Thenganatt MA, Jankovic J. Response to Shill and colleagues. Parkinsonism Relat Disord. 2016 Feb; 23:108. PMID: 26639977.
      Citations:    Fields:    
    228. Wijemanne S, Jankovic J, Evans RW. Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine. Headache. 2016 Jan; 56(1):153-61. PMID: 26573884.
      Citations: 7     Fields:    Translation:Humans
    229. Ashoori A, Eagleman DM, Jankovic J. Effects of Auditory Rhythm and Music on Gait Disturbances in Parkinson's Disease. Front Neurol. 2015; 6:234. PMID: 26617566; PMCID: PMC4641247.
      Citations: 27     
    230. Jankovic J, Bressman S, Dauer W, Kang UJ. Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions. Mov Disord. 2015 Dec; 30(14):1862-9. PMID: 26477883.
      Citations: 3     Fields:    Translation:Humans
    231. Thenganatt MA, Jankovic J. The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2016 Jan; 22 Suppl 1:S162-5. PMID: 26522219.
      Citations: 39     Fields:    Translation:HumansAnimals
    232. Jankovic J. Therapeutic Developments for Tics and Myoclonus. Mov Disord. 2015 Sep 15; 30(11):1566-73. PMID: 26315614.
      Citations: 12     Fields:    Translation:Humans
    233. Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Mov Disord. 2015 Dec; 30(14):1885-92. PMID: 26260437.
      Citations: 31     Fields:    Translation:Humans
    234. Jankovic J. Leg stereotypy disorder. J Neurol Neurosurg Psychiatry. 2016 Feb; 87(2):220-1. PMID: 26209715.
      Citations: 2     Fields:    Translation:Humans
    235. Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, Dale RC, Vincent A, Lim M, King M. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e130. PMID: 26236759; PMCID: PMC4516400.
      Citations: 26     Fields:    
    236. Jankovic J, Baizabal-Carvallo JF. Speech and voice disorders in patients with psychogenic movement disorders. J Neurol. 2015 Nov; 262(11):2420-4. PMID: 26194199.
      Citations: 8     Fields:    Translation:Humans
    237. Waln O, Wu Y, Perlman R, Wendt J, Van AK, Jankovic J. Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm (Vienna). 2015 Nov; 122(11):1515-21. PMID: 26133163.
      Citations: 8     Fields:    Translation:Humans
    238. Feng Y, Liu T, Dong SY, Guo YJ, Jankovic J, Xu H, Wu YC. Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cells. J Neurochem. 2015 Aug; 134(4):668-76. PMID: 25991017.
      Citations: 34     Fields:    Translation:HumansCells
    239. Wijemanne S, Jankovic J. Dopa-responsive dystonia--clinical and genetic heterogeneity. Nat Rev Neurol. 2015 Jul; 11(7):414-24. PMID: 26100751.
      Citations: 59     Fields:    Translation:Humans
    240. Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, Henderson JM, Stern M, Baltuch G, Goetz CG, Herzog C, Kordower JH, Alterman R, Lozano AM, Lang AE. Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial. Ann Neurol. 2015 Aug; 78(2):248-57. PMID: 26061140.
      Citations: 99     Fields:    Translation:HumansCells
    241. Calleo JS, Amspoker AB, Sarwar AI, Kunik ME, Jankovic J, Marsh L, York M, Stanley MA. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7. PMID: 26047635.
      Citations: 14     Fields:    Translation:Humans
    242. Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Natural history of multiple system atrophy in the USA: a prospective cohort study. Lancet Neurol. 2015 Jul; 14(7):710-9. PMID: 26025783; PMCID: PMC4472464.
      Citations: 93     Fields:    Translation:Humans
    243. Wijemanne S, Shulman JM, Jimenez-Shahed J, Curry D, Jankovic J. SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia. Mov Disord Clin Pract. 2015 Jun; 2(2):149-154. PMID: 30363882; PMCID: PMC6183009.
      Citations: 4     
    244. Deng H, Zheng W, Jankovic J. Genetics and molecular biology of brain calcification. Ageing Res Rev. 2015 Jul; 22:20-38. PMID: 25906927.
      Citations: 14     Fields:    Translation:HumansCells
    245. Jost WH, Benecke R, Hauschke D, Jankovic J, Simpson DM, Comella CL, Kanovsk? P, Roggenk?mper P. Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders. Drug Des Devel Ther. 2015; 9:1913-26. PMID: 25897202; PMCID: PMC4389813.
      Citations: 10     Fields:    Translation:Humans
    246. Wijemanne S, Jankovic J. Restless legs syndrome: clinical presentation diagnosis and treatment. Sleep Med. 2015 Jun; 16(6):678-90. PMID: 25979181.
      Citations: 11     Fields:    Translation:Humans
    247. Kluger B, Triolo P, Jones W, Jankovic J. The therapeutic potential of cannabinoids for movement disorders. Mov Disord. 2015 Mar; 30(3):313-27. PMID: 25649017; PMCID: PMC4357541.
      Citations: 28     Fields:    Translation:HumansAnimals
    248. Waln O, Jankovic J. Paroxysmal movement disorders. Neurol Clin. 2015 Feb; 33(1):137-52. PMID: 25432727.
      Citations: 16     Fields:    Translation:Humans
    249. Thenganatt MA, Jankovic J. Psychogenic movement disorders. Neurol Clin. 2015 Feb; 33(1):205-24. PMID: 25432730.
      Citations: 20     Fields:    Translation:Humans
    250. Jankovic J. Gait disorders. Neurol Clin. 2015 Feb; 33(1):249-68. PMID: 25432732.
      Citations: 14     Fields:    Translation:Humans
    251. Jankovic J. Movement disorders. Neurol Clin. 2015 Feb; 33(1):xv-xvi. PMID: 25432734.
      Citations:    Fields:    Translation:Humans
    252. Baizabal-Carvallo JF, Xia G, Botros P, Laguna J, Ashizawa T, Jankovic J. Bolivian kindred with combined spinocerebellar ataxia types 2 and 10. Acta Neurol Scand. 2015 Aug; 132(2):139-42. PMID: 25630585; PMCID: PMC4496286.
      Citations: 6     Fields:    Translation:HumansCells
    253. Jankovic J, Adler CH, Charles D, Comella C, Stacy M, Schwartz M, Manack Adams A, Brin MF. Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE). J Neurol Sci. 2015 Feb 15; 349(1-2):84-93. PMID: 25595221.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    254. Feng Y, Jankovic J, Wu YC. Epigenetic mechanisms in Parkinson's disease. J Neurol Sci. 2015 Feb 15; 349(1-2):3-9. PMID: 25553963.
      Citations: 41     Fields:    Translation:HumansCells
    255. Jankovic J, Baizabal-Carvallo JF. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015 Aug; 86(8):840-8. PMID: 25511790.
      Citations: 42     Fields:    Translation:Humans
    256. Cardoso F, Jankovic J, Baizabal-Carvallo JF. Myorhythmia: phenomenology, etiology, and treatment. Mov Disord. 2015 Feb; 30(2):171-9. PMID: 25487777.
      Citations: 20     Fields:    Translation:HumansAnimals
    257. Inzelberg R, Hassin-Baer S, Jankovic J. Genetic movement disorders in patients of Jewish ancestry. JAMA Neurol. 2014 Dec; 71(12):1567-72. PMID: 25347348.
      Citations: 5     Fields:    Translation:Humans
    258. Fekete R, Jankovic J. Upper facial chorea in Huntington disease. J Clin Mov Disord. 2014; 1:7. PMID: 26788333; PMCID: PMC4711000.
      Citations: 5     
    259. Wijemanne S, Jankovic J. Movement disorders in catatonia. J Neurol Neurosurg Psychiatry. 2015 Aug; 86(8):825-32. PMID: 25411548.
      Citations: 5     Fields:    Translation:Humans
    260. Jankovic J, Sherer T. The future of research in Parkinson disease. JAMA Neurol. 2014 Nov; 71(11):1351-2. PMID: 25178587.
      Citations: 14     Fields:    Translation:HumansAnimals
    261. Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, Illmann C, McGrath LM, Mayerfeld C, Arepalli S, Barlassina C, Barr CL, Bellodi L, Benarroch F, Bienvenu OJ, Black DW, Bloch MH, Brentani H, Bruun RD, Budman CL, Camarena B, Campbell DD, Cappi C, Silgado JC, Cavallini MC, Chavira DA, Chouinard S, Cook EH, Cookson MR, Coric V, Cullen B, Cusi D, Delorme R, Denys D, Dion Y, Eapen V, Egberts K, Falkai P, Fernandez T, Fournier E, Garrido H, Geller D, Gilbert DL, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Hardy J, Heiman GA, Hemmings SM, Herrera LD, Hezel DM, Hoekstra PJ, Jankovic J, Kennedy JL, King RA, Konkashbaev AI, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Lupoli S, Macciardi F, Maier W, Manunta P, Marconi M, McCracken JT, Mesa Restrepo SC, Moessner R, Moorjani P, Morgan J, Muller H, Murphy DL, Naarden AL, Nurmi E, Ochoa WC, Ophoff RA, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner T, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosenberg D, Ruhrmann S, Sabatti C, Salvi E, Sampaio AS, Samuels J, Sandor P, Service SK, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Turiel M, Valencia Duarte AV, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Weale M, Weiss R, Wendland JR, Westenberg HG, Shugart YY, Hounie AG, Miguel EC, Nicolini H, Wagner M, Ruiz-Linares A, Cath DC, McMahon W, Posthuma D, Oostra BA, Nestadt G, Rouleau GA, Purcell S, Jenike MA, Heutink P, Hanna GL, Conti DV, Arnold PD, Freimer NB, Stewart SE, Knowles JA, Cox NJ, Pauls DL, Berri? GB, Gr?nblatt E, Ros?rio MC. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry. 2015 Jan; 172(1):82-93. PMID: 25158072; PMCID: PMC4282594.
      Citations: 47     Fields:    Translation:Humans
    262. Factor SA, Jankovic J. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014 Oct 07; 83(15):1388-9. PMID: 25288700.
      Citations: 3     Fields:    Translation:Humans
    263. Black KJ, Jankovic J, Hershey T, McNaught KS, Mink JW, Walkup J. Progress in research on Tourette syndrome. J Obsessive Compuls Relat Disord. 2014 Oct 01; 3(4):359-362. PMID: 25436182; PMCID: PMC4243166.
      Citations: 5     
    264. Giladi N, Ghys L, Surmann E, Boroojerdi B, Jankovic J. Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease. Parkinsonism Relat Disord. 2014 Dec; 20(12):1345-51. PMID: 25444083.
      Citations: 8     Fields:    Translation:Humans
    265. Jankovic J. "Psychogenic" versus "functional" movement disorders? That is the question. Mov Disord. 2014 Nov; 29(13):1697-8. PMID: 25255973.
      Citations: 3     Fields:    Translation:Humans
    266. Thenganatt MA, Jankovic J. Psychogenic tremor: a video guide to its distinguishing features. Tremor Other Hyperkinet Mov (N Y). 2014; 4:253. PMID: 25243097; PMCID: PMC4161970.
      Citations: 12     Fields:    
    267. Jankovic J, Roos RA. Chorea associated with Huntington's disease: to treat or not to treat? Mov Disord. 2014 Sep 15; 29(11):1414-8. PMID: 25156927.
      Citations: 14     Fields:    Translation:Humans
    268. Ramirez-Castaneda J, Jankovic J. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon. 2014 Nov; 90:344-8. PMID: 25130293.
      Citations: 32     Fields:    Translation:Humans
    269. Evidente VG, Truong D, Jankovic J, Comella CL, Grafe S, Hanschmann A. IncobotulinumtoxinA (Xeomin?) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014 Nov 15; 346(1-2):116-20. PMID: 25186131.
      Citations: 12     Fields:    Translation:Humans
    270. Deng H, Xiu X, Jankovic J. Genetic convergence of Parkinson's disease and lysosomal storage disorders. Mol Neurobiol. 2015; 51(3):1554-68. PMID: 25099932.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    271. Feng Y, Liu T, Li XQ, Liu Y, Zhu XY, Jankovic J, Pan TH, Wu YC. Neuroprotection by Orexin-A via HIF-1a induction in a cellular model of Parkinson's disease. Neurosci Lett. 2014 Sep 05; 579:35-40. PMID: 25038418.
      Citations: 26     Fields:    Translation:HumansCells
    272. Fernandez HH, Jankovic J, Holds JB, Lin D, Burns J, Verma A, Sethi K, Pappert EJ. Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm. Tremor Other Hyperkinet Mov (N Y). 2014; 4:238. PMID: 25120942; PMCID: PMC4107228.
      Citations: 4     Fields:    
    273. McGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, Gallagher P, Fagerness JA, Barr CL, Benarroch F, Bienvenu OJ, Black DW, Bloch MH, Bruun RD, Budman CL, Cath DC, Cavallini MC, Chouinard S, Coric V, Cullen B, Delorme R, Denys D, Derks EM, Dion Y, Eapen V, Evans P, Falkai P, Fernandez TV, Geller D, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Heiman GA, Hemmings SM, Jankovic J, Kennedy JL, King RA, Kurlan R, Lanzagorta N, Leckman JF, Lennertz L, Lochner C, Lowe TL, Lyon GJ, Macciardi F, Maier W, McCracken JT, McMahon W, Murphy DL, Naarden AL, Neale BM, Nurmi E, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Reus VI, Richter MA, Riddle M, Robertson MM, Rosenberg D, Rouleau GA, Ruhrmann S, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Tischfield JA, Veenstra-VanderWeele J, Wang Y, Wendland JR, Shugart YY, Nicolini H, Oostra BA, Moessner R, Wagner M, Ruiz-Linares A, Heutink P, Nestadt G, Freimer N, Petryshen T, Posthuma D, Jenike MA, Cox NJ, Hanna GL, Scherer SW, Arnold PD, Stewart SE, Mathews CA, Knowles JA, Cook EH, Pauls DL, Wang K, Scharf JM, Cappi C, Bellodi L, Camarena B, Ros?rio MC, Garrido H, Gr?nblatt E, Herrera LD, Hounie AG, Leboyer M, Sampaio AS, Vallada H, Walitza S, Miguel EC, Brentani H. Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. J Am Acad Child Adolesc Psychiatry. 2014 Aug; 53(8):910-9. PMID: 25062598; PMCID: PMC4218748.
      Citations: 54     Fields:    Translation:Humans
    274. DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Neurohistopathological findings at the electrode-tissue interface in long-term deep brain stimulation: systematic literature review, case report, and assessment of stimulation threshold safety. Neuromodulation. 2014 Jul; 17(5):405-18; discussion 418. PMID: 24947418.
      Citations: 7     Fields:    Translation:Humans
    275. Deng H, Gao K, Jankovic J. The role of FUS gene variants in neurodegenerative diseases. Nat Rev Neurol. 2014 Jun; 10(6):337-48. PMID: 24840975.
      Citations: 114     Fields:    Translation:Humans
    276. Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Sandler DP, Langston JW, Tanner CM. Peptidoglycan recognition protein genes and risk of Parkinson's disease. Mov Disord. 2014 Aug; 29(9):1171-80. PMID: 24838182; PMCID: PMC4777298.
      Citations: 19     Fields:    Translation:Humans
    277. Patel N, Hanfelt J, Marsh L, Jankovic J, members of the Dystonia Coalition. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):882-4. PMID: 24828895; PMCID: PMC4871143.
      Citations: 29     Fields:    Translation:Humans
    278. Charles PD, Adler CH, Stacy M, Comella C, Jankovic J, Manack Adams A, Schwartz M, Brin MF. Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy). J Neurol. 2014 Jul; 261(7):1309-19. PMID: 24752807; PMCID: PMC4098041.
      Citations: 21     Fields:    Translation:Humans
    279. Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014 Apr; 71(4):499-504. PMID: 24514863.
      Citations: 147     Fields:    Translation:Humans
    280. Jankovic J, Berkovich E, Eyal E, Tolosa E. Symptomatic efficacy of rasagiline monotherapy in early Parkinson's disease: post-hoc analyses from the ADAGIO trial. Parkinsonism Relat Disord. 2014 Jun; 20(6):640-3. PMID: 24637126.
      Citations: 11     Fields:    Translation:Humans
    281. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Reply: dystonia after severe head injuries. Mov Disord. 2014 Apr; 29(4):578-9. PMID: 24590449.
      Citations:    Fields:    Translation:Humans
    282. Galpern WR, Coffey CS, Albanese A, Cheung K, Comella CL, Ecklund DJ, Fahn S, Jankovic J, Kieburtz K, Lang AE, McDermott MP, Shefner JM, Teller JK, Thompson JL, Yeatts SD, Jinnah HA. Designing clinical trials for dystonia. Neurotherapeutics. 2014 Jan; 11(1):117-27. PMID: 24282121; PMCID: PMC3899487.
      Citations: 8     Fields:    Translation:Humans
    283. Factor SA, Jankovic J. Editorial: Neurotherapeutics of movement disorders. Neurotherapeutics. 2014 Jan; 11(1):3-5. PMID: 24366609; PMCID: PMC3899485.
      Citations:    Fields:    Translation:HumansAnimals
    284. Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. Lancet Neurol. 2014 Jan; 13(1):100-12. PMID: 24331796; PMCID: PMC4759644.
      Citations: 97     Fields:    Translation:HumansAnimals
    285. Thenganatt MA, Jankovic J. Treatment of dystonia. Neurotherapeutics. 2014 Jan; 11(1):139-52. PMID: 24142590; PMCID: PMC3899473.
      Citations: 20     Fields:    Translation:Humans
    286. Le W, Sayana P, Jankovic J. Animal models of Parkinson's disease: a gateway to therapeutics? Neurotherapeutics. 2014 Jan; 11(1):92-110. PMID: 24158912; PMCID: PMC3899493.
      Citations: 32     Fields:    Translation:HumansAnimals
    287. Jankovic J, Baizabal-Carvallo JF. The clinical features of psychogenic movement disorders resembling tics. J Neurol Neurosurg Psychiatry. 2014 May; 85(5):573-5. PMID: 24259592.
      Citations: 26     Fields:    Translation:Humans
    288. Defazio G, Jankovic J, Giel JL, Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 24255801; PMCID: PMC3822401.
      Citations: 46     Fields:    
    289. Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, Bloch MH, Blom RM, Bruun RD, Budman CL, Camarena B, Campbell D, Cappi C, Cardona Silgado JC, Cath DC, Cavallini MC, Chavira DA, Chouinard S, Conti DV, Cook EH, Coric V, Cullen BA, Deforce D, Delorme R, Dion Y, Edlund CK, Egberts K, Falkai P, Fernandez TV, Gallagher PJ, Garrido H, Geller D, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Haddad S, Heiman GA, Hemmings SM, Hounie AG, Illmann C, Jankovic J, Jenike MA, Kennedy JL, King RA, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Macciardi F, McCracken JT, McGrath LM, Mesa Restrepo SC, Moessner R, Morgan J, Muller H, Murphy DL, Naarden AL, Ochoa WC, Ophoff RA, Osiecki L, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner TJ, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosenberg D, Rouleau GA, Ruhrmann S, Ruiz-Linares A, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Valencia Duarte AV, Vallada H, Van Nieuwerburgh F, Veenstra-Vanderweele J, Walitza S, Wang Y, Wendland JR, Westenberg HG, Shugart YY, Miguel EC, McMahon W, Wagner M, Nicolini H, Posthuma D, Hanna GL, Heutink P, Denys D, Arnold PD, Oostra BA, Nestadt G, Freimer NB, Pauls DL, Wray NR, Stewart SE, Mathews CA, Knowles JA, Cox NJ, Scharf JM, Ros?rio MC. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet. 2013 Oct; 9(10):e1003864. PMID: 24204291; PMCID: PMC3812053.
      Citations: 116     Fields:    Translation:Humans
    290. Shen V, Clarence-Smith K, Hunter C, Jankovic J. Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 24255799; PMCID: PMC3822048.
      Citations: 9     Fields:    
    291. Wijemanne S, Wu LJ, Jankovic J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord. 2014 Jan; 29(1):126-30. PMID: 24150997.
      Citations: 11     Fields:    Translation:Humans
    292. Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J, Baizabal-Carvallo JF. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry. 2014 May; 85(5):567-72. PMID: 24096713.
      Citations: 52     Fields:    Translation:Humans
    293. Patel AJ, Sarwar AI, Jankovic J, Viswanathan A. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism. World Neurosurg. 2014 Jul-Aug; 82(1-2):241.e1-4. PMID: 24076056.
      Citations: 10     Fields:    Translation:Humans
    294. Strickland BA, Jimenez-Shahed J, Jankovic J, Viswanathan A. Radiofrequency lesioning through deep brain stimulation electrodes: a pilot study of lesion geometry and temperature characteristics. J Clin Neurosci. 2013 Dec; 20(12):1709-12. PMID: 24035651.
      Citations: 2     Fields:    Translation:Animals
    295. Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S, APEX-PD Investigators. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Parkinsonism Relat Disord. 2014 Feb; 20(2):142-8. PMID: 24055014.
      Citations: 34     Fields:    Translation:Humans
    296. Mehanna R, Jankovic J. Restless legs syndrome and cerebrovascular disease - authors' reply. Lancet Neurol. 2013 Aug; 12(8):734-5. PMID: 23867192.
      Citations:    Fields:    Translation:HumansAnimals
    297. Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013 Nov; 28(13):1775-83. PMID: 23868503.
      Citations: 46     Fields:    Translation:HumansAnimals
    298. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23858394; PMCID: PMC3709416.
      Citations: 64     Fields:    
    299. Louis ED, Bain PG, Hallett M, Jankovic J, Vonsattel JP. What is It? Difficult to Pigeon Hole Tremor: a Clinical-Pathological Study of a Man with Jaw Tremor. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23864988; PMCID: PMC3712322.
      Citations:    Fields:    
    300. Jankovic J. Medical treatment of dystonia. Mov Disord. 2013 Jun 15; 28(7):1001-12. PMID: 23893456.
      Citations: 52     Fields:    Translation:Humans
    301. Fernandez HH, Pagan F, Danisi F, Greeley D, Jankovic J, Verma A, Sethi K, Pappert EJ, XCiDaBLE Study Group. Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23724362; PMCID: PMC3638085.
      Citations: 10     Fields:    
    302. Jankovic J, Feld J, Baizabal-Carvallo JF. Flu-like symptoms and associated immunological response following therapy with botulinum toxins. Neurotox Res. 2013 Aug; 24(2):298-306. PMID: 23677449.
      Citations: 7     Fields:    Translation:Humans
    303. Jankovic J, Baizabal-Carvallo JF. Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism. Neuromodulation. 2014 Jan; 17(1):104-6. PMID: 23663196.
      Citations: 3     Fields:    Translation:Humans
    304. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, Hallett M, Jankovic J, Jinnah HA, Klein C, Lang AE, Mink JW, Teller JK. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013 Jun 15; 28(7):863-73. PMID: 23649720; PMCID: PMC3729880.
      Citations: 584     Fields:    Translation:Humans
    305. Waln O, Jankovic J. Zolpidem improves tardive dyskinesia and akathisia. Mov Disord. 2013 Oct; 28(12):1748-9. PMID: 23637028.
      Citations: 13     Fields:    Translation:Humans
    306. Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, Young AB, Shoulson I. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 2013 May 28; 80(22):2022-7. PMID: 23624566; PMCID: PMC3716408.
      Citations: 25     Fields:    Translation:HumansCells
    307. Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013 Jun; 12(6):597-608. PMID: 23602779.
      Citations: 63     Fields:    Translation:HumansAnimals
    308. Fernandez HH, Pappert EJ, Comella CL, Evidente VG, Truong DD, Verma A, Jankovic J. Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Na?ve Subjects with Cervical Dystonia. Tremor Other Hyperkinet Mov (N Y). 2013; 3. PMID: 23610743; PMCID: PMC3629862.
      Citations: 7     Fields:    
    309. Bonnet C, Jankovic J, Baizabal-Carvallo JF. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna). 2013 Nov; 120(11):1579-89. PMID: 23580159.
      Citations: 22     Fields:    Translation:Humans
    310. Waln O, Jankovic J. Bilateral globus pallidus internus deep brain stimulation after bilateral pallidotomy in a patient with generalized early-onset primary dystonia. Mov Disord. 2013 Jul; 28(8):1162-3. PMID: 23580321.
      Citations: 3     Fields:    Translation:Humans
    311. Deng H, Gao K, Jankovic J. The VPS35 gene and Parkinson's disease. Mov Disord. 2013 May; 28(5):569-75. PMID: 23536430.
      Citations: 39     Fields:    Translation:HumansAnimals
    312. Dhungana S, Jankovic J. Yips and other movement disorders in golfers. Mov Disord. 2013 May; 28(5):576-81. PMID: 23519739.
      Citations: 11     Fields:    Translation:Humans
    313. Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci. 2013 May 15; 328(1-2):1-8. PMID: 23522528.
      Citations: 21     Fields:    Translation:Humans
    314. Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH, Xeomin US Blepharospasm Study Group. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(?)) injections in blepharospasm. J Neural Transm (Vienna). 2013 Sep; 120(9):1345-53. PMID: 23435927; PMCID: PMC3751217.
      Citations: 17     Fields:    Translation:Humans
    315. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70. PMID: 23408503.
      Citations: 220     Fields:    Translation:Humans
    316. Stocco A, Muscal E, Jankovic J, Baizabal-Carvallo JF. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013 Apr; 28(4):543-7. PMID: 23400857.
      Citations: 32     Fields:    Translation:Humans
    317. Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013 Jun 01; 67:94-114. PMID: 23380701.
      Citations: 74     Fields:    Translation:Humans
    318. Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013 Feb 04; 5(2):249-66. PMID: 23381141; PMCID: PMC3640534.
      Citations: 31     Fields:    Translation:Humans
    319. Deng H, Liang H, Jankovic J. F-box only protein 7 gene in parkinsonian-pyramidal disease. JAMA Neurol. 2013 Jan; 70(1):20-4. PMID: 23318512.
      Citations: 19     Fields:    Translation:Humans
    320. Schneider SA, Dusek P, Hardy J, Westenberger A, Jankovic J, Bhatia KP. Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA). Curr Neuropharmacol. 2013 Jan; 11(1):59-79. PMID: 23814539; PMCID: PMC3580793.
      Citations: 45     Fields:    
    321. Mehanna R, Hunter C, Davidson A, Jimenez-Shahed J, Jankovic J. Analysis of CYP2D6 genotype and response to tetrabenazine. Mov Disord. 2013 Feb; 28(2):210-5. PMID: 23280482.
      Citations: 13     Fields:    Translation:Humans
    322. Mehanna R, Jankovic J. Respiratory disorders associated with dystonia. Mov Disord. 2012 Dec; 27(14):1816-9. PMID: 23208724.
      Citations: 4     Fields:    Translation:Humans
    323. Naumann M, Dressler D, Hallett M, Jankovic J, Schiavo G, Segal KR, Truong D. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon. 2013 Jun 01; 67:141-52. PMID: 23178324.
      Citations: 17     Fields:    Translation:Humans
    324. Baizabal-Carvallo JF, Jankovic J. Spinocerebellar ataxia types 2 and 10: more than a coincidental association? Arch Neurol. 2012 Nov; 69(11):1524-5; Author reply 1525. PMID: 23117922.
      Citations: 1     Fields:    Translation:Humans
    325. Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, Watts R, Zesiewicz T. Reliability of a new scale for essential tremor. Mov Disord. 2012 Oct; 27(12):1567-9. PMID: 23032792; PMCID: PMC4157921.
      Citations: 56     Fields:    Translation:Humans
    326. Ferrara JM, Mostile G, Hunter C, Adam OR, Jankovic J. Effect of tetrabenazine on motor function in patients with huntington disease. Neurol Ther. 2012 Dec; 1(1):5. PMID: 26000211; PMCID: PMC4389035.
      Citations: 4     
    327. Squitieri F, Jankovic J. Huntington's disease: how intermediate are intermediate repeat lengths? Mov Disord. 2012 Dec; 27(14):1714-7. PMID: 23008174.
      Citations: 15     Fields:    Translation:HumansCells
    328. Pan T, Zhu J, Hwu WJ, Jankovic J. The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One. 2012; 7(9):e45183. PMID: 23028833; PMCID: PMC3446957.
      Citations: 40     Fields:    Translation:HumansCells
    329. Ondo WG, Jankovic J, Simpson R, Jimenez-Shahed J. Globus pallidus deep brain stimulation for refractory idiopathic restless legs syndrome. Sleep Med. 2012 Oct; 13(9):1202-4. PMID: 22995627.
      Citations: 5     Fields:    Translation:Humans
    330. Zhang Z, Li X, Xie WJ, Tuo H, Hintermann S, Jankovic J, Le W. Anti-parkinsonian effects of Nurr1 activator in ubiquitin-proteasome system impairment induced animal model of Parkinson's disease. CNS Neurol Disord Drug Targets. 2012 Sep; 11(6):768-73. PMID: 22483304.
      Citations: 15     Fields:    Translation:AnimalsCells
    331. Guo Y, Deng X, Jankovic J, Su L, Zhang J, Le W, Xu H, Yang Z, Tang J, Kuang S, Deng H. Mutation screening of the HTR2B gene in patients with Tourette syndrome. Neurosci Lett. 2012 Sep 27; 526(2):150-3. PMID: 22917605.
      Citations: 2     Fields:    Translation:Humans
    332. Fekete R, Davidson A, Jankovic J. Clinical assessment of the effect of tetrabenazine on functional scales in huntington disease: a pilot open label study. Tremor Other Hyperkinet Mov (N Y). 2012; 2. PMID: 23439575; PMCID: PMC3569975.
      Citations: 1     Fields:    
    333. Jankovic J. Current concepts in Parkinson's disease and other movement disorders. Curr Opin Neurol. 2012 Aug; 25(4):429-32. PMID: 22772873.
      Citations: 2     Fields:    Translation:Humans
    334. Mahlknecht P, Jankovic J, Poewe W. Emerging therapies for Parkinson's disease. Curr Opin Neurol. 2012 Aug; 25(4):448-59. PMID: 22772874.
      Citations: 23     Fields:    Translation:Humans
    335. Jankovic J, Poewe W. Therapies in Parkinson's disease. Curr Opin Neurol. 2012 Aug; 25(4):433-47. PMID: 22691758.
      Citations: 54     Fields:    Translation:Humans
    336. Mostile G, Almaguer M, Davidson A, Simpson R, Jankovic J, Baizabal Carvallo JF. Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlations. Stereotact Funct Neurosurg. 2012; 90(5):300-6. PMID: 22797749.
      Citations: 17     Fields:    Translation:Humans
    337. Kansara S, Trivedi A, Chen S, Jankovic J, Le W. Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed? J Neural Transm (Vienna). 2013 Jan; 120(1):197-210. PMID: 22733089.
      Citations: 4     Fields:    Translation:Humans
    338. Viswanathan A, Jimenez-Shahed J, Jankovic J, Baizabal Carvallo JF. Deep brain stimulation for Tourette syndrome: target selection. Stereotact Funct Neurosurg. 2012; 90(4):213-24. PMID: 22699684.
      Citations: 31     Fields:    Translation:Humans
    339. Fekete R, Jankovic J. Childhood stiff-person syndrome improved with rituximab. Case Rep Neurol. 2012 May; 4(2):92-6. PMID: 22740823; PMCID: PMC3383307.
      Citations: 11     
    340. Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31. PMID: 22632922.
      Citations: 11     Fields:    Translation:Humans
    341. Mostile G, Fekete R, Giuffrida JP, Yaltho T, Davidson A, Nicoletti A, Zappia M, Jankovic J. Amplitude fluctuations in essential tremor. Parkinsonism Relat Disord. 2012 Aug; 18(7):859-63. PMID: 22591578.
      Citations: 17     Fields:    Translation:Humans
    342. Jankovic J, Baizabal-Carvallo JF. Movement disorders in autoimmune diseases. Mov Disord. 2012 Jul; 27(8):935-46. PMID: 22555904.
      Citations: 32     Fields:    Translation:Humans
    343. Deng H, Gao K, Jankovic J. The genetics of Tourette syndrome. Nat Rev Neurol. 2012 Mar 13; 8(4):203-13. PMID: 22410579.
      Citations: 31     Fields:    Translation:Humans
    344. Elmer LW, Surmann E, Boroojerdi B, Jankovic J. Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study. Parkinsonism Relat Disord. 2012 Jun; 18(5):488-93. PMID: 22326237.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    345. Ha AD, Beck CA, Jankovic J. Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT. Tremor Other Hyperkinet Mov (N Y). 2012; 2. PMID: 23440000; PMCID: PMC3569951.
      Citations: 13     Fields:    
    346. Li XP, Xie WJ, Zhang Z, Kansara S, Jankovic J, Le WD. A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration. Neurosignals. 2012; 20(4):223-36. PMID: 22269801.
      Citations: 10     Fields:    Translation:HumansCells
    347. Dusek P, Jankovic J, Le W. Iron dysregulation in movement disorders. Neurobiol Dis. 2012 Apr; 46(1):1-18. PMID: 22266337.
      Citations: 57     Fields:    Translation:HumansAnimals
    348. Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, Alterman R, Jankovic J, Simpson R, Junn F, Verhagen L, Arle JE, Ford B, Goodman RR, Stewart RM, Horn S, Baltuch GH, Kopell BH, Marshall F, Peichel D, Pahwa R, Lyons KE, Vitek JL, Tagliati M, SJM DBS Study Group, Tr?ster AI. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol. 2012 Feb; 11(2):140-9. PMID: 22239915.
      Citations: 117     Fields:    Translation:Humans
    349. Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. Head injury, a-synuclein Rep1, and Parkinson's disease. Ann Neurol. 2012 Jan; 71(1):40-8. PMID: 22275250; PMCID: PMC3270814.
      Citations: 31     Fields:    Translation:HumansCells
    350. Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, Caraballo R, Echenne B, Fejerman N, Frucht S, Gurnett CA, Hirsch E, Houlden H, Jankovic J, Lee WL, Lynch DR, Mohammed S, Nespeca MP, Renner D, Rochette J, Rudolf G, Saiki S, Soong BW, Swoboda KJ, Tucker S, Wood N, Hanna M, Bowcock AM, Szepetowski P, Fu YH, M?ller U, Pt?cek LJ. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012 Jan 26; 1(1):2-12. PMID: 22832103; PMCID: PMC3334308.
      Citations: 96     Fields:    Translation:HumansAnimalsCells
    351. Lees A, Fahn S, Eggert KM, Jankovic J, Lang A, Micheli F, Mouradian MM, Oertel WH, Olanow CW, Poewe W, Rascol O, Tolosa E, Squillacote D, Kumar D. Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Mov Disord. 2012 Feb; 27(2):284-8. PMID: 22161845.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    352. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. J Neuroimmunol. 2011 Dec 15; 240-241:121-8. PMID: 22079193.
      Citations: 4     Fields:    Translation:HumansCells
    353. Jankovic J, Adler CH, Charles PD, Comella C, Stacy M, Schwartz M, Sutch SM, Brin MF, Papapetropoulos S. Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE). BMC Neurol. 2011 Nov 04; 11:140. PMID: 22054223; PMCID: PMC3220636.
      Citations: 11     Fields:    Translation:Humans
    354. Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother. 2011 Nov; 11(11):1509-23. PMID: 22014129.
      Citations: 33     Fields:    Translation:Humans
    355. Patel SS, Jankovic J, Hood AJ, Jeter CB, Sereno AB. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. J Neurol Sci. 2012 Feb 15; 313(1-2):35-41. PMID: 22018763; PMCID: PMC3254798.
      Citations: 14     Fields:    Translation:Humans
    356. Fekete R, Baizabal-Carvallo JF, Ha AD, Davidson A, Jankovic J. Convergence spasm in conversion disorders: prevalence in psychogenic and other movement disorders compared with controls. J Neurol Neurosurg Psychiatry. 2012 Feb; 83(2):202-4. PMID: 21949106.
      Citations: 14     Fields:    Translation:Humans
    357. Ha AD, Jankovic J. Pain in Parkinson's disease. Mov Disord. 2012 Apr; 27(4):485-91. PMID: 21953990.
      Citations: 60     Fields:    Translation:Humans
    358. Jankovic J. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry. 2011 Dec; 82(12):1300-3. PMID: 21933950.
      Citations: 12     Fields:    Translation:Humans
    359. Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8. PMID: 21689962.
      Citations: 31     Fields:    Translation:Humans
    360. Ha AD, Jankovic J. Exploring the correlates of intermediate CAG repeats in Huntington disease. Postgrad Med. 2011 Sep; 123(5):116-21. PMID: 21904093.
      Citations: 18     Fields:    Translation:HumansCells
    361. Atassi MZ, Jankovic J, Steward LE, Aoki KR, Dolimbek BZ. Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule. Immunobiology. 2012 Jan; 217(1):17-27. PMID: 21962573.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    362. Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T. Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals. 2011; 19(3):163-74. PMID: 21778691; PMCID: PMC3699815.
      Citations: 170     Fields:    Translation:HumansAnimalsCells
    363. Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S, U.S. XEOMIN Cervical Dystonia Study Group. Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN?, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. J Neurol Sci. 2011 Sep 15; 308(1-2):103-9. PMID: 21764407.
      Citations: 56     Fields:    Translation:Humans
    364. Oshima M, Deitiker PR, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients. J Neuroimmunol. 2011 Aug 15; 237(1-2):66-72. PMID: 21737146.
      Citations: 2     Fields:    Translation:HumansCells
    365. Simpson R, Jankovic J, Baizabal Carvallo JF. Diagnosis and treatment of complications related to deep brain stimulation hardware. Mov Disord. 2011 Jul; 26(8):1398-406. PMID: 21714001.
      Citations: 11     Fields:    Translation:Humans
    366. Strutt AM, Simpson R, Jankovic J, York MK. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7. PMID: 21668586.
      Citations: 21     Fields:    Translation:Humans
    367. Baizabal-Carvallo JF, Jankovic J, Pappert E. Flu-like symptoms following botulinum toxin therapy. Toxicon. 2011 Jul; 58(1):1-7. PMID: 21620881.
      Citations: 10     Fields:    Translation:Humans
    368. Heldman DA, Jankovic J, Vaillancourt DE, Prodoehl J, Elble RJ, Giuffrida JP. Essential tremor quantification during activities of daily living. Parkinsonism Relat Disord. 2011 Aug; 17(7):537-42. PMID: 21570891; PMCID: PMC3137659.
      Citations: 33     Fields:    Translation:Humans
    369. Jankovic J, Comella C, Hanschmann A, Grafe S. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial. Mov Disord. 2011 Jul; 26(8):1521-8. PMID: 21520284.
      Citations: 21     Fields:    Translation:Humans
    370. van Rooijen DE, Geraedts EJ, Marinus J, Jankovic J, van Hilten JJ. Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry. 2011 Aug; 82(8):892-8. PMID: 21493756.
      Citations: 31     Fields:    Translation:Humans
    371. Ha AD, Jankovic J. Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011 Jul; 26(8):1556-8. PMID: 21495070.
      Citations: 1     Fields:    Translation:Humans
    372. Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord. 2011 May; 26(6):1149-56. PMID: 21484868.
      Citations: 43     Fields:    Translation:Humans
    373. Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol. 2011 May; 10(5):415-23. PMID: 21482191.
      Citations: 60     Fields:    Translation:Humans
    374. Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord. 2011 Aug 01; 26(9):1582-92. PMID: 21469208.
      Citations: 45     Fields:    Translation:Humans
    375. Guo Y, Le WD, Jankovic J, Yang HR, Xu HB, Xie WJ, Song Z, Deng H. Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease. Mov Disord. 2011 Aug 01; 26(9):1729-32. PMID: 21469209.
      Citations: 3     Fields:    Translation:Humans
    376. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol. 2011 Apr; 178(4):1509-16. PMID: 21435440; PMCID: PMC3078443.
      Citations: 43     Fields:    Translation:Humans
    377. Pan T, Li X, Jankovic J. The association between Parkinson's disease and melanoma. Int J Cancer. 2011 May 15; 128(10):2251-60. PMID: 21207412.
      Citations: 44     Fields:    Translation:Humans
    378. Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011 Mar; 69(3):570-80. PMID: 21400565; PMCID: PMC3117674.
      Citations: 185     Fields:    Translation:HumansCells
    379. Squitieri F, Esmaeilzadeh M, Ciarmiello A, Jankovic J. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene. Mov Disord. 2011 Apr; 26(5):925-7. PMID: 21370274.
      Citations: 7     Fields:    Translation:HumansCells
    380. Fekete R, Jankovic J. Revisiting the relationship between essential tremor and Parkinson's disease. Mov Disord. 2011 Feb 15; 26(3):391-8. PMID: 21462256.
      Citations: 30     Fields:    Translation:Humans
    381. Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7. PMID: 21316292; PMCID: PMC3109216.
      Citations: 30     Fields:    Translation:Humans
    382. Jankovic J, Ha AD. An introduction to dyskinesia--the clinical spectrum. Int Rev Neurobiol. 2011; 98:1-29. PMID: 21907081.
      Citations: 4     Fields:    Translation:Humans
    383. Wu Y, Le W, Jankovic J. Preclinical biomarkers of Parkinson disease. Arch Neurol. 2011 Jan; 68(1):22-30. PMID: 21220674.
      Citations: 49     Fields:    Translation:HumansAnimals
    384. Ferrara J, Stamey W, Strutt AM, Adam OR, Jankovic J. Transcutaneous electrical stimulation (TENS) for psychogenic movement disorders. J Neuropsychiatry Clin Neurosci. 2011; 23(2):141-8. PMID: 21677241.
      Citations: 7     Fields:    Translation:Humans
    385. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology. 2011 Jul; 216(7):782-92. PMID: 21281977.
      Citations: 9     Fields:    Translation:HumansCells
    386. Li X, Jankovic J, Le W. Iron chelation and neuroprotection in neurodegenerative diseases. J Neural Transm (Vienna). 2011 Mar; 118(3):473-7. PMID: 21161300.
      Citations: 28     Fields:    Translation:HumansCells
    387. Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF A?(42) and tau in Parkinson's disease with cognitive impairment. Mov Disord. 2010 Nov 15; 25(15):2682-5. PMID: 20818673; PMCID: PMC2978754.
      Citations: 88     Fields:    Translation:Humans
    388. Wu Y, Davidson AL, Pan T, Jankovic J. Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia. J Neurol Sci. 2010 Nov 15; 298(1-2):61-3. PMID: 20864122.
      Citations: 12     Fields:    Translation:Humans
    389. Yaltho TC, Jankovic J, Lotze T. The association of Tourette syndrome and dopa-responsive dystonia. Mov Disord. 2011 Feb 01; 26(2):359-60. PMID: 21412842.
      Citations: 5     Fields:    Translation:Humans
    390. Mostile G, Jankovic J. Alcohol in essential tremor and other movement disorders. Mov Disord. 2010 Oct 30; 25(14):2274-84. PMID: 20721919.
      Citations: 19     Fields:    Translation:HumansAnimals
    391. Ondo WG, Adam OR, Jankovic J, Chinnery PF. Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord. 2010 Oct 30; 25(14):2470-2. PMID: 20818611.
      Citations: 9     Fields:    Translation:Humans
    392. Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, Tagliati M, Alterman R, Stern M, Baltuch G, Starr PA, Larson PS, Ostrem JL, Nutt J, Kieburtz K, Kordower JH, Olanow CW. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Dec; 9(12):1164-1172. PMID: 20970382.
      Citations: 248     Fields:    Translation:HumansCellsCTClinical Trials
    393. Jankovic J, Gelineau-Kattner R, Davidson A. Tourette's syndrome in adults. Mov Disord. 2010 Oct 15; 25(13):2171-5. PMID: 20690167.
      Citations: 18     Fields:    Translation:Humans
    394. Guo Y, Jankovic J, Song Z, Yang H, Zheng W, Le W, Tang X, Deng X, Yang Y, Deng S, Luo Z, Deng H. LINGO1 rs9652490 variant in Parkinson disease patients. Neurosci Lett. 2011 Jan 07; 487(2):174-6. PMID: 20951767.
      Citations: 6     Fields:    Translation:Humans
    395. Deitiker PR, Oshima M, Jankovic J, Duane DD, Aoki KR, Atassi MZ. Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 2011 May; 44(3):167-76. PMID: 20843162.
      Citations: 3     Fields:    Translation:Humans
    396. Mostile G, Giuffrida JP, Adam OR, Davidson A, Jankovic J. Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor. Mov Disord. 2010 Sep 15; 25(12):1938-43. PMID: 20623687.
      Citations: 19     Fields:    Translation:Humans
    397. Yaltho TC, Jankovic J, Pe?a MS. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Mov Disord. 2011 Jan; 26(1):147-52. PMID: 20818603.
      Citations: 20     Fields:    Translation:Humans
    398. Xie W, Li X, Li C, Zhu W, Jankovic J, Le W. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease. J Neurochem. 2010 Oct; 115(1):188-99. PMID: 20649845.
      Citations: 37     Fields:    Translation:AnimalsCells
    399. Mehanna R, Jankovic J. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec; 16(10):628-38. PMID: 20674459.
      Citations: 38     Fields:    Translation:Humans
    400. Lim J, Sanghera MK, Darbin O, Stewart RM, Jankovic J, Simpson R. Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients. Exp Neurol. 2010 Aug; 224(2):542-4. PMID: 20653074.
      Citations: 11     Fields:    Translation:HumansCells
    401. Stocchi F, Rascol O, Kieburtz K, Poewe W, Jankovic J, Tolosa E, Barone P, Lang AE, Olanow CW. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010 Jul; 68(1):18-27. PMID: 20582993.
      Citations: 73     Fields:    Translation:Humans
    402. Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett. 2010 Aug 09; 480(1):78-82. PMID: 20540987; PMCID: PMC2943649.
      Citations: 81     Fields:    Translation:HumansCells
    403. Mejia NI, Jankovic J. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother. 2010 Jun; 10(6):893-901. PMID: 20518606.
      Citations: 5     Fields:    Translation:Humans
    404. Lim J, Sanghera MK, Darbin O, Stewart RM, Jankovic J, Simpson R. Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients. Exp Neurol. 2010 May 28. PMID: 20685206.
      Citations:    Fields:    
    405. Wu Y, Li X, Xie W, Jankovic J, Le W, Pan T. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int. 2010 Oct; 57(3):198-205. PMID: 20546814.
      Citations: 41     Fields:    Translation:HumansCells
    406. Okun MS, Lang A, Jankovic J. Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease. Mov Disord. 2010 May 15; 25(7):961-2; author reply 962-3. PMID: 20461816.
      Citations: 4     Fields:    Translation:Humans
    407. Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, Chen ML, Lin CH, Mao XY, Chang XL, Prakash KM, Liu JJ, Au WL, Le WD, Jankovic J, Burgunder JM, Zhao Y, Wu RM. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat. 2010 May; 31(5):561-8. PMID: 20186690.
      Citations: 56     Fields:    Translation:Humans
    408. Jankovic J. Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of Parkinsonian deformities. Mov Disord. 2010 Apr 15; 25(5):527-8. PMID: 20425791.
      Citations: 14     Fields:    Translation:Humans
    409. Wider C, Ross OA, Jasinska-Myga B, Kachergus J, Cobb SA, Soto-Ortolaza AI, Behrouz B, Heckman MG, Diehl NN, Testa CM, Wszolek ZK, Uitti RJ, Jankovic J, Louis ED, Clark LN, Rajput A, Farrer MJ, Vilari?o-G?ell C. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics. 2010 Oct; 11(4):401-8. PMID: 20369371; PMCID: PMC3930084.
      Citations: 56     Fields:    Translation:Humans
    410. Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S, Global Dysport Cervical Dystonia Study Group. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia. Parkinsonism Relat Disord. 2010 Jun; 16(5):316-23. PMID: 20359934.
      Citations: 50     Fields:    Translation:Humans
    411. Frank S, Jankovic J. Advances in the pharmacological management of Huntington's disease. Drugs. 2010 Mar 26; 70(5):561-71. PMID: 20329804.
      Citations: 14     Fields:    Translation:HumansAnimals
    412. Fekete R, Jankovic J. Psychogenic chorea associated with family history of Huntington disease. Mov Disord. 2010 Mar 15; 25(4):503-4. PMID: 20063405.
      Citations: 3     Fields:    Translation:Humans
    413. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010 Mar; 133(Pt 3):713-26. PMID: 20157014; PMCID: PMC2842513.
      Citations: 268     Fields:    Translation:Humans
    414. DiLorenzo DJ, Jankovic J, Simpson RK, Takei H, Powell SZ. Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up. Mov Disord. 2010 Jan 30; 25(2):232-8. PMID: 20063387.
      Citations: 10     Fields:    Translation:HumansCells
    415. Deng H, Yang H, Le W, Deng X, Xu H, Xiong W, Zhu S, Xie W, Song Z, Jankovic J. Examination of the MASH1 gene in patients with Parkinson's disease. Biochem Biophys Res Commun. 2010 Feb 19; 392(4):548-50. PMID: 20097173.
      Citations:    Fields:    Translation:Humans
    416. Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J. Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev. 2010 Jan-Feb; 29(1):79-125. PMID: 19358229; PMCID: PMC2799547.
      Citations: 36     Fields:    Translation:HumansCells
    417. Deng H, Zhu SH, Le WD, Yang HR, Lv HW, Xu HB, Xie WJ, Jankovic J. Examination of the MSX1 gene in patients with Parkinson's disease. Acta Neurol Scand. 2009 Dec; 120(6):442-4. PMID: 19922584.
      Citations:    Fields:    Translation:Humans
    418. Jankovic J. Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. Eur J Neurol. 2009 Dec; 16 Suppl 2:14-8. PMID: 20002742.
      Citations: 7     Fields:    Translation:Humans
    419. Mostile G, Jankovic J. Treatment of dysautonomia associated with Parkinson's disease. Parkinsonism Relat Disord. 2009 Dec; 15 Suppl 3:S224-32. PMID: 20082997.
      Citations: 12     Fields:    Translation:Humans
    420. Deng S, Deng H, Le W, Xu H, Yang H, Deng X, Lv H, Xie W, Zhu S, Jankovic J. Genetic analysis of the NEUROG2 gene in patients with Parkinson's disease. Neurosci Lett. 2010 Jan 14; 468(3):195-7. PMID: 19879328.
      Citations:    Fields:    Translation:Humans
    421. Adam OR, Ferrara JM, Jankovic J. Motor-phonic tic mimicking essential palatal myoclonus. Mov Disord. 2009 Oct 15; 24(13):2030-2. PMID: 19672987.
      Citations: 2     Fields:    Translation:Humans
    422. Zhu W, Li X, Xie W, Luo F, Kaur D, Andersen JK, Jankovic J, Le W. Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration. Neurobiol Dis. 2010 Feb; 37(2):307-13. PMID: 19818853.
      Citations: 20     Fields:    Translation:AnimalsCells
    423. Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E, ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med. 2009 Sep 24; 361(13):1268-78. PMID: 19776408.
      Citations: 244     Fields:    Translation:Humans
    424. York MK, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71. PMID: 19767016; PMCID: PMC2783787.
      Citations: 44     Fields:    Translation:Humans
    425. Adam OR, Ferrara JM, Aguilar Tabora LG, Nashatizadeh MM, Negoita M, Jankovic J. Education research: patient telephone calls in a movement disorders center: lessons in physician-trainee education. Neurology. 2009 Sep 08; 73(10):e50-2. PMID: 19738167.
      Citations: 2     Fields:    Translation:Humans
    426. Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):315-9. PMID: 19726415.
      Citations: 10     Fields:    Translation:Humans
    427. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):70-3. PMID: 19726418.
      Citations: 39     Fields:    Translation:Humans
    428. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009 Sep; 8(9):844-56. PMID: 19679276.
      Citations: 48     Fields:    Translation:Humans
    429. Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol. 2009 Sep; 66(9):1106-13. PMID: 19752299.
      Citations: 71     Fields:    Translation:HumansPHPublic Health
    430. Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009 Dec 01; 164(2):541-51. PMID: 19682553.
      Citations: 110     Fields:    Translation:HumansCells
    431. Jankovic J. Movement disorders. Preface. Neurol Clin. 2009 Aug; 27(3):ix-x. PMID: 19555822.
      Citations:    Fields:    Translation:Humans
    432. Jankovic J. Peripherally induced movement disorders. Neurol Clin. 2009 Aug; 27(3):821-32, vii. PMID: 19555833.
      Citations: 21     Fields:    Translation:Humans
    433. Ferrara JM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial. J Neurol Sci. 2009 Oct 15; 285(1-2):195-7. PMID: 19631949.
      Citations: 16     Fields:    Translation:Humans
    434. Ravina B, Elm J, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11. PMID: 19412939; PMCID: PMC2788307.
      Citations: 16     Fields:    Translation:Humans
    435. Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord. 2009 Nov; 15(9):621-6. PMID: 19559641.
      Citations: 12     Fields:    Translation:HumansCells
    436. Sitburana O, Wu LJ, Sheffield JK, Davidson A, Jankovic J. Motor overflow and mirror dystonia. Parkinsonism Relat Disord. 2009 Dec; 15(10):758-61. PMID: 19505838.
      Citations: 14     Fields:    Translation:Humans
    437. Le W, Nguyen D, Lin XW, Rawal P, Huang M, Ding Y, Xie W, Deng H, Jankovic J. Transcription factor PITX3 gene in Parkinson's disease. Neurobiol Aging. 2011 Apr; 32(4):750-3. PMID: 19394114.
      Citations: 12     Fields:    Translation:Humans
    438. Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS, National Parkinson Foundation DBS Working Group. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage. 2009 Aug; 47 Suppl 2:T53-7. PMID: 19376247.
      Citations: 28     Fields:    Translation:Humans
    439. Jankovic J. Atomoxetine for freezing of gait in Parkinson disease. J Neurol Sci. 2009 Sep 15; 284(1-2):177-8. PMID: 19361809.
      Citations: 13     Fields:    Translation:Humans
    440. Mata IF, Hutter CM, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP, Gonz?lez-Fern?ndez MC, G?mez-Esteban JC. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain. Neurogenetics. 2009 Oct; 10(4):347-53. PMID: 19308469; PMCID: PMC2821036.
      Citations: 11     Fields:    Translation:Humans
    441. Guo Y, Jankovic J, Zhu S, Le W, Song Z, Xie W, Liao D, Yang H, Deng H. GIGYF2 Asn56Ser and Asn457Thr mutations in Parkinson disease patients. Neurosci Lett. 2009 May 01; 454(3):209-11. PMID: 19429085.
      Citations: 4     Fields:    Translation:Humans
    442. Wijemanne S, Jankovic J. Hemidystonia-hemiatrophy syndrome. Mov Disord. 2009 Mar 15; 24(4):583-9. PMID: 19097182.
      Citations: 7     Fields:    Translation:Humans
    443. Ferrara J, Jankovic J. Acquired hepatocerebral degeneration. J Neurol. 2009 Mar; 256(3):320-32. PMID: 19224314.
      Citations: 22     Fields:    Translation:Humans
    444. Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord. 2009 Feb 15; 24(3):407-13. PMID: 19053054.
      Citations: 39     Fields:    Translation:Humans
    445. Jankovic J, Albanese A, Hallett M. Unique properties of botulinum toxins. Toxicon. 2009 Oct; 54(5):675. PMID: 19470348.
      Citations: 2     Fields:    Translation:Humans
    446. Ferrara J, Jankovic J. Epidemiology and management of essential tremor in children. Paediatr Drugs. 2009; 11(5):293-307. PMID: 19725596.
      Citations: 3     Fields:    Translation:HumansAnimals
    447. Wu LJ, Sitburana O, Davidson A, Jankovic J. Applause sign in Parkinsonian disorders and Huntington's disease. Mov Disord. 2008 Dec 15; 23(16):2307-11. PMID: 18972544.
      Citations: 8     Fields:    Translation:Humans
    448. Jankovic J. Disease-oriented approach to botulinum toxin use. Toxicon. 2009 Oct; 54(5):614-23. PMID: 19073203.
      Citations: 25     Fields:    Translation:Humans
    449. Freeman RD, Zinner SH, Fast DK, Burd LJ, Kano Y, Rothenberger A, Roessner V, Kerbeshian J, Stern JS, Jankovic J, Loughin T, Janik P, Shady G, Robertson MM, Lang AE, Budman C, Magor A, Bruun R, Berlin CM, M?ller-Vahl KR. Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009 Mar; 51(3):218-27. PMID: 19183216.
      Citations: 24     Fields:    Translation:Humans
    450. Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. Mov Disord. 2008 Nov 15; 23(15):2194-201. PMID: 18932271.
      Citations: 43     Fields:    Translation:HumansCTClinical Trials
    451. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70. PMID: 19025984.
      Citations: 1634     Fields:    Translation:Humans
    452. Jankovic J. Etiopathogenesis of Parkinson disease: a new beginning? Neuroscientist. 2009 Feb; 15(1):28-35. PMID: 19008336.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    453. Jankovic J, Ashoori A. Movement disorders in musicians. Mov Disord. 2008 Oct 30; 23(14):1957-65. PMID: 18785647.
      Citations: 19     Fields:    Translation:Humans
    454. Deng H, Le WD, Jankovic J. Genetic study of an American family with DYT3 dystonia (lubag). Neurosci Lett. 2008 Dec 26; 448(2):180-3. PMID: 18952144.
      Citations: 5     Fields:    Translation:HumansCells
    455. Ferrara J, Jankovic J. Psychogenic movement disorders in children. Mov Disord. 2008 Oct 15; 23(13):1875-81. PMID: 18709677.
      Citations: 22     Fields:    Translation:Humans
    456. Hallett M, Evinger C, Jankovic J, Stacy M, BEBRF International Workshop. Update on blepharospasm: report from the BEBRF International Workshop. Neurology. 2008 Oct 14; 71(16):1275-82. PMID: 18852443; PMCID: PMC2676990.
      Citations: 60     Fields:    Translation:HumansAnimals
    457. Atassi MZ, Jankovic J, Dolimbek BZ. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology. 2008 Sep 23; 71(13):1040; author reply 1040-1. PMID: 18809844.
      Citations: 2     Fields:    Translation:Humans
    458. Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, Zhang X, Deng H, Jankovic J. Decreased NURR1 gene expression in patients with Parkinson's disease. J Neurol Sci. 2008 Oct 15; 273(1-2):29-33. PMID: 18684475; PMCID: PMC2572302.
      Citations: 56     Fields:    Translation:Humans
    459. Atassi MZ, Dolimbek BZ, Jankovic J, Steward LE, Aoki KR. Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment. Mol Immunol. 2008 Sep; 45(15):3878-88. PMID: 18676021.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    460. Stamey W, Davidson A, Jankovic J. Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol. 2008 Aug; 14(4):253-4. PMID: 18766134.
      Citations: 12     Fields:    Translation:Humans
    461. Jankovic J, Aguilar LG. Current approaches to the treatment of Parkinson's disease. Neuropsychiatr Dis Treat. 2008 Aug; 4(4):743-57. PMID: 19043519; PMCID: PMC2536542.
      Citations: 99     
    462. Brin MF, Comella CL, Jankovic J, Lai F, Naumann M, CD-017 BoNTA Study Group. Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Mov Disord. 2008 Jul 30; 23(10):1353-60. PMID: 18546321.
      Citations: 65     Fields:    Translation:HumansAnimalsCTClinical Trials
    463. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis. 2008 Oct; 32(1):16-25. PMID: 18640276.
      Citations: 94     Fields:    Translation:AnimalsCells
    464. Strutt AM, Lai EC, Jankovic J, Atassi F, Soety EM, Levin HS, Grossman RG, York MK. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8. PMID: 18514283; PMCID: PMC2735757.
      Citations:    Fields:    Translation:Humans
    465. Ashoori A, Jankovic J. Mozart's movements and behaviour: a case of Tourette's syndrome? Postgrad Med J. 2008 Jun; 84(992):313-7. PMID: 18644922.
      Citations:    Fields:    Translation:Humans
    466. Pan T, Zhu W, Zhao H, Deng H, Xie W, Jankovic J, Le W. Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo. Brain Res. 2008 Jul 30; 1222:222-9. PMID: 18579122.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    467. Molho E, Jankovic J, Lew M. Role of botulinum toxin in the treatment of cervical dystonia. Neurol Clin. 2008 May; 26 Suppl 1:43-53. PMID: 18603167.
      Citations: 3     Fields:    Translation:Humans
    468. Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J. A study of chorea after tetrabenazine withdrawal in patients with Huntington disease. Clin Neuropharmacol. 2008 May-Jun; 31(3):127-33. PMID: 18520979.
      Citations: 24     Fields:    Translation:Humans
    469. Zhu W, Xie W, Pan T, Jankovic J, Li J, Youdim MB, Le W. Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration. J Neurochem. 2008 Jun; 105(5):1970-8. PMID: 18399960.
      Citations: 21     Fields:    Translation:Animals
    470. Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 2008 Apr; 129(4):526-9. PMID: 18343778; PMCID: PMC2688655.
      Citations: 107     Fields:    Translation:Humans
    471. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr; 79(4):368-76. PMID: 18344392.
      Citations: 1217     Fields:    Translation:Humans
    472. Adam OR, Jankovic J. Symptomatic treatment of Huntington disease. Neurotherapeutics. 2008 Apr; 5(2):181-97. PMID: 18394562; PMCID: PMC5084162.
      Citations: 36     Fields:    Translation:Humans
    473. Kuo SH, Kenney C, Jankovic J. Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov Disord. 2008 Mar 15; 23(4):616-9. PMID: 18181207.
      Citations: 14     Fields:    Translation:Humans
    474. Stamey W, Jankovic J. Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist. 2008 Mar; 14(2):89-99. PMID: 18332838.
      Citations: 12     Fields:    Translation:Humans
    475. Jankovic J. Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease? Ann Neurol. 2008 Mar; 63(3):267-9. PMID: 18383071.
      Citations: 7     Fields:    Translation:HumansAnimals
    476. Kenney C, Hunter C, Davidson A, Jankovic J. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol. 2008 Mar; 48(3):379-84. PMID: 18223146.
      Citations: 19     Fields:    Translation:Humans
    477. Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. J Proteome Res. 2008 Feb; 7(2):720-30. PMID: 18186601.
      Citations: 24     Fields:    Translation:HumansCells
    478. Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain. 2008 Aug; 131(Pt 8):1969-78. PMID: 18187492.
      Citations: 214     Fields:    Translation:HumansCells
    479. Deng H, Le W, Shahed J, Xie W, Jankovic J. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families. Neurosci Lett. 2008 Jan 03; 430(1):18-22. PMID: 18068301.
      Citations: 11     Fields:    Translation:Humans
    480. Azher SN, Jankovic J. Clinical aspects of progressive supranuclear palsy. Handb Clin Neurol. 2008; 89:461-73. PMID: 18631769.
      Citations:    Fields:    Translation:Humans
    481. Dulay MF, Strutt AM, Levin HS, Jankovic J, Lai EC, Grossman RG, York MK. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63. PMID: 18806240.
      Citations: 1     Fields:    Translation:Humans
    482. Jankovic J. Parkinson's disease and movement disorders: moving forward. Lancet Neurol. 2008 Jan; 7(1):9-11. PMID: 18093549.
      Citations: 11     Fields:    Translation:Humans
    483. May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW, North American Multiple System Atrophy Study Group. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord. 2007 Dec; 22(16):2371-7. PMID: 17914727.
      Citations: 28     Fields:    Translation:Humans
    484. Kuo SH, Jankovic J. Tardive gait. Clin Neurol Neurosurg. 2008 Feb; 110(2):198-201. PMID: 17997030.
      Citations: 4     Fields:    Translation:Humans
    485. Ashoori A, Jankovic J. Mozart's movements and behaviour: a case of Tourette's syndrome? J Neurol Neurosurg Psychiatry. 2007 Nov; 78(11):1171-5. PMID: 17940168; PMCID: PMC2117611.
      Citations: 3     Fields:    Translation:Humans
    486. Diamond A, Kenney C, Almaguer M, Jankovic J. Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Case report. J Neurosurg. 2007 Nov; 107(5):1036-8. PMID: 17977278.
      Citations: 6     Fields:    Translation:Humans
    487. York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95. PMID: 17965146.
      Citations: 48     Fields:    Translation:Humans
    488. Wijemanne S, Jankovic J. Hemiparkinsonism-hemiatrophy syndrome. Neurology. 2007 Oct 16; 69(16):1585-94. PMID: 17938368.
      Citations: 5     Fields:    Translation:Humans
    489. Sitburana O, Jankovic J. Focal hand dystonia, mirror dystonia and motor overflow. J Neurol Sci. 2008 Mar 15; 266(1-2):31-3. PMID: 17888455.
      Citations: 12     Fields:    Translation:Humans
    490. Cheung MY, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord. 2007 Sep 15; 22(12):1743-50. PMID: 17566119.
      Citations: 44     Fields:    Translation:Humans
    491. LeWitt PA, Boroojerdi B, MacMahon D, Patton J, Jankovic J. Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease. Clin Neuropharmacol. 2007 Sep-Oct; 30(5):256-65. PMID: 17909303.
      Citations: 10     Fields:    Translation:Humans
    492. Inzelberg R, Jankovic J. Are Parkinson disease patients protected from some but not all cancers? Neurology. 2007 Oct 09; 69(15):1542-50. PMID: 17699801.
      Citations: 44     Fields:    Translation:Humans
    493. Zhu W, Xie W, Pan T, Xu P, Fridkin M, Zheng H, Jankovic J, Youdim MB, Le W. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J. 2007 Dec; 21(14):3835-44. PMID: 17690154.
      Citations: 37     Fields:    Translation:AnimalsCells
    494. Stamey W, Jankovic J. The other Babinski sign in hemifacial spasm. Neurology. 2007 Jul 24; 69(4):402-4. PMID: 17646635.
      Citations: 13     Fields:    Translation:Humans
    495. York MK, Lai EC, Jankovic J, Macias A, Atassi F, Levin HS, Grossman RG. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866. PMID: 17624489.
      Citations: 8     Fields:    Translation:Humans
    496. Adair JC, Cooke N, Jankovic J. Alexia without agraphia in Creutzfeldt-Jakob disease. J Neurol Sci. 2007 Dec 15; 263(1-2):208-10. PMID: 17628601.
      Citations: 2     Fields:    Translation:Humans
    497. Erer S, Jankovic J. Hereditary chin tremor in Parkinson's disease. Clin Neurol Neurosurg. 2007 Nov; 109(9):784-5. PMID: 17618046.
      Citations: 2     Fields:    Translation:Humans
    498. Jankovic J, Deng H. Candidate locus for chorea and tic disorders at 15q? Pediatr Neurol. 2007 Jul; 37(1):70-3. PMID: 17628228.
      Citations: 3     Fields:    Translation:HumansCells
    499. Kenney C, Diamond A, Mejia N, Davidson A, Hunter C, Jankovic J. Distinguishing psychogenic and essential tremor. J Neurol Sci. 2007 Dec 15; 263(1-2):94-9. PMID: 17604055.
      Citations: 15     Fields:    Translation:Humans
    500. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, Elm J. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007 Jul 24; 69(4):342-7. PMID: 17581943; PMCID: PMC2031220.
      Citations: 86     Fields:    Translation:HumansPHPublic Health
    501. Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm (Vienna). 2008; 115(4):585-91. PMID: 17558461.
      Citations: 24     Fields:    Translation:Humans
    502. Diamond A, Shahed J, Jankovic J. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. J Neurol Sci. 2007 Sep 15; 260(1-2):199-203. PMID: 17561121.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    503. Sheffield JK, Jankovic J. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease. Expert Rev Neurother. 2007 Jun; 7(6):637-47. PMID: 17563247.
      Citations: 15     Fields:    Translation:Humans
    504. Kenney C, Jankovic J. Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome. Expert Opin Pharmacother. 2007 Jun; 8(9):1329-35. PMID: 17563266.
      Citations: 2     Fields:    Translation:Humans
    505. Jankovic J, Watts RL, Martin W, Boroojerdi B. Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease. Arch Neurol. 2007 May; 64(5):676-82. PMID: 17502466.
      Citations: 42     Fields:    Translation:Humans
    506. Deng H, Le W, Huang M, Xie W, Pan T, Jankovic J. Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease. Neurosci Lett. 2007 May 29; 419(2):104-7. PMID: 17482357.
      Citations: 4     Fields:    Translation:Humans
    507. Jankovic J, Tsui J, Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Relat Disord. 2007 Oct; 13(7):411-6. PMID: 17442609.
      Citations: 33     Fields:    Translation:HumansPHPublic Health
    508. Warren L, Gibson R, Ishihara L, Elango R, Xue Z, Akkari A, Ragone L, Pahwa R, Jankovic J, Nance M, Freeman A, Watts RL, Hentati F. A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Parkinsonism Relat Disord. 2008; 14(1):77-80. PMID: 17433753.
      Citations: 12     Fields:    Translation:Humans
    509. Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007 Apr; 106(4):621-5. PMID: 17432713.
      Citations: 38     Fields:    Translation:Humans
    510. Ozelius LJ, Foroud T, May S, Senthil G, Sandroni P, Low PA, Reich S, Colcher A, Stern MB, Ondo WG, Jankovic J, Huang N, Tanner CM, Novak P, Gilman S, Marshall FJ, Wooten GF, Chelimsky TC, Shults CW, North American Multiple System Atrophy Study Group. G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Mov Disord. 2007 Mar 15; 22(4):546-9. PMID: 17230458.
      Citations: 10     Fields:    Translation:Humans
    511. Deng H, Le W, Jankovic J. Genetics of essential tremor. Brain. 2007 Jun; 130(Pt 6):1456-64. PMID: 17353225.
      Citations: 45     Fields:    Translation:HumansAnimals
    512. Deng H, Le WD, Hunter CB, Mejia N, Xie WJ, Jankovic J. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations. Arch Neurol. 2007 Mar; 64(3):421-4. PMID: 17353387.
      Citations: 4     Fields:    Translation:Humans
    513. Erer S, Jankovic J. Adult onset tics after peripheral injury. Parkinsonism Relat Disord. 2008; 14(1):75-6. PMID: 17292653.
      Citations:    Fields:    Translation:Humans
    514. Kenney C, Hunter C, Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord. 2007 Jan 15; 22(2):193-7. PMID: 17133512.
      Citations: 43     Fields:    Translation:Humans
    515. Shahed J, Poysky J, Kenney C, Simpson R, Jankovic J. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology. 2007 Jan 09; 68(2):159-60. PMID: 17210901.
      Citations: 46     Fields:    Translation:Humans
    516. Watts RL, Jankovic J, Waters C, Rajput A, Boroojerdi B, Rao J. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology. 2007 Jan 23; 68(4):272-6. PMID: 17202432.
      Citations: 58     Fields:    Translation:HumansCTClinical Trials
    517. Kenney C, Hunter C, Davidson A, Jankovic J. Short-term effects of tetrabenazine on chorea associated with Huntington's disease. Mov Disord. 2007 Jan; 22(1):10-3. PMID: 17078062.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    518. Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. CNS Drugs. 2007; 21(8):677-92. PMID: 17630819.
      Citations: 61     Fields:    Translation:Humans
    519. Adam OR, Jankovic J. Treatment of dystonia. Parkinsonism Relat Disord. 2007; 13 Suppl 3:S362-8. PMID: 18267265.
      Citations: 11     Fields:    Translation:Humans
    520. Atassi MZ, Dolimbek BZ, Deitiker P, Jankovic J, Aoki KR. A peptide-based immunoassay for antibodies against botulinum neurotoxin A. J Mol Recognit. 2007 Jan-Feb; 20(1):15-21. PMID: 16981247.
      Citations:    Fields:    Translation:HumansAnimalsCells
    521. Ishihara L, Gibson RA, Warren L, Amouri R, Lyons K, Wielinski C, Hunter C, Swartz JE, Elango R, Akkari PA, Leppert D, Surh L, Reeves KH, Thomas S, Ragone L, Hattori N, Pahwa R, Jankovic J, Nance M, Freeman A, Gouider-Khouja N, Kefi M, Zouari M, Ben Sassi S, Ben Yahmed S, El Euch-Fayeche G, Middleton L, Burn DJ, Watts RL, Hentati F. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord. 2007 Jan; 22(1):55-61. PMID: 17115391.
      Citations: 29     Fields:    Translation:Humans
    522. Shahed J, Jankovic J. Motor symptoms in Parkinson's disease. Handb Clin Neurol. 2007; 83:329-42. PMID: 18808920.
      Citations: 7     Fields:    
    523. Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord. 2007 Jan; 22(1):127-30. PMID: 17115386.
      Citations: 25     Fields:    Translation:HumansCells
    524. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007 Jan; 22(1):41-7. PMID: 17115387.
      Citations: 406     Fields:    Translation:Humans
    525. Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology. 2006 Dec 26; 67(12):2233-5. PMID: 17190952.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    526. Tan EK, Lee J, Hunter C, Shinawi L, Fook-Chong S, Jankovic J. Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population. J Neurol Sci. 2007 Jan 31; 252(2):113-20. PMID: 17174340.
      Citations: 22     Fields:    Translation:Humans
    527. Deng H, Le WD, Xie WJ, Jankovic J. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand. 2006 Dec; 114(6):400-2. PMID: 17083340.
      Citations: 29     Fields:    Translation:Humans
    528. Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J. Genetic analysis of LRRK2 mutations in patients with Parkinson disease. J Neurol Sci. 2006 Dec 21; 251(1-2):102-6. PMID: 17097110.
      Citations: 20     Fields:    Translation:HumansCells
    529. Wu LJ, Jankovic J. Runner's dystonia. J Neurol Sci. 2006 Dec 21; 251(1-2):73-6. PMID: 17097111.
      Citations: 16     Fields:    Translation:Humans
    530. Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL, Tourette Syndrome Association, Inc. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006 Nov; 21(11):1831-8. PMID: 16991144.
      Citations: 44     Fields:    Translation:Humans
    531. Ashour R, Jankovic J. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Mov Disord. 2006 Nov; 21(11):1856-63. PMID: 16941460.
      Citations: 54     Fields:    Translation:Humans
    532. Jankovic J. Treatment of dystonia. Lancet Neurol. 2006 Oct; 5(10):864-72. PMID: 16987733.
      Citations: 65     Fields:    Translation:Humans
    533. Collins A, Jankovic J. Botulinum toxin injection for congenital muscular torticollis presenting in children and adults. Neurology. 2006 Sep 26; 67(6):1083-5. PMID: 17000985.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    534. Browner N, Azher SN, Jankovic J. Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis. Mov Disord. 2006 Sep; 21(9):1500-2. PMID: 16758485.
      Citations: 5     Fields:    Translation:Humans
    535. Kenney C, Hunter C, Mejia N, Jankovic J. Is history of depression a contraindication to treatment with tetrabenazine? Clin Neuropharmacol. 2006 Sep-Oct; 29(5):259-64. PMID: 16960470.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    536. Tan EK, Jankovic J. Genetic testing in Parkinson disease: promises and pitfalls. Arch Neurol. 2006 Sep; 63(9):1232-7. PMID: 16966499.
      Citations: 18     Fields:    Translation:Humans
    537. Deng H, Le W, Davidson AL, Xie W, Jankovic J. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor. Neurosci Lett. 2006 Oct 23; 407(2):97-100. PMID: 16939701.
      Citations: 9     Fields:    Translation:Humans
    538. Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2007 Mar; 13(2):67-76. PMID: 16887374.
      Citations: 60     Fields:    Translation:HumansCells
    539. Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis. 2006 Aug; 9(3):293-348. PMID: 16914840.
      Citations: 124     Fields:    Translation:Humans
    540. Diamond A, Kenney C, Jankovic J. Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy. Mov Disord. 2006 Aug; 21(8):1273-5. PMID: 16703589.
      Citations: 5     Fields:    Translation:Humans
    541. Ondo WG, Silay Y, Almaguer M, Jankovic J. Subthalamic deep brain stimulation in patients with a previous pallidotomy. Mov Disord. 2006 Aug; 21(8):1252-4. PMID: 16673406.
      Citations: 4     Fields:    Translation:Humans
    542. Diamond A, Jankovic J. Treatment of advanced Parkinson's disease. Expert Rev Neurother. 2006 Aug; 6(8):1181-97. PMID: 16893346.
      Citations: 10     Fields:    Translation:Humans
    543. Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr. 2006 Jul; 11(7):501-8. PMID: 16816790.
      Citations: 10     Fields:    Translation:Humans
    544. Jankovic J. An update on the treatment of Parkinson's disease. Mt Sinai J Med. 2006 Jul; 73(4):682-9. PMID: 16878274.
      Citations: 12     Fields:    Translation:Humans
    545. Jankovic J, Deng H, Lagarde JP, Sokoloff P, Jeanneteau F, Funalot B, Lucotte G. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci U S A. 2006 Jul 11; 103(28):10753-8. PMID: 16809426; PMCID: PMC1502303.
      Citations: 67     Fields:    Translation:HumansCells
    546. Thomas M, Vuong KD, Jankovic J. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord. 2006 Sep; 12(6):382-7. PMID: 16737838.
      Citations: 19     Fields:    Translation:Humans
    547. Diamond A, Jankovic J. Botulinum toxin in dermatology - beyond wrinkles and sweat. J Cosmet Dermatol. 2006 Jun; 5(2):169. PMID: 17173593.
      Citations: 2     Fields:    Translation:Humans
    548. Shatunov A, Sambuughin N, Jankovic J, Elble R, Lee HS, Singleton AB, Dagvadorj A, Ji J, Zhang Y, Kimonis VE, Hardy J, Hallett M, Goldfarb LG. Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain. 2006 Sep; 129(Pt 9):2318-31. PMID: 16702189.
      Citations: 53     Fields:    Translation:HumansCells
    549. Dolimbek BZ, Aoki KR, Steward LE, Jankovic J, Atassi MZ. Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A. Mol Immunol. 2007 Feb; 44(5):1029-41. PMID: 16647121.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    550. Deng H, Xie W, Guo Y, Le W, Jankovic J. Gene dosage analysis of alpha-synuclein (SNCA) in patients with Parkinson's disease. Mov Disord. 2006 May; 21(5):728-9. PMID: 16552756.
      Citations:    Fields:    Translation:Humans
    551. Diamond A, Shahed J, Azher S, Dat-Vuong K, Jankovic J. Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2006 May; 21(5):692-5. PMID: 16342255.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    552. Jankovic J. Botulinum toxin therapy for cervical dystonia. Neurotox Res. 2006 Apr; 9(2-3):145-8. PMID: 16785112.
      Citations: 20     Fields:    Translation:Humans
    553. Pahwa R, Lyons KE, Wilkinson SB, Simpson RK, Ondo WG, Tarsy D, Norregaard T, Hubble JP, Smith DA, Hauser RA, Jankovic J. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006 Apr; 104(4):506-12. PMID: 16619653.
      Citations: 81     Fields:    Translation:Humans
    554. Scahill L, Erenberg G, Berlin CM, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy T, Zinner S, Walkup J, Tourette Syndrome Association Medical Advisory Board: Practice Committee. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx. 2006 Apr; 3(2):192-206. PMID: 16554257; PMCID: PMC3593444.
      Citations: 68     Fields:    Translation:Humans
    555. Deng H, Xie WJ, Le WD, Huang MS, Jankovic J. Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci Lett. 2006 Jun 19; 401(1-2):16-9. PMID: 16530959.
      Citations: 20     Fields:    Translation:HumansCells
    556. Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol. 2006 Mar; 3(3):138-48. PMID: 16511548.
      Citations: 36     Fields:    Translation:Humans
    557. Higgins JJ, Lombardi RQ, Pucilowska J, Jankovic J, Golbe LI, Verhagen L. HS1-BP3 gene variant is common in familial essential tremor. Mov Disord. 2006 Mar; 21(3):306-9. PMID: 16211613.
      Citations: 6     Fields:    Translation:HumansCells
    558. Deng H, Le WD, Hunter CB, Ondo WG, Guo Y, Xie WJ, Jankovic J. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations. Arch Neurol. 2006 Feb; 63(2):273-7. PMID: 16476817.
      Citations: 17     Fields:    Translation:Humans
    559. Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF, Topiramate Essential Tremor Study Investigators. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology. 2006 Mar 14; 66(5):672-7. PMID: 16436648.
      Citations: 43     Fields:    Translation:Humans
    560. Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH. Nurr1 in Parkinson's disease and related disorders. J Comp Neurol. 2006 Jan 20; 494(3):495-514. PMID: 16320253; PMCID: PMC2564615.
      Citations: 71     Fields:    Translation:HumansCells
    561. Jankovic J, Kwak C, Frankoff R. Tourette's syndrome and the law. J Neuropsychiatry Clin Neurosci. 2006; 18(1):86-95. PMID: 16525075.
      Citations: 5     Fields:    Translation:Humans
    562. Jankovic J, Mejia NI. Tics associated with other disorders. Adv Neurol. 2006; 99:61-8. PMID: 16536352.
      Citations: 6     Fields:    Translation:Humans
    563. Kenney C, Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother. 2006 Jan; 6(1):7-17. PMID: 16466307.
      Citations: 37     Fields:    Translation:Humans
    564. Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry. 2005 Dec; 76(12):1636-9. PMID: 16291885; PMCID: PMC1739456.
      Citations: 70     Fields:    Translation:Humans
    565. Pan T, Li X, Xie W, Jankovic J, Le W. Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett. 2005 Dec 19; 579(30):6716-20. PMID: 16313906.
      Citations: 26     Fields:    Translation:HumansCells
    566. Jankovic J, Chen S, Le WD. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol. 2005 Sep-Oct; 77(1-2):128-38. PMID: 16243425.
      Citations: 119     Fields:    Translation:HumansAnimalsCells
    567. Deng H, Jankovic J, Guo Y, Xie W, Le W. Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun. 2005 Dec 02; 337(4):1133-8. PMID: 16226715.
      Citations: 61     Fields:    Translation:HumansAnimalsCells
    568. Jankovic J. Dystonia and other deformities in Parkinson's disease. J Neurol Sci. 2005 Dec 15; 239(1):1-3. PMID: 16199057.
      Citations: 6     Fields:    Translation:Humans
    569. Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J. Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial. Neurology. 2005 Sep 13; 65(5):765-7. PMID: 16157918.
      Citations: 22     Fields:    Translation:HumansCellsCTClinical Trials
    570. Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1188-93. PMID: 16107348; PMCID: PMC1739801.
      Citations: 30     Fields:    Translation:Humans
    571. Ross S, Jankovic J. Palatal myoclonus: an unusual presentation. Mov Disord. 2005 Sep; 20(9):1200-3. PMID: 15929094.
      Citations: 5     Fields:    Translation:Humans
    572. Imam SZ, Jankovic J, Ali SF, Skinner JT, Xie W, Conneely OM, Le WD. Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice. FASEB J. 2005 Sep; 19(11):1441-50. PMID: 16126911.
      Citations: 18     Fields:    Translation:Animals
    573. Deng H, Le WD, Guo Y, Huang MS, Xie WJ, Jankovic J. Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology. 2005 Aug 23; 65(4):651-2. PMID: 16116142.
      Citations: 11     Fields:    Translation:Humans
    574. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology. 2005 Aug 09; 65(3):355-9. PMID: 16087897.
      Citations: 74     Fields:    Translation:Humans
    575. Tintner R, Manian P, Gauthier P, Jankovic J. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease. Arch Neurol. 2005 Aug; 62(8):1290-5. PMID: 16087771.
      Citations: 9     Fields:    Translation:HumansCells
    576. Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson's disease. Lancet Neurol. 2005 Jul; 4(7):423-31. PMID: 15963445.
      Citations: 27     Fields:    Translation:HumansAnimals
    577. Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord. 2005 Jul; 20(7):783-91. PMID: 15736159.
      Citations: 76     Fields:    Translation:HumansCTClinical Trials
    578. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology. 2005 Jun 28; 64(12):2021-8. PMID: 15985567.
      Citations: 51     Fields:    Translation:HumansPHPublic Health
    579. Deng H, Le WD, Zhang X, Pan TH, Jankovic J. G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients. Acta Neurol Scand. 2005 Jun; 111(6):351-2. PMID: 15876334.
      Citations: 1     Fields:    Translation:Humans
    580. Deng H, Le W, Guo Y, Hunter CB, Xie W, Jankovic J. Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation. Ann Neurol. 2005 Jun; 57(6):933-4. PMID: 15929036.
      Citations: 21     Fields:    Translation:Humans
    581. Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord. 2005 May; 20(5):592-7. PMID: 15645481.
      Citations: 52     Fields:    Translation:HumansCTClinical Trials
    582. Silay YS, Jankovic J. Emerging drugs in Tourette syndrome. Expert Opin Emerg Drugs. 2005 May; 10(2):365-80. PMID: 15934872.
      Citations: 5     Fields:    Translation:Humans
    583. Mejia NI, Jankovic J. Secondary tics and tourettism. Braz J Psychiatry. 2005 Mar; 27(1):11-7. PMID: 15867978.
      Citations: 15     Fields:    Translation:Humans
    584. Deng H, Le WD, Xie WJ, Pan TH, Zhang X, Jankovic J. Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonism. Neurosci Lett. 2005 Jul 15; 382(3):297-9. PMID: 15925106.
      Citations: 2     Fields:    Translation:Humans
    585. Pan T, Xie W, Jankovic J, Le W. Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection. Neurosci Lett. 2005 Mar 29; 377(2):106-9. PMID: 15740846.
      Citations: 16     Fields:    Translation:HumansCells
    586. Wan XH, Vuong KD, Jankovic J. Clinical application of botulinum toxin type B in movement disorders and autonomic symptoms. Chin Med Sci J. 2005 Mar; 20(1):44-7. PMID: 15844312.
      Citations: 4     Fields:    Translation:Humans
    587. Jankovic J, Noebels JL. Genetic mouse models of essential tremor: are they essential? J Clin Invest. 2005 Mar; 115(3):584-6. PMID: 15765140; PMCID: PMC1052020.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    588. Jankovic J. Progression of Parkinson disease: are we making progress in charting the course? Arch Neurol. 2005 Mar; 62(3):351-2. PMID: 15767498.
      Citations: 17     Fields:    Translation:Humans
    589. Jankovic J. Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations. Mov Disord. 2005; 20 Suppl 11:S11-6. PMID: 15822109.
      Citations: 135     Fields:    Translation:Humans
    590. Olanow CW, Jankovic J. Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. Mov Disord. 2005; 20 Suppl 11:S3-10. PMID: 15822111.
      Citations: 20     Fields:    Translation:Humans
    591. Jiang C, Wan X, He Y, Pan T, Jankovic J, Le W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol. 2005 Jan; 191(1):154-62. PMID: 15589522.
      Citations: 48     Fields:    Translation:Animals
    592. Mejia NI, Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005 Jan; 20(1):86-9. PMID: 15390048.
      Citations: 4     Fields:    Translation:Humans
    593. Jankovic J, Madisetty J, Vuong KD. Essential tremor among children. Pediatrics. 2004 Nov; 114(5):1203-5. PMID: 15520096.
      Citations: 13     Fields:    Translation:Humans
    594. Ondo WG, Jimenez JE, Vuong KD, Jankovic J. An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol. 2004 Nov-Dec; 27(6):274-7. PMID: 15613931.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    595. Jankovic J. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology. 2004 Oct 26; 63(8):1541-2; author reply 1541-2. PMID: 15505193.
      Citations: 2     Fields:    Translation:Humans
    596. Deng H, Le W, Jankovic J. Premutation alleles associated with Parkinson disease and essential tremor. JAMA. 2004 Oct 13; 292(14):1685-6. PMID: 15479932.
      Citations: 17     Fields:    Translation:Humans
    597. de Carvalho Aguiar P, Fazzari M, Jankovic J, Ozelius LJ. Examination of the SGCE gene in Tourette syndrome patients with obsessive-compulsive disorder. Mov Disord. 2004 Oct; 19(10):1237-8. PMID: 15368614.
      Citations: 3     Fields:    Translation:Humans
    598. Brodsky H, Dat Vuong K, Thomas M, Jankovic J. Glabellar and palmomental reflexes in Parkinsonian disorders. Neurology. 2004 Sep 28; 63(6):1096-8. PMID: 15452308.
      Citations: 4     Fields:    Translation:Humans
    599. Jankovic J, Esquenazi A, Fehlings D, Freitag F, Lang AM, Naumann M. Evidence-based review of patient-reported outcomes with botulinum toxin type A. Clin Neuropharmacol. 2004 Sep-Oct; 27(5):234-44. PMID: 15602105.
      Citations: 4     Fields:    Translation:Humans
    600. Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol. 2004 Aug; 17(4):437-42. PMID: 15247539.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    601. Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A, Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53. PMID: 15262734.
      Citations: 159     Fields:    Translation:HumansCTClinical Trials
    602. Jankovic J. Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry. 2004 Jul; 75(7):951-7. PMID: 15201348; PMCID: PMC1739107.
      Citations: 104     Fields:    Translation:HumansCells
    603. Jankovic J, Naumann M. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin. 2004 Jul; 20(7):981-90. PMID: 15265242.
      Citations: 60     Fields:    Translation:Humans
    604. Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Small GW, Mastaglia F, Haines JL, Pericak-Vance MA, Vance JM. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 2004 Jun 08; 62(11):2005-9. PMID: 15184605.
      Citations: 57     Fields:    Translation:Humans
    605. Thomas M, Ashizawa T, Jankovic J. Minocycline in Huntington's disease: a pilot study. Mov Disord. 2004 Jun; 19(6):692-5. PMID: 15197710.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    606. Suteerawattananon M, Morris GS, Etnyre BR, Jankovic J, Protas EJ. Effects of visual and auditory cues on gait in individuals with Parkinson's disease. J Neurol Sci. 2004 Apr 15; 219(1-2):63-9. PMID: 15050439.
      Citations: 66     Fields:    Translation:Humans
    607. Lassinger BK, Kwak C, Walford RL, Jankovic J. Atypical parkinsonism and motor neuron syndrome in a Biosphere 2 participant: a possible complication of chronic hypoxia and carbon monoxide toxicity? Mov Disord. 2004 Apr; 19(4):465-9. PMID: 15077246.
      Citations: 3     Fields:    Translation:Humans
    608. Jankovic J. Treatment of cervical dystonia with botulinum toxin. Mov Disord. 2004 Mar; 19 Suppl 8:S109-15. PMID: 15027062.
      Citations: 27     Fields:    Translation:Humans
    609. Jiang C, Wan X, Jankovic J, Christian ST, Pristupa ZB, Niznik HB, Sundsmo JS, Le W. Dopaminergic properties and experimental anti-parkinsonian effects of IPX750 in rodent models of Parkinson disease. Clin Neuropharmacol. 2004 Mar-Apr; 27(2):63-73. PMID: 15252266.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    610. Pan T, Le W, Jankovic J. Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology. 2004 Jan 27; 62(2):343; author reply 343-4. PMID: 14750218.
      Citations: 1     Fields:    Translation:HumansCells
    611. Thomas M, Jankovic J, Suteerawattananon M, Wankadia S, Caroline KS, Vuong KD, Protas E. Clinical gait and balance scale (GABS): validation and utilization. J Neurol Sci. 2004 Jan 15; 217(1):89-99. PMID: 14675615.
      Citations: 26     Fields:    Translation:Humans
    612. Thomas M, Hayflick SJ, Jankovic J. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord. 2004 Jan; 19(1):36-42. PMID: 14743358.
      Citations: 33     Fields:    Translation:HumansCells
    613. Thomas M, Jankovic J. Psychogenic movement disorders: diagnosis and management. CNS Drugs. 2004; 18(7):437-52. PMID: 15139799.
      Citations: 14     Fields:    Translation:Humans
    614. Sanghera MK, Grossman RG, Kalhorn CG, Hamilton WJ, Ondo WG, Jankovic J. Basal ganglia neuronal discharge in primary and secondary dystonia. Adv Neurol. 2004; 94:29-36. PMID: 14509651.
      Citations: 1     Fields:    Translation:HumansCells
    615. Jankovic J. Dystonia: medical therapy and botulinum toxin. Adv Neurol. 2004; 94:275-86. PMID: 14509685.
      Citations: 7     Fields:    Translation:Humans
    616. Kwak C, Dat Vuong K, Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord. 2003 Dec; 18(12):1530-3. PMID: 14673893.
      Citations: 72     Fields:    Translation:Humans
    617. Walker RH, Jankovic J, O'Hearn E, Margolis RL. Phenotypic features of Huntington's disease-like 2. Mov Disord. 2003 Dec; 18(12):1527-30. PMID: 14673892.
      Citations: 13     Fields:    Translation:HumansCells
    618. Tintner R, Jankovic J. Dopamine agonists in Parkinson's disease. Expert Opin Investig Drugs. 2003 Nov; 12(11):1803-20. PMID: 14585056.
      Citations: 6     Fields:    Translation:Humans
    619. Kwak C, Vuong KD, Jankovic J. Migraine headache in patients with Tourette syndrome. Arch Neurol. 2003 Nov; 60(11):1595-8. PMID: 14623732.
      Citations: 15     Fields:    Translation:Humans
    620. Ondo WG, Sutton L, Dat Vuong K, Lai D, Jankovic J. Hearing impairment in essential tremor. Neurology. 2003 Oct 28; 61(8):1093-7. PMID: 14581670.
      Citations: 39     Fields:    Translation:Humans
    621. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA, Hulette C, Welsh-Bohmer KA. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet. 2003 Dec 15; 12(24):3259-67. PMID: 14570706.
      Citations: 74     Fields:    Translation:HumansCells
    622. Hill AN, Jankovic J, Vuong KD, Donovan D. Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism. Mov Disord. 2003 Oct; 18(10):1190-2. PMID: 14534926.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    623. He Y, Imam SZ, Dong Z, Jankovic J, Ali SF, Appel SH, Le W. Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem. 2003 Sep; 86(6):1338-45. PMID: 12950443.
      Citations: 34     Fields:    Translation:AnimalsCells
    624. Simpkins N, Jankovic J. Neuroprotection in Parkinson disease. Arch Intern Med. 2003 Jul 28; 163(14):1650-4. PMID: 12885679.
      Citations: 6     Fields:    Translation:HumansCells
    625. Kuniyoshi SM, Jankovic J. MDMA and Parkinsonism. N Engl J Med. 2003 Jul 03; 349(1):96-7. PMID: 12840102.
      Citations: 8     Fields:    Translation:Humans
    626. Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, Mastaglia FL, Stajich JM, Zhang F, Booze MW, Reaves JA, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM, Martin ER. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol. 2003 Jul; 60(7):975-80. PMID: 12873854.
      Citations: 19     Fields:    Translation:Humans
    627. Sanghera MK, Grossman RG, Kalhorn CG, Hamilton WJ, Ondo WG, Jankovic J. Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery. 2003 Jun; 52(6):1358-70; discussion 1370-3. PMID: 12762881.
      Citations: 24     Fields:    Translation:HumansCells
    628. Higgins JJ, Jankovic J, Lombardi RQ, Pucilowska J, Tan EK, Ashizawa T, Ruszczyk MU. Haplotype analysis of the ETM2 locus in familial essential tremor. Neurogenetics. 2003 Aug; 4(4):185-9. PMID: 12761658.
      Citations: 6     Fields:    Translation:HumansCells
    629. Simon DK, Friedman J, Breakefield XO, Jankovic J, Brin MF, Provias J, Bressman SB, Charness ME, Tarsy D, Johns DR, Tarnopolsky MA. A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics. 2003 Aug; 4(4):199-205. PMID: 12756609.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    630. van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Roses AD, Stajich JM, Booze MW, Fujiwara K, Gibson RA, Middleton LT, Scott BL, Pericak-Vance MA, Vance JM. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology. 2003 Apr 08; 60(7):1189-91. PMID: 12682333.
      Citations: 4     Fields:    Translation:HumansCells
    631. Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology. 2003 Apr 08; 60(7):1186-8. PMID: 12682332.
      Citations: 72     Fields:    Translation:HumansCTClinical Trials
    632. Rosa AL, Jankovic J, Ashizawa T. Screening for mutations in the MECP2 (Rett syndrome) gene in Gilles de la Tourette syndrome. Arch Neurol. 2003 Apr; 60(4):502-3. PMID: 12707062.
      Citations:    Fields:    Translation:Humans
    633. Lotze T, Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol. 2003 Mar; 10(1):68-79. PMID: 12785750.
      Citations: 9     Fields:    Translation:Humans
    634. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet. 2003 Apr; 72(4):804-11. PMID: 12618962; PMCID: PMC1180345.
      Citations: 209     Fields:    Translation:HumansCells
    635. Sabbahi M, Etnyre B, Al-Jawayed I, Jankovic J. Soleus H-reflex measures in patients with focal and generalized dystonia. Clin Neurophysiol. 2003 Feb; 114(2):288-94. PMID: 12559236.
      Citations: 1     Fields:    Translation:HumansCells
    636. Savant CS, Singhal BS, Jankovic J, Khan M, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord. 2003 Feb; 18(2):213-6. PMID: 12539218.
      Citations: 6     Fields:    Translation:Humans
    637. Pan T, Fei J, Zhou X, Jankovic J, Le W. Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. Life Sci. 2003 Jan 17; 72(9):1073-83. PMID: 12495785.
      Citations: 15     Fields:    Translation:AnimalsCells
    638. Hou JG, Jankovic J. Movement disorders in Friedreich's ataxia. J Neurol Sci. 2003 Jan 15; 206(1):59-64. PMID: 12480086.
      Citations: 11     Fields:    Translation:Humans
    639. Thomas M, Le WD, Jankovic J. Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease. Clin Neuropharmacol. 2003 Jan-Feb; 26(1):18-23. PMID: 12567160.
      Citations: 17     Fields:    Translation:HumansAnimals
    640. Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging. 2003; 20(10):711-21. PMID: 12875608.
      Citations: 26     Fields:    Translation:HumansAnimals
    641. Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL. Benefits and risks of pharmacological treatments for essential tremor. Drug Saf. 2003; 26(7):461-81. PMID: 12735785.
      Citations: 22     Fields:    Translation:Humans
    642. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, Vassilatis DK. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet. 2003 Jan; 33(1):85-9. PMID: 12496759.
      Citations: 167     Fields:    Translation:HumansCells
    643. Ondo WG, Tintner R, Thomas M, Jankovic J. Tetrabenazine treatment for Huntington's disease-associated chorea. Clin Neuropharmacol. 2002 Nov-Dec; 25(6):300-2. PMID: 12469001.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    644. Dolimbek BZ, Jankovic J, Atassi MZ. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response. Immunol Invest. 2002 Aug-Nov; 31(3-4):247-62. PMID: 12472183.
      Citations: 8     Fields:    Translation:HumansAnimalsPHPublic Health
    645. Tintner R, Jankovic J. Treatment options for Parkinson's disease. Curr Opin Neurol. 2002 Aug; 15(4):467-76. PMID: 12151845.
      Citations: 9     Fields:    Translation:Humans
    646. Jankovic J. Essential tremor: a heterogenous disorder. Mov Disord. 2002 Jul; 17(4):638-44. PMID: 12210851.
      Citations: 46     Fields:    Translation:Humans
    647. Kwak CH, Jankovic J. Tourettism and dystonia after subcortical stroke. Mov Disord. 2002 Jul; 17(4):821-5. PMID: 12210884.
      Citations: 11     Fields:    Translation:Humans
    648. Blakeley J, Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord. 2002 Jul; 17(4):726-34. PMID: 12210862.
      Citations: 35     Fields:    Translation:Humans
    649. Sabbahi M, Etnyre B, Al-Jawayed I, Jankovic J. H-reflex recovery curves differentiate essential tremor, Parkinson's disease, and the combination of essential tremor and Parkinson's disease. J Clin Neurophysiol. 2002 Jun; 19(3):245-51. PMID: 12226570.
      Citations: 1     Fields:    Translation:Humans
    650. Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, Ashizawa T, Lai D, Le WD. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology. 2002 Mar 26; 58(6):881-4. PMID: 11914402.
      Citations: 33     Fields:    Translation:Humans
    651. Jankovic J, Hunter C. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease. Parkinsonism Relat Disord. 2002 Mar; 8(4):271-6. PMID: 12039422.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    652. Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet. 2002 Apr; 70(4):985-93. PMID: 11875758; PMCID: PMC379130.
      Citations: 119     Fields:    Translation:HumansCells
    653. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol. 2002 Mar; 59(3):421-4. PMID: 11890847.
      Citations: 69     Fields:    Translation:Humans
    654. Opal P, Tintner R, Jankovic J, Leung J, Breakefield XO, Friedman J, Ozelius L. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord. 2002 Mar; 17(2):339-45. PMID: 11921121.
      Citations: 28     Fields:    Translation:HumansCells
    655. Jankovic J. Levodopa strengths and weaknesses. Neurology. 2002 Feb 26; 58(4 Suppl 1):S19-32. PMID: 11909982.
      Citations: 26     Fields:    Translation:HumansAnimals
    656. Sabbahi M, Etnyre B, Al-Jawayed IA, Hasson S, Jankovic J. Methods of H-reflex evaluation in the early stages of Parkinson's disease. J Clin Neurophysiol. 2002 Jan; 19(1):67-72. PMID: 11896355.
      Citations: 3     Fields:    Translation:HumansCells
    657. Jankovic J. Surgery for Parkinson disease and other movement disorders: benefits and limitations of ablation, stimulation, restoration, and radiation. Arch Neurol. 2001 Dec; 58(12):1970-2. PMID: 11735770.
      Citations: 1     Fields:    Translation:Humans
    658. Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Ribble RC, Booze MW, Rogala A, Hauser MA, Zhang F, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Pericak-Vance MA, Vance JM. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA. 2001 Nov 14; 286(18):2245-50. PMID: 11710889; PMCID: PMC3973175.
      Citations: 47     Fields:    Translation:HumansCells
    659. Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck B, Booze MW, Ribble RC, Rampersaud E, West SG, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, Pericak-Vance MA. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 2001 Nov 14; 286(18):2239-44. PMID: 11710888.
      Citations: 87     Fields:    Translation:HumansCells
    660. Ondo W, Dat Vuong K, Almaguer M, Jankovic J, Simpson RK. Thalamic deep brain stimulation: effects on the nontarget limbs. Mov Disord. 2001 Nov; 16(6):1137-42. PMID: 11748749.
      Citations: 8     Fields:    Translation:Humans
    661. Xu P, Liang X, Jankovic J, Le W. Identification of a high frequency of mutation at exon 8 of the ATP7B gene in a Chinese population with Wilson disease by fluorescent PCR. Arch Neurol. 2001 Nov; 58(11):1879-82. PMID: 11708998.
      Citations: 3     Fields:    Translation:Humans
    662. Jankovic J. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required. Muscle Nerve. 2001 Nov; 24(11):1568-70. PMID: 11745964.
      Citations: 10     Fields:    Translation:Humans
    663. Jankovic J. Parkinson's disease. A half century of progress. Neurology. 2001 Nov; 57(10 Suppl 3):S1-3. PMID: 11771154.
      Citations: 3     Fields:    Translation:HumansAnimals
    664. Jankovic J. Tourette's syndrome. N Engl J Med. 2001 Oct 18; 345(16):1184-92. PMID: 11642235.
      Citations: 80     Fields:    Translation:Humans
    665. Tintner R, Jankovic J. Focal dystonia: the role of botulinum toxin. Curr Neurol Neurosci Rep. 2001 Jul; 1(4):337-45. PMID: 11898539.
      Citations: 2     Fields:    Translation:Humans
    666. Tan EK, Nagamitsu S, Matsuura T, Khajavi M, Jankovic J, Ondo W, Ashizawa T. Alcohol dehydrogenase polymorphism and Parkinson's disease. Neurosci Lett. 2001 Jun 01; 305(1):70-2. PMID: 11356310.
      Citations: 5     Fields:    Translation:Humans
    667. Weiner WJ, Factor SA, Jankovic J, Hauser RA, Tetrud JW, Waters CH, Shulman LM, Glassman PM, Beck B, Paume D, Doyle C. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease. Parkinsonism Relat Disord. 2001 Apr; 7(2):115-120. PMID: 11248592.
      Citations: 13     Fields:    
    668. Yoshor D, Hamilton WJ, Ondo W, Jankovic J, Grossman RG. Comparison of thalamotomy and pallidotomy for the treatment of dystonia. Neurosurgery. 2001 Apr; 48(4):818-24; discussion 824-6. PMID: 11322442.
      Citations: 15     Fields:    Translation:Humans
    669. Krauss JK, Simpson RK, Ondo WG, Pohle T, Burgunder JM, Jankovic J. Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery. 2001 Mar; 48(3):535-41; discussion 541-3. PMID: 11270543.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    670. Jankovic J. Parkinson's disease therapy: treatment of early and late disease. Chin Med J (Engl). 2001 Mar; 114(3):227-34. PMID: 11780303.
      Citations: 5     Fields:    Translation:Humans
    671. Vanek Z, Jankovic J. Dystonia in corticobasal degeneration. Mov Disord. 2001 Mar; 16(2):252-7. PMID: 11295777.
      Citations: 14     Fields:    Translation:Humans
    672. Ondo W, Almaguer M, Jankovic J, Simpson RK. Thalamic deep brain stimulation: comparison between unilateral and bilateral placement. Arch Neurol. 2001 Feb; 58(2):218-22. PMID: 11176959.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    673. Jankovic J, Lai EC, Ondo WG, Roberts-Warrior D, Olson SL, Krauss JK, Grossman RG. Effects of pallidotomy on gait and balance. Adv Neurol. 2001; 87:271-81. PMID: 11347232.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    674. Le WD, Jankovic J. Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs Aging. 2001; 18(6):389-96. PMID: 11419913.
      Citations: 13     Fields:    Translation:HumansAnimals
    675. Shahed J, Jankovic J. Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis. Mov Disord. 2001 Jan; 16(1):114-8. PMID: 11215569.
      Citations: 12     Fields:    Translation:Humans
    676. Hanna PA, Ratkos L, Ondo WG, Jankovic J. Switching from pergolide to pramipexole in patients with Parkinson's disease. J Neural Transm (Vienna). 2001; 108(1):63-70. PMID: 11261747.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    677. Lai EC, Jankovic J, Krauss JK, Ondo WG, Grossman RG. Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease. Neurology. 2000 Oct 24; 55(8):1218-22. PMID: 11071505.
      Citations: 4     Fields:    Translation:Humans
    678. Ondo WG, Hunter C, Vuong KD, Jankovic J. The pharmacokinetic and clinical effects of tolcapone on a single dose of sublingual apomorphine in Parkinson's disease. Parkinsonism Relat Disord. 2000 Oct 01; 6(4):237-240. PMID: 10900399.
      Citations: 4     Fields:    
    679. Roberts-Warrior D, Overby A, Jankovic J, Olson S, Lai EC, Krauss JK, Grossman R. Postural control in Parkinson's disease after unilateral posteroventral pallidotomy. Brain. 2000 Oct; 123 ( Pt 10):2141-9. PMID: 11004130.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    680. Ondo W, Warrior D, Overby A, Calmes J, Hendersen N, Olson S, Jankovic J. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls. Arch Neurol. 2000 Oct; 57(10):1464-9. PMID: 11030799.
      Citations: 27     Fields:    Translation:Humans
    681. Rettig GM, York MK, Lai EC, Jankovic J, Krauss JK, Grossman RG, Levin HS. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep; 69(3):326-36. PMID: 10945807; PMCID: PMC1737102.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    682. Jankovic J. Parkinson's disease therapy: tailoring choices for early and late disease, young and old patients. Clin Neuropharmacol. 2000 Sep-Oct; 23(5):252-61. PMID: 11154092.
      Citations: 12     Fields:    Translation:Humans
    683. Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 2000 Aug 22; 55(4):533-8. PMID: 10953187.
      Citations: 41     Fields:    Translation:Humans
    684. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000 Aug; 57(8):1190-3. PMID: 10927800.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    685. Ondo W, Hunter C, Vuong KD, Schwartz K, Jankovic J. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord. 2000 Jul; 15(4):678-82. PMID: 10928578.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    686. Tan EK, Matsuura T, Nagamitsu S, Khajavi M, Jankovic J, Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology. 2000 Mar 14; 54(5):1195-8. PMID: 10720300.
      Citations: 32     Fields:    Translation:Humans
    687. Zou L, Xu J, Jankovic J, He Y, Appel SH, Le W. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice. Neurosci Lett. 2000 Mar 10; 281(2-3):167-70. PMID: 10704769.
      Citations: 36     Fields:    Translation:AnimalsCells
    688. Jankovic J, Rajput AH, McDermott MP, Perl DP. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol. 2000 Mar; 57(3):369-72. PMID: 10714663.
      Citations: 60     Fields:    Translation:HumansCTClinical Trials
    689. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000 Feb; 131(2):211-6. PMID: 10680389.
      Citations: 37     Fields:    Translation:Humans
    690. Ondo WG, Ben-Aire L, Jankovic J, Lai E, Contant C, Grossman R. Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol Scand. 2000 Feb; 101(2):79-84. PMID: 10685852.
      Citations: 13     Fields:    Translation:Humans
    691. Tan EK, Jankovic J. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry. 2000 Feb; 68(2):186-90. PMID: 10644785; PMCID: PMC1736782.
      Citations: 19     Fields:    Translation:Humans
    692. Le WD, Jankovic J, Xie W, Appel SH. Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm (Vienna). 2000; 107(10):1165-73. PMID: 11129106.
      Citations: 33     Fields:    Translation:AnimalsCells
    693. Tan EK, Jankovic J, Ondo W. Bruxism in Huntington's disease. Mov Disord. 2000 Jan; 15(1):171-3. PMID: 10634263.
      Citations: 8     Fields:    Translation:Humans
    694. Jankovic J. Essential tremor: clinical characteristics. Neurology. 2000; 54(11 Suppl 4):S21-5. PMID: 10854348.
      Citations: 23     Fields:    Translation:Humans
    695. Jankovic J. Complications and limitations of drug therapy for Parkinson's disease. Neurology. 2000; 55(12 Suppl 6):S2-6. PMID: 11188970.
      Citations: 14     Fields:    Translation:Humans
    696. Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999 Dec 10; 53(9):2102-7. PMID: 10599789.
      Citations: 51     Fields:    Translation:Humans
    697. Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Nov; 67(5):646-50. PMID: 10519872; PMCID: PMC1736624.
      Citations: 55     Fields:    Translation:Humans
    698. Le W, Conneely OM, He Y, Jankovic J, Appel SH. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem. 1999 Nov; 73(5):2218-21. PMID: 10537083.
      Citations: 54     Fields:    Translation:AnimalsCells
    699. Le W, Conneely OM, Zou L, He Y, Saucedo-Cardenas O, Jankovic J, Mosier DR, Appel SH. Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice. Exp Neurol. 1999 Oct; 159(2):451-8. PMID: 10506516.
      Citations: 41     Fields:    Translation:AnimalsCells
    700. Hanna PA, Janjua FN, Contant CF, Jankovic J. Bilineal transmission in Tourette syndrome. Neurology. 1999 Sep 11; 53(4):813-8. PMID: 10489047.
      Citations: 12     Fields:    Translation:Humans
    701. Scott WK, Yamaoka LH, Stajich JM, Scott BL, Vance JM, Roses AD, Pericak-Vance MA, Watts RL, Nance M, Hubble J, Koller W, Stern MB, Colcher A, Allen FH, Hiner BC, Jankovic J, Ondo W, Laing NG, Mastaglia F, Goetz C, Pappert E, Small GW, Masterman D, Haines JL, Davies TL. The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. Neurogenetics. 1999 Sep; 2(3):191-2. PMID: 10541595.
      Citations: 8     Fields:    Translation:Humans
    702. Jankovic J, Lai E, Ben-Arie L, Krauss JK, Grossman R. Levodopa-induced dyskinesias treated by pallidotomy. J Neurol Sci. 1999 Aug 01; 167(1):62-7. PMID: 10500264.
      Citations: 5     Fields:    Translation:Humans
    703. Ondo WG, Hanna PA, Jankovic J. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry. 1999 Aug; 156(8):1279-81. PMID: 10450276.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    704. Jankovic J. New and emerging therapies for Parkinson disease. Arch Neurol. 1999 Jul; 56(7):785-90. PMID: 10404979.
      Citations: 2     Fields:    Translation:Humans
    705. Ondo W, Hunter C, Almaguer M, Jankovic J. A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease. Mov Disord. 1999 Jul; 14(4):664-8. PMID: 10435505.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    706. Watts MW, Tan EK, Jankovic J. Bruxism and cranial-cervical dystonia: is there a relationship? Cranio. 1999 Jul; 17(3):196-201. PMID: 10650407.
      Citations: 15     Fields:    Translation:Humans
    707. Stanley RK, Protas EJ, Jankovic J. Exercise performance in those having Parkinson's disease and healthy normals. Med Sci Sports Exerc. 1999 Jun; 31(6):761-6. PMID: 10378900.
      Citations: 16     Fields:    Translation:Humans
    708. Hanna PA, Jankovic J, Vincent A. Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies. J Neurol Neurosurg Psychiatry. 1999 May; 66(5):612-6. PMID: 10209172; PMCID: PMC1736353.
      Citations: 14     Fields:    Translation:HumansAnimals
    709. Tan EK, Jankovic J. Bilateral hemifacial spasm: a report of five cases and a literature review. Mov Disord. 1999 Mar; 14(2):345-9. PMID: 10091632.
      Citations: 10     Fields:    Translation:Humans
    710. Le WD, Rowe DB, Jankovic J, Xie W, Appel SH. Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Arch Neurol. 1999 Feb; 56(2):194-200. PMID: 10025424.
      Citations: 19     Fields:    Translation:HumansCells
    711. Ondo W, Hunter C, Almaguer M, Gancher S, Jankovic J. Efficacy and tolerability of a novel sublingual apomorphine preparation in patients with fluctuating Parkinson's disease. Clin Neuropharmacol. 1999 Jan-Feb; 22(1):1-4. PMID: 10047926.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    712. Jankovic J, Ben-Arie L, Schwartz K, Chen K, Khan M, Lai EC, Krauss JK, Grossman R. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord. 1999 Jan; 14(1):57-62. PMID: 9918345.
      Citations: 8     Fields:    Translation:Humans
    713. Hanna PA, Jankovic J, Kirkpatrick JB. Multiple system atrophy: the putative causative role of environmental toxins. Arch Neurol. 1999 Jan; 56(1):90-4. PMID: 9923766.
      Citations: 21     Fields:    Translation:Humans
    714. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999 Jan; 56(1):98-102. PMID: 9923767.
      Citations: 53     Fields:    Translation:Humans
    715. Zou L, Jankovic J, Rowe DB, Xie W, Appel SH, Le W. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity. Life Sci. 1999; 64(15):1275-85. PMID: 10227583.
      Citations: 17     Fields:    Translation:AnimalsCells
    716. Mathew SJ, Yudofsky SC, McCullough LB, Teasdale TA, Jankovic J. Attitudes toward neurosurgical procedures for Parkinson's disease and obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 1999; 11(2):259-67. PMID: 10333998.
      Citations: 1     Fields:    Translation:Humans
    717. Wang WW, Khajavi M, Patel BJ, Beach J, Jankovic J, Ashizawa T. The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations. Arch Neurol. 1998 Dec; 55(12):1521-3. PMID: 9865795.
      Citations: 4     Fields:    Translation:Humans
    718. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998 Dec; 21(12):1740-7. PMID: 9843077.
      Citations: 86     Fields:    Translation:Humans
    719. Sankhla C, Lai EC, Jankovic J. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry. 1998 Nov; 65(5):722-8. PMID: 9810945; PMCID: PMC2170345.
      Citations: 26     Fields:    Translation:Humans
    720. Ondo W, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology. 1998 Oct; 51(4):1063-9. PMID: 9781530.
      Citations: 47     Fields:    Translation:HumansCTClinical Trials
    721. Litvan I, Jankovic J, Goetz CG, Wenning GK, Sastry N, Jellinger K, McKee A, Lai EC, Brandel JP, Verny M, Ray-Chaudhuri K, Pearce RK, Bartko JJ, Agid Y. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. Eur J Neurol. 1998 Sep; 5(5):451-457. PMID: 10210873.
      Citations: 4     Fields:    
    722. Desaloms JM, Krauss JK, Lai EC, Jankovic J, Grossman RG. Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome. J Neurosurg. 1998 Aug; 89(2):194-9. PMID: 9688112.
      Citations: 1     Fields:    Translation:Humans
    723. Ondo WG, Desaloms JM, Jankovic J, Grossman RG. Pallidotomy for generalized dystonia. Mov Disord. 1998 Jul; 13(4):693-8. PMID: 9686777.
      Citations: 24     Fields:    Translation:Humans
    724. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998 Jul; 55(7):969-78. PMID: 9678315.
      Citations: 72     Fields:    Translation:HumansCellsCTClinical Trials
    725. Hanna PA, Jankovic J. Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response. Neurology. 1998 Jun; 50(6):1624-9. PMID: 9633703.
      Citations: 22     Fields:    Translation:HumansAnimals
    726. Scarano VR, Jankovic J. Post-traumatic movement disorders: effect of the legal system on outcome. J Forensic Sci. 1998 Mar; 43(2):334-9. PMID: 9544540.
      Citations: 1     Fields:    Translation:Humans
    727. Jankovic J. Medical therapy and botulinum toxin in dystonia. Adv Neurol. 1998; 78:169-83. PMID: 9750914.
      Citations: 5     Fields:    Translation:Humans
    728. Sankhla C, Jankovic J, Duane D. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Mov Disord. 1998 Jan; 13(1):150-4. PMID: 9452341.
      Citations: 16     Fields:    Translation:HumansAnimals
    729. Ondo WG, Jankovic J, Lai EC, Sankhla C, Khan M, Ben-Arie L, Schwartz K, Grossman RG, Krauss JK. Assessment of motor function after stereotactic pallidotomy. Neurology. 1998 Jan; 50(1):266-70. PMID: 9443490.
      Citations: 6     Fields:    Translation:Humans
    730. Krauss JK, Toups EG, Jankovic J, Grossman RG. Symptomatic and functional outcome of surgical treatment of cervical dystonia. J Neurol Neurosurg Psychiatry. 1997 Nov; 63(5):642-8. PMID: 9408107; PMCID: PMC2169822.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    731. Krauss JK, Desaloms JM, Lai EC, King DE, Jankovic J, Grossman RG. Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg. 1997 Sep; 87(3):358-67. PMID: 9285599.
      Citations: 8     Fields:    Translation:Humans
    732. Krauss JK, Jankovic J. Tics secondary to craniocerebral trauma. Mov Disord. 1997 Sep; 12(5):776-82. PMID: 9380066.
      Citations: 6     Fields:    Translation:Humans
    733. Krauss JK, Jankovic J, Lai EC, Rettig GM, Grossman RG. Posteroventral medial pallidotomy in levodopa-unresponsive parkinsonism. Arch Neurol. 1997 Aug; 54(8):1026-9. PMID: 9267978.
      Citations: 1     Fields:    Translation:Humans
    734. Jankovic J, Ruzicka E. [Tics and Tourette's syndrome]. Cas Lek Cesk. 1997 Jun 26; 136(13):399-404. PMID: 9333513.
      Citations:    Fields:    Translation:Humans
    735. Krauss JK, Jankovic J. Hemidystonia secondary to carotid artery gunshot injury. Childs Nerv Syst. 1997 May; 13(5):285-8. PMID: 9224919.
      Citations: 2     Fields:    Translation:Humans
    736. Jankovic J. Tourette syndrome. Phenomenology and classification of tics. Neurol Clin. 1997 May; 15(2):267-75. PMID: 9115460.
      Citations: 55     Fields:    Translation:Humans
    737. Le W, Jankovic J, Xie W, Kong R, Appel SH. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition. Neurosci Lett. 1997 Mar 21; 224(3):197-200. PMID: 9131670.
      Citations: 7     Fields:    Translation:AnimalsCells
    738. Jankovic J, Beach J, Pandolfo M, Patel PI. Familial essential tremor in 4 kindreds. Prospects for genetic mapping. Arch Neurol. 1997 Mar; 54(3):289-94. PMID: 9074398.
      Citations: 15     Fields:    Translation:Humans
    739. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997 Feb; 48(2):358-62. PMID: 9040721.
      Citations: 82     Fields:    Translation:Humans
    740. Jankovic J, Hamilton WJ, Grossman RG. Thalamic surgery for movement disorders. Adv Neurol. 1997; 74:221-33. PMID: 9348417.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    741. Krauss JK, Grossman RG, Jankovic J. Improvement of parkinsonian signs after vascular lesions of the basal ganglia circuitry. Mov Disord. 1997 Jan; 12(1):124-6. PMID: 8990069.
      Citations:    Fields:    Translation:Humans
    742. Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl. 1997; 6:S129-45. PMID: 9826986.
      Citations: 26     Fields:    Translation:Humans
    743. Krauss JK, Grossman RG, Lai EC, Schwartz K, Jankovic J. [Medial posteroventral pallidotomy for the treatment of Parkinson's disease]. Zentralbl Neurochir. 1997; 58(4):153-62. PMID: 9487651.
      Citations:    Fields:    Translation:Humans
    744. Alford RL, Ashizawa T, Jankovic J, Caskey CT, Richards CS. Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease. Am J Med Genet. 1996 Dec 18; 66(3):281-6. PMID: 8985488.
      Citations: 2     Fields:    Translation:HumansCells
    745. Ondo W, Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology. 1996 Dec; 47(6):1435-41. PMID: 8960723.
      Citations: 38     Fields:    Translation:Humans
    746. Krauss JK, Jankovic J. Surgical treatment of Parkinson's disease. Am Fam Physician. 1996 Oct; 54(5):1621-9. PMID: 8857784.
      Citations: 2     Fields:    Translation:Humans
    747. Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette's syndrome. Mov Disord. 1996 Sep; 11(5):563-6. PMID: 8866498.
      Citations: 17     Fields:    Translation:Humans
    748. Krauss JK, Akeyson EW, Giam P, Jankovic J. Propofol-induced dyskinesias in Parkinson's disease. Anesth Analg. 1996 Aug; 83(2):420-22. PMID: 8694329.
      Citations: 12     Fields:    Translation:Humans
    749. Scott BL, Jankovic J, Donovan DT. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome. Mov Disord. 1996 Jul; 11(4):431-3. PMID: 8813224.
      Citations: 17     Fields:    Translation:Humans
    750. Ashizawa T, Jankovic J. Cervical dystonia as the initial presentation of Huntington's disease. Mov Disord. 1996 Jul; 11(4):457-9. PMID: 8813235.
      Citations: 1     Fields:    Translation:Humans
    751. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord. 1996 May; 11(3):250-6. PMID: 8723140.
      Citations: 54     Fields:    Translation:HumansCTClinical Trials
    752. Demirkiran M, Jankovic J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology. 1996 Apr; 46(4):1040-3. PMID: 8780087.
      Citations: 4     Fields:    Translation:Humans
    753. Demirkiran M, Jankovic J, Dean JM. Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome. Clin Neuropharmacol. 1996 Apr; 19(2):157-64. PMID: 8777769.
      Citations: 10     Fields:    Translation:Humans
    754. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology. 1996 Mar; 46(3):720-6. PMID: 8618672.
      Citations: 11     Fields:    Translation:Humans
    755. Scott BL, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology. 1996 Jan; 46(1):68-74. PMID: 8559423.
      Citations: 30     Fields:    Translation:Humans
    756. Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery. 1995 Oct; 37(4):680-6; discussion 686-7. PMID: 8559296.
      Citations: 39     Fields:    Translation:Humans
    757. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995 Oct; 38(4):571-9. PMID: 7574453.
      Citations: 103     Fields:    Translation:Humans
    758. Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology. 1995 Sep; 45(9):1743-6. PMID: 7675238.
      Citations: 58     Fields:    Translation:Humans
    759. Jankovic J. International Classification of Diseases, tenth revision: neurological adaptation (ICD-10 NA): extrapyramidal and movement disorders. Mov Disord. 1995 Sep; 10(5):533-40. PMID: 8552102.
      Citations: 3     Fields:    Translation:Humans
    760. Jankovic J, Beach J, Ashizawa T. Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease. J Med Genet. 1995 Jul; 32(7):516-8. PMID: 7562962; PMCID: PMC1050542.
      Citations: 3     Fields:    Translation:HumansCells
    761. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol. 1995 Jun; 18(3):197-214. PMID: 8635179.
      Citations: 18     Fields:    Translation:Humans
    762. Jankovic J, Beach J, Schwartz K, Contant C. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology. 1995 Apr; 45(4):645-8. PMID: 7723949.
      Citations: 20     Fields:    Translation:Humans
    763. Cardoso F, Jankovic J, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for dystonia and hemiballismus. Neurosurgery. 1995 Mar; 36(3):501-7; discussion 507-8. PMID: 7753350.
      Citations: 20     Fields:    Translation:Humans
    764. Cardoso F, Jankovic J. Peripherally induced tremor and parkinsonism. Arch Neurol. 1995 Mar; 52(3):263-70. PMID: 7872879.
      Citations: 11     Fields:    Translation:Humans
    765. Jankovic J, Ashizawa T. Tourettism associated with Huntington's disease. Mov Disord. 1995 Jan; 10(1):103-5. PMID: 7885343.
      Citations: 14     Fields:    Translation:Humans
    766. Chacko RC, Hurley RA, Harper RG, Jankovic J, Cardoso F. Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1995; 7(4):471-5. PMID: 8555750.
      Citations: 1     Fields:    Translation:Humans
    767. Jankovic J. Post-traumatic movement disorders: central and peripheral mechanisms. Neurology. 1994 Nov; 44(11):2006-14. PMID: 7969951.
      Citations: 20     Fields:    Translation:Humans
    768. Jankovic J. Botulinum toxin in movement disorders. Curr Opin Neurol. 1994 Aug; 7(4):358-66. PMID: 7952246.
      Citations: 9     Fields:    Translation:Humans
    769. Ashizawa T, Wong LJ, Richards CS, Caskey CT, Jankovic J. CAG repeat size and clinical presentation in Huntington's disease. Neurology. 1994 Jun; 44(6):1137-43. PMID: 8208412.
      Citations: 16     Fields:    Translation:HumansCells
    770. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord. 1994 May; 9(3):347-9. PMID: 8041378.
      Citations: 24     Fields:    Translation:Humans
    771. Piwinski SE, Jankovic J, McElligott MA. A comparison of postspace-flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions. J Clin Pharmacol. 1994 May; 34(5):466-71. PMID: 7522240.
      Citations: 3     Fields:    Translation:Humans
    772. Percy AK, Glaze DG, Schultz RJ, Zoghbi HY, Williamson D, Frost JD, Jankovic JJ, del Junco D, Skender M, Waring S, et al. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol. 1994 Apr; 35(4):464-70. PMID: 8154874.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    773. Winikates J, Jankovic J. Vascular progressive supranuclear palsy. J Neural Transm Suppl. 1994; 42:189-201. PMID: 7964687.
      Citations: 14     Fields:    Translation:Humans
    774. Jankovic J, Rajput AH, Golbe LI, Goodman JC. What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis. Mov Disord. 1993 Oct; 8(4):525-32. PMID: 8232366.
      Citations: 3     Fields:    Translation:Humans
    775. Cardoso FE, Jankovic J. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve. 1993 Sep; 16(9):904-10. PMID: 8355721.
      Citations: 8     Fields:    Translation:Humans
    776. Jankovic J, Schwartz KS. Use of botulinum toxin in the treatment of hand dystonia. J Hand Surg Am. 1993 Sep; 18(5):883-7. PMID: 8228064.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    777. Jankovic J, Gilden JL, Hiner BC, Kaufmann H, Brown DC, Coghlan CH, Rubin M, Fouad-Tarazi FM. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993 Jul; 95(1):38-48. PMID: 7687093.
      Citations: 78     Fields:    Translation:HumansCTClinical Trials
    778. Stacy M, Cardoso F, Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology. 1993 May; 43(5):937-41. PMID: 8492949.
      Citations: 10     Fields:    Translation:Humans
    779. Cardoso FE, Jankovic J. Cocaine-related movement disorders. Mov Disord. 1993 Apr; 8(2):175-8. PMID: 8474485.
      Citations: 11     Fields:    Translation:Humans
    780. Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology. 1993 Apr; 43(4):834-6. PMID: 8469349.
      Citations: 16     Fields:    Translation:Humans
    781. Jankovic J. Deprenyl in attention deficit associated with Tourette's syndrome. Arch Neurol. 1993 Mar; 50(3):286-8. PMID: 8442708.
      Citations: 10     Fields:    Translation:Humans
    782. Monday K, Jankovic J. Psychogenic myoclonus. Neurology. 1993 Feb; 43(2):349-52. PMID: 8437701.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    783. Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 1992 Sep; 55(9):806-10. PMID: 1402972; PMCID: PMC1015106.
      Citations: 37     Fields:    Translation:Humans
    784. Burnett L, Jankovic J. Chorea and ballism. Curr Opin Neurol Neurosurg. 1992 Jun; 5(3):308-13. PMID: 1535815.
      Citations: 4     Fields:    Translation:Humans
    785. Jankovic J, Wooten M, Van der Linden C, Jansson B. Low body weight in Parkinson's disease. South Med J. 1992 Apr; 85(4):351-4. PMID: 1566133.
      Citations: 7     Fields:    Translation:Humans
    786. Lew H, Jordan C, Jerger J, Jankovic J. Acoustic reflex abnormalities in cranial-cervical dystonia. Neurology. 1992 Mar; 42(3 Pt 1):594-7. PMID: 1549220.
      Citations: 2     Fields:    Translation:Humans
    787. Miller LG, Jankovic J. Persistent dystonia possibly induced by flecainide. Mov Disord. 1992; 7(1):62-3. PMID: 1557067.
      Citations: 3     Fields:    Translation:Humans
    788. Stacy M, Jankovic J. Tardive tremor. Mov Disord. 1992; 7(1):53-7. PMID: 1348352.
      Citations: 18     Fields:    Translation:Humans
    789. Jankovic J. Diagnosis and classification of tics and Tourette syndrome. Adv Neurol. 1992; 58:7-14. PMID: 1414646.
      Citations: 10     Fields:    Translation:Humans
    790. Jankovic J, Schwartz KS. Clinical correlates of response to botulinum toxin injections. Arch Neurol. 1991 Dec; 48(12):1253-6. PMID: 1845028.
      Citations: 14     Fields:    Translation:Humans
    791. Taylor LD, Krizman DB, Jankovic J, Hayani A, Steuber PC, Greenberg F, Fenwick RG, Caskey CT. 9p monosomy in a patient with Gilles de la Tourette's syndrome. Neurology. 1991 Sep; 41(9):1513-5. PMID: 1679912.
      Citations: 10     Fields:    Translation:HumansCells
    792. Stone LA, Jankovic J. The coexistence of tics and dystonia. Arch Neurol. 1991 Aug; 48(8):862-5. PMID: 1898264.
      Citations: 4     Fields:    Translation:Humans
    793. Jankovic J, Leder S, Warner D, Schwartz K. Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991 Jul; 41(7):1088-91. PMID: 2067638.
      Citations: 106     Fields:    Translation:Humans
    794. Narayan RK, Loubser PG, Jankovic J, Donovan WH, Bontke CF. Intrathecal baclofen for intractable axial dystonia. Neurology. 1991 Jul; 41(7):1141-2. PMID: 2067645.
      Citations: 22     Fields:    Translation:Humans
    795. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med. 1991 Apr 25; 324(17):1186-94. PMID: 2011163.
      Citations: 122     Fields:    Translation:Humans
    796. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology. 1991 Feb; 41(2 ( Pt 1)):234-8. PMID: 1992367.
      Citations: 98     Fields:    Translation:Humans
    797. FitzGerald PM, Jankovic J. Orthostatic tremor: an association with essential tremor. Mov Disord. 1991; 6(1):60-4. PMID: 2005923.
      Citations: 17     Fields:    Translation:Humans
    798. Jankovic J, Stone L. Dystonic tics in patients with Tourette's syndrome. Mov Disord. 1991; 6(3):248-52. PMID: 1922130.
      Citations: 15     Fields:    Translation:Humans
    799. Blum P, Jankovic J. Stiff-person syndrome: an autoimmune disease. Mov Disord. 1991; 6(1):12-20. PMID: 2005917.
      Citations: 18     Fields:    Translation:Humans
    800. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology. 1990 Oct; 40(10):1529-34. PMID: 2215943.
      Citations: 449     Fields:    Translation:Humans
    801. Persing JA, Muir A, Becker DG, Jankovic JJ, Anderson RL, Edlich RF. Blepharospasm-oromandibular dystonia associated with a left cerebellopontine angle meningioma. J Emerg Med. 1990 Sep-Oct; 8(5):571-4. PMID: 2254604.
      Citations: 3     Fields:    Translation:Humans
    802. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug; 53(8):633-9. PMID: 2213039; PMCID: PMC488162.
      Citations: 60     Fields:    Translation:Humans
    803. Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990 May; 83(5):525-32. PMID: 1971459.
      Citations: 10     Fields:    Translation:Humans
    804. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990 Feb; 40(2):277-80. PMID: 2300249.
      Citations: 41     Fields:    Translation:Humans
    805. FitzGerald PM, Jankovic J, Glaze DG, Schultz R, Percy AK. Extrapyramidal involvement in Rett's syndrome. Neurology. 1990 Feb; 40(2):293-5. PMID: 2073236.
      Citations: 13     Fields:    Translation:Humans
    806. Jankovic J, Friedman DI, Pirozzolo FJ, McCrary JA. Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol. 1990; 53:293-304. PMID: 2239467.
      Citations: 5     Fields:    Translation:Humans
    807. FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov Disord. 1990; 5(3):195-202. PMID: 2388636.
      Citations: 37     Fields:    Translation:Humans
    808. Miller LG, Jankovic J. Sulpiride-induced tardive dystonia. Mov Disord. 1990; 5(1):83-4. PMID: 1967484.
      Citations: 4     Fields:    Translation:Humans
    809. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med. 1989 Nov; 149(11):2486-92. PMID: 2684075.
      Citations: 41     Fields:    Translation:Humans
    810. FitzGerald PM, Jankovic J. Tardive oculogyric crises. Neurology. 1989 Nov; 39(11):1434-7. PMID: 2573005.
      Citations: 10     Fields:    Translation:Humans
    811. Jankovic J, Grossman R, Goodman C, Pirozzolo F, Schneider L, Zhu Z, Scardino P, Garber AJ, Jhingran SG, Martin S. Clinical, biochemical, and neuropathologic findings following transplantation of adrenal medulla to the caudate nucleus for treatment of Parkinson's disease. Neurology. 1989 Sep; 39(9):1227-34. PMID: 2475820.
      Citations: 5     Fields:    Translation:Humans
    812. Dewey RB, Jankovic J. Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol. 1989 Aug; 46(8):862-7. PMID: 2757526.
      Citations: 60     Fields:    Translation:Humans
    813. Jankovic J, Shale H. Dystonia in musicians. Semin Neurol. 1989 Jun; 9(2):131-5. PMID: 2602695.
      Citations: 9     Fields:    Translation:Humans
    814. Jankovic J. Parkinsonism-plus syndromes. Mov Disord. 1989; 4 Suppl 1:S95-119. PMID: 2657411.
      Citations: 3     Fields:    Translation:Humans
    815. Jankovic J, Schwartz K, Vander Linden C. Comparison of Sinemet CR4 and standard Sinemet: double blind and long-term open trial in parkinsonian patients with fluctuations. Mov Disord. 1989; 4(4):303-9. PMID: 2682215.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    816. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord. 1989; 4(3):249-60. PMID: 2779595.
      Citations: 41     Fields:    Translation:Humans
    817. Jankovic J, Van der Linden C. Dystonia and tremor induced by peripheral trauma: predisposing factors. J Neurol Neurosurg Psychiatry. 1988 Dec; 51(12):1512-9. PMID: 3221219; PMCID: PMC1032766.
      Citations: 39     Fields:    Translation:Humans
    818. Jankovic J. Parkinson's disease: recent advances in therapy. South Med J. 1988 Aug; 81(8):1021-7. PMID: 3043683.
      Citations:    Fields:    Translation:Humans
    819. Jankovic J, Caskey TC, Stout JT, Butler IJ. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol. 1988 May; 23(5):466-9. PMID: 2455472.
      Citations: 15     Fields:    Translation:Humans
    820. Rosenbaum F, Jankovic J. Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology. 1988 Apr; 38(4):522-7. PMID: 3352903.
      Citations: 25     Fields:    Translation:Humans
    821. Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology. 1988 Mar; 38(3):391-4. PMID: 3279337.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    822. Jankovic J, Nutt JG. Blepharospasm and cranial-cervical dystonia (Meige's syndrome): familial occurrence. Adv Neurol. 1988; 49:117-23. PMID: 3344632.
      Citations: 4     Fields:    Translation:Humans
    823. Jankovic J. Cranial-cervical dyskinesias: an overview. Adv Neurol. 1988; 49:1-13. PMID: 3278534.
      Citations: 4     Fields:    Translation:Humans
    824. Jankovic J. Orofacial and other self-mutilations. Adv Neurol. 1988; 49:365-81. PMID: 3278547.
      Citations: 1     Fields:    Translation:Humans
    825. Jankovic J. Botulinum A toxin in the treatment of blepharospasm. Adv Neurol. 1988; 49:467-72. PMID: 3278552.
      Citations: 5     Fields:    Translation:Humans
    826. Jankovic J. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy. Adv Neurol. 1988; 50:583-91. PMID: 3041763.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    827. Percy AK, Zoghbi HY, Lewis KR, Jankovic J. Rett syndrome: qualitative and quantitative differentiation from autism. J Child Neurol. 1988; 3 Suppl:S65-7. PMID: 3198904.
      Citations: 10     Fields:    Translation:Humans
    828. Jankovic J, Armstrong D, Low NL, Goetz CG. Case 2, 1988. Congenital mental retardation and juvenile parkinsonism. Mov Disord. 1988; 3(4):352-61. PMID: 3211183.
      Citations:    Fields:    Translation:HumansCells
    829. Singh SK, Jankovic J. Tardive dystonia in patients with Tourette's syndrome. Mov Disord. 1988; 3(3):274-80. PMID: 2904122.
      Citations: 3     Fields:    Translation:Humans
    830. Jankovic J, Armstrong D, Low NL, Rapin I. Case 3, 1988. Progressive myoclonic epilepsy, dementia, and blindness in a young girl. Mov Disord. 1988; 3(4):362-9. PMID: 3145418.
      Citations:    Fields:    Translation:Humans
    831. Jankovic J. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol. 1988; 49:103-16. PMID: 3278535.
      Citations: 13     Fields:    Translation:Humans
    832. Jankovic J, Casabona J. Coexistent tardive dyskinesia and parkinsonism. Clin Neuropharmacol. 1987 Dec; 10(6):511-21. PMID: 2892586.
      Citations: 6     Fields:    Translation:Humans
    833. Jankovic J, Rohaidy H. Motor, behavioral and pharmacologic findings in Tourette's syndrome. Can J Neurol Sci. 1987 Aug; 14(3 Suppl):541-6. PMID: 2890426.
      Citations: 20     Fields:    Translation:Humans
    834. Little JT, Jankovic J. Tardive myoclonus. Mov Disord. 1987; 2(4):307-11. PMID: 3504556.
      Citations: 4     Fields:    Translation:Humans
    835. Jankovic J, Patten BM. Blepharospasm and autoimmune diseases. Mov Disord. 1987; 2(3):159-63. PMID: 3509774.
      Citations:    Fields:    Translation:Humans
    836. Gospe SM, Jankovic J. Drug-induced dystonia in neuronal ceroid-lipofuscinosis. Pediatr Neurol. 1986 Jul-Aug; 2(4):236-7. PMID: 3508694.
      Citations: 1     Fields:    Translation:Humans
    837. Jankovic J, Newmark M, Peter P. Parkinsonism and acquired hydrocephalus. Mov Disord. 1986; 1(1):59-64. PMID: 3504232.
      Citations: 6     Fields:    Translation:Humans
    838. Jankovic J, Fahn S. The phenomenology of tics. Mov Disord. 1986; 1(1):17-26. PMID: 3332803.
      Citations: 7     Fields:    Translation:Humans
    JANKOVIC's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (1433)
    Explore
    _
    Co-Authors (67)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _